var title_f39_19_40240="Gastric carcinoid Gross";
var content_f39_19_40240=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F74672&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F74672&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Gastric carcinoid",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 413px; height: 288px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Full thickness specimen of a gastric carcinoid demonstrates a typical ulcerated mucosal surface and yellowish submucosal cut surface.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     From Lewin KJ, Appelman HD. Tumors of the esophagus and stomach. Atlas of tumor pathology (electronic fascicle), Third series, fascicle 18, 1996, Washington, DC. Armed Forces Institute of Pathology.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f39_19_40240=[""].join("\n");
var outline_f39_19_40240=null;
var title_f39_19_40241="Port placement for laparoscopic radical cystectomy";
var content_f39_19_40241=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F55963&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F55963&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 498px\">",
"   <div class=\"ttl\">",
"    Port placement for laparoscopic radical cystectomy",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 478px; height: 581px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    For laparoscopic/robotic cystectomy, port placement is as shown in the figure. The camera port (12 mm, pink) is placed in the midline between the umbilicus and the xiphoid. The assistant uses ports, one placed lateral to the rectus muscle in the subcostal region (12 mm, purple) and the other placed superior to the iliac crest in the anterior axillary line (15 mm, brown). Three robotic ports (8 mm, green) are positioned at the same level, approximately 3 cm cephalad to the umbilicus.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f39_19_40241=[""].join("\n");
var outline_f39_19_40241=null;
var title_f39_19_40242="Hemangioma and angiokeratoma";
var content_f39_19_40242=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F66439&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F66439&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Dermoscopy of hemangioma and angiokeratoma",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 318px; height: 546px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    (A) Red lacunae seen in a hemangioma.",
"    <br>",
"     (B) Red, blue and black lacunae seen in an angiokeratoma.",
"     <div class=\"footnotes\">",
"     </div>",
"     <div class=\"reference\">",
"      Reproduced with permission from: Drs. Ashfaq Marghoob and Natalia Jaimes.",
"     </div>",
"    </br>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f39_19_40242=[""].join("\n");
var outline_f39_19_40242=null;
var title_f39_19_40243="Fibrous dysplasia";
var content_f39_19_40243=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F81627&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F81627&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Radiographic appearance of fibrous dysplasia in McCune-Albright syndrome",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 300px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A) A proximal femur with typical ground glass appearance and shepherd's crook deformity characteristic of fibrous dysplasia (FD) in a 10-year-old child. B) The appearance of FD in the femur of an untreated 40-year-old man demonstrates the tendency for FD to appear more sclerotic with time. C) The typical ground glass appearance of FD in the craniofacial region on a CT image of a 10-year-old child is shown. The white arrows indicate the optic nerves, which are typically encased with FD. D) A CT image in a 40-year-old woman demonstrates the typical appearance of craniofacial FD in an older person, with mixed solid and \"cystic\" lesions. The Hounsfield Unit measurements of \"cystic\" lesions are quite useful in distinguishing soft tissue \"cystic\" lesions from true fluid-filled cysts, which are much more uncommon and tend to behave aggressively with rapid expansion and compression of vital structures. E-G) Bone Scintigraphy in FD. Representative 99Tc-MDP bone scans which show tracer uptake at affected skeletal sites, and the associated skeletal disease burden score are shown. E) A 50-year-old woman with monostotic FD confined to a single focus involving contiguous bones in the craniofacial region. F) A 42-year-old man with polyostotic FD shows the tendency for FD to be predominantly (but not exclusively) unilateral, and to involve the skull base and proximal femur. G) A 16-year-old boy with McCune-Albright syndrome and involvement of virtually all skeletal sites (panostotic) is shown.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced from: Dumitrescu, CE, Collins, MT. McCune-Albright syndrome. Orphanet J Rare Dis 2008; 3:12. Copyright &copy;2008 BioMed Central Ltd.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f39_19_40243=[""].join("\n");
var outline_f39_19_40243=null;
var title_f39_19_40244="Fallots tetralogy PA";
var content_f39_19_40244=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F66743&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F66743&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic2\" style=\"width: 1040px;\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Fallot's tetralogy with Blalock-Taussig anastomosis to the right pulmonary artery",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 352px; height: 345px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAFZAWADASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD5zhsyxHy1ow6XuAyn863dO0wyYO35c/nXT2ejR7FAjK9OcmgDiYtHGR8nbpin/wBkAnhP513smjtCuSNw9s1XWxx05FAHHJoO4ZZcZ+tJP4Zm2l4IzKByQgJI+td0kMWQJUbA54rTsvsUTAxyFG980AeOTaa6sQ0f6GoDaED7uK90v/D2maspddsF0R98E7W9MiuT1fwde2Ry1v5iZ+8mSKAPNPs/sKPs/J45rqJ9JwSGTkHNQnTj/c6UAc+LYdl5qxFZ5x8tay2RA+7+dWI7UKRkfjQBRt7NVABUZrUtLVFxlafDBubdjgVfSPjGOlAFy0hTb90YrTSBGPC8VTsoyw9q07YEMVK5x1oAa1uAT8uTV7S53tHBxmPuPSkMbl8qM+wpSzxsGZAyDrjrQB2ukyR3UavHyO4rVjZRgHkDHeuO0++FuoMRKMOSvrWvDq8Vxwf3b8cGgDfKgEBQufTFN8pVJZlBfp05qhHO28HdyBxzVtLr5WDKSQM59aAB0VuDGCDwakgjRVIWMbcYAFRCZJc4O3ParMPchgT9aAHCJdhJVc847UBFzuZR06VYZPkOWA4qrI8anJbOOooAeAjHaFHpTJGt4znapI4qm8+MmM7QTk8mq7yLzuPJ5oAfcMJ3BZRj0rMvntreIlwuR2FUdU8Q29t8kbeY47D/ABridX1K5vuNzRp/dU0AY/jnXUuBLb2q/L03Dp0rzZ4gz5Yc+tdlqVplW4rl7iMpOw2nA79qAKwgUZ+UU7yF7qKmVaUjkGgCE28eB8oB+lILePnKirJpNvHSgCt9nTsg/Kk+yx5GVX8qskcdOKBkc0AVjaxc/u1/KkNpEf8Almv5VawetGOKAKTWkXaNc/Smm1jAyUX8qusuV46mmsvPNAFBraP+4PyqvNAoHC1ounXFVJxhTigD2vSrVVjQY6c/Wuit4CVO1DjA596ydMRs/KAQDwCK6e0ugqr5qbVzyQKAFhtDICskZKEYPtWZeaY9udygvF2OOldZa7JEJhYMPYYpbgx+S5kwqqMkgcigDhHhV+MUx7ZcYI/Kt66s0Z90fAwDwPUVWe3ZfvJkfTNAGXGJbd8xuwHpmuh0/WCUWO4wD05HBrLMJPAAP0FONsyjJUjtkrQBrXmiabqUbSCMRTN/Ep46+lc3qXhKa2JaD97H/sjmra3EtswZDle4rUstbTOJhtz6DigDgLix25VkZW9xiqjWpLBQD+Ar1eSxs7+NmSNCO5CYOfWsC58PtB88WX5/u9KAOLSHZ8oU1esbFpgCwIX+dbUWmCeYggqB1OK0ks9iAYAVRwaAMn7MsaYC7Vqe2hzuKHLYqeZ4YyVLZ49KZFLE5G1gp+lAEyb0YDBB96lWMyAFjtfJPHSnJxgcFR3qeDYzqD8o56CgCo1u6uCRnFNlyvLZDDFb9vgpglSPpVOeNckuuR6kUAUYNWmtvlGXXtuzxV+PxDGI28wFDjrgmqgELDa8Qx7jFVZ0t1RvkAGfSgDZh1SGRt6zde1a1neBwdrVxCpCPmCAnOOlbGl2wlJIUACgDrmuwATu57Vn3V9BCC00qjPXmsXUI3XiPO3vxisWYpuIB3HOOlAG7d69EqkQDe3bjisK81K7vN3zmNPRMimrb9WYEYPA6VOluePl/SgDJNsR94cnuRVeSEcDvjOK6V7fco+UY9SKzZ7Uwtggnjg4oA5fUoAI24964y8iJmYgd69A1OP5GOOcYxXH3sJDnj9KAMXZjPrTevFXZIuc4/Sq7R4znNAEZHHtRgetOK4HFIenNADevGaMcUvc4ox2oATGOtNPPApxpOwoAQ9OKacnrzTjz3ppz+FAETg4qnN905q6/cdvWqk2NpoA+gbJdg+VTj1rWQGWI4AyB24zVe2QCIADJqUrtfdG20+lAEkMrwMHjHPGa27eZLyMHBDdDWMjpKAJAEkH5GpbTMNwpySpoA0bmFmhO3krz9Biqqw5yeeexrXIjVC8hwCOMVAJbQMFZc59MUAUBZhnJwFwM5xUtxHshwRkHp6VtRLYGEyOJFHQAkc1Ez2DoVZm56dDQBx2oxLsLqMc8gCsK680DFuitJuUENwAM8n64zXa39tYOoRXkz16is3yLSJvlUMc/wAQoAzbF7mBleAHI9en411dpcJeeUsmEmI5wODWIQjEYUgelWrCIyMWRcHgbqANySxhddpQAg9QK53WrWeNGA+WEdx1P4V0dvMtvCd+SR/Ee1YOp6hAzMqTB19E5oA5O4wGwp/pSQY3YBP0NXrhrZ1+WLDepqkHeKYExfJ6pigDZW1dSroflqe2cmVVdQh9B0pthcCQAKTx61bkVSBgZ+goAsQLjzAOmc1GcnK444xU9qkZTBcqSe56moriOS3O5uQaAGSxBUCnBzzWTfKjMPlHHFaM9wpwQvpWRMwZjkNkmgBBGM4AA+tbmmowj9OayrW3eRsldqiuhggMcCiQ7T6GgDL1eXzJCmflyc4qCC3CgNt5POTVmdR5xCqCc5zVpbYLAN3TsPSgCi6gDIXc3pjioxLMBuEY2ikvriNCVZkRR6kVSW+h3ELcofqwFAGtb3KSEJINjHjI6Ut1b7oyGGB6+nvVOLZIMEbgehXFaNuhUeWW3oeh9KAON1WIxsysOf6YrmL2DcScV6HrliZYG+X51GRjvXITQf3h/wDWoA5mWLnBqpLF1PP0reu7X5iVFUZICTjFAGNLHgZ6VF5QzkAZ7mtp7bcDgZqu1mcZA4oAyivXikC1ota8nimG3IbgUAUMZpOccVdFqWfAViT2FXbfQr6cfu7aRvc8CgDEdWAbaOe2aagbYC4AbHIFdLJ4fmhGblkT2DBj+lVJdOjGQpYn3xQBhOCR71TmyAa2p7Uxkgjis26i+VzjFAH0XExCHB69MVKMcdwBVSNz0z1OOtOLuG9fWgC2FD9T9KkjDpIhLnaD0pkDfKp56USuxPBxmgC5dXLSnAbgcYqS3ihVfNuDiNRn73U+lVbWPzJACQc+v0qDWbvzJxHGf3MZO3pz05oAmv8AUjPIQvEY4UVTW5c9GPWqm7P3unpmpeqdhzmgCR5Gz3zSAhmbPXrSL8232NaNhaiRzK4HHGe59qAILaDcCWzt6jmtWOWK0tUMrfgMZP4VDqM8dmgXhnx0zwv1rnZ7yScBpG3EelAEuuatJLavHGSien/164tLySKQMHOM9K6Ft0jY7+9Y1zp8iktuTB7k0AX7a6W4QkE5A6GrcPOCODWJbo0YyrYb1rVsyxIBZSx96ANKBQkgdDtatNZj5YyM59KoQxkDIBODj6VaibLgDOc80AacIiMYcFhn+H3pZJCRjsetJbp+6O4DNS+WCwA+n0oAoTxoELFR+BqkSMACMZzWhe5BxVI9wvHpQA+2OZQXP5VpztuZ2LnaMk8VRtowXGQCas3YHluBjpQBUSZRK2FNQ6rffZrfajHzH69OBQoZAWOM9hWdfWsk+XlIGPzoA5jUp2eRizH1OaobjnI4rcnsot3IY/Q1XSwiZCdzgg9KAK1rqNzbEeVIQB2PIrr9D1yC7KwzfupOOWIAJrlDprj5ldce9AtpYXDbc47gUAepyWkd1AsnfvXIa1pRtrmTg+WeQfwro/Bt/LPaeROhO3gZ7cVu6jpAubcEuu08delAHk8lkrg8dBVGTTfmyiswNekPoEUGN7M4J45qeG3ihGERF46k0Aed22hXdxhVhIz3JArTt/BbPg3MoQe2M9a6q71C2tFYyy7sfwoRmsO88VMuUtoAATwSck/pQBF/whenKP3ksrn2I/wph0TR7Q5EagjvIRWdPrmo3DHbIEX0AFUpYprlg00jMaANaXUNOsxiLazf9MgDVC614Of3aOFHr9Kg+wBRkg5NIbUAetAEU2oLMGDx5J68CqM6ROSU49q1BZF2yozVhdElfqQoHvQByV3AGAA561k3lg5jY7DXoo0qG3BJLO/qTxWPqluNjAnqKAO4jIPA65qZu2OMe9Z1vKNgXOTVtX2xl3yEUUAXraYeUN+NwNSqA7Aghs9axLK4aa4YMSC3T2rbhXaox1+tAFueVbS0ZUwXYYJz0GKwGG9ick/jV7UH42r27VUiBIOefSgAVPXHPvUijv059aF4+9n8amjBwMjigCS0i82RQvTua2pZUs7IsMB8YT/Go9Ptyuw4wz/yqhrkwMpQZITgenWgDDv5XmY4yfemW2AgAUk561XudRhi6NvYfwjp+dZsmpyyN8nyKewPNAGxs+c5dEU+rYqq09vuKbwxPpWQZHMm5nY+5JpSdr71HGOmaALXnwAsrKw96WG4g84EORiqjuGV8c5HJqkjeW2V5oA7zTrtdirkMQOorU+V8EjJPNcNZ3Ukcy7VOR3zXTQXbMikja3WgDoLeNHG08HtU6xMpJUgiqVpch4kOMN0q6GPl7FHXnigDHvGZnb5enFVwJPugDBPYVpOvPzjd65oXavCCgBbS2beBkep/KpJyiKVIBIqS36k88+9Q37JDH7t60AVQAzZOMk1BqEixZ2gOemM8CoWuTuO3IxnvSojy9ec0AZUsrs3+rQAdsU4OiIN1vEw6nrWk1kxQuRtHvVKS2LEhHyQeaAGJeQbsfZwvuDmrsN1HKMQlfTHSsO8jEA+Zgx9Bms6W6uQ48uIj0KmgD0TS49hL9MnGa2VuhHC2XDgdVB68V55pl/cQwos0jsW5wSeK6C1v4inykqfSgDeuLlGj3Rr8rj16Vz2oRySSMu7Ye2Dwa17SZHUqRgEevT3qG+tjja3/AWzQByd7p8ygsRkdcg5rLktWLdAa60O0RIyQwJB5xTxdHgSgMP9oZoA5KKyZnHHetyy0obQ8mMHsDWg01tkb4VLezYratha3Kr5J2jbznnB9KAMN9MhK42j8TWbJbCM+grsL6x8pVCyxgEZxmsZ7CTYcsCD3BoAyQqqeOvpT/KkkOEHP1q6LQE7VyMVHd3UdvmOMbm+vSgCrLYgKDJg9c84rA1mGBYZMsmcf3quzzyzMd8jY54yaxtSjzG4AJ/GgDctF3S8dM8cU29uPMby4j+6GMkdzT5pPs1sRz5zgYGOgqlbg7eQCKALulxk3sQwcf8A1q6FPlbGcjPasrSI/wDSC3YD0rUVT8pJPHOBnFAFO9JZjjIJ4Bpsedg34Bptw/zEHOc8YFPTH5UAOUbh3J61oabBvkUsMr1+tQWtv5kmSSEUcn1rXs9kRZ5OIwOOKALskqW1u8rHaqjg155reoyTyOEO2MnqOp5rpNVupbpHQEhOwHSuWubYFD5nP04oAxgGbgZP0FNWCZjlEYfhWnCjLxHFgZ7CmTMkLDzZQD6daAKgs2UDzZMA9MDNWFtkHDOxFPe4tiucsffFVG1BA/EZ46UAWmslAbY2CRxmqsenuWZmOe1Xlv7dosmNkYjr1qL7bANyiUjnuKAEgjaMhSD9fxrpbK1digBGDWFDMsjKQwIzXSaWxIQE49DQBfggaNTyeO1XYd2CcYOODSomOZPujnkdach4x+mKAGsqsCMZx3NRKnOSe9SYLMu4YzT/ACsPgHA96AJYIhsz2qveWxnwrccHHtV+LCgLn86r3ZdmbHCigDG/s7y3zuDZ9BV63jSKIBQSfWpCVRcs3GKqy3OQREMH1oAjvrhIom3sAa5m71CJSdshAz2B5qbVN7yEMxOfX61g34CAKecnFAEl7eQSEFmcHNTWU1sxAWcFvQgjFYM5J2jrxnNOgZVUtQB2KxBlUsN4I4IqOWNo1LI7ewPFYunX8sTgI52DoueK1JNUt5W8qb5D/e7UAXdO1OWBwJMlffNdxZPFfWvDBsA4Pf6V58oH3kdXToDWxo969s6sjFecY7UAaeq2WwiRBxnnFY7KQxyTXbzxxzxE4BR+SBXK3tu0Mx4+QnigDOAwSxHPSnwXEkbEK7KPY0SLzn2qKLOeSMZ9O1AGwskl/bZ3t50WB35HrTYXliUKxOO+e1VtPlaG6Qg5UjBHqCKu3UYQ5BOw8igBbxhFbtIpDFuP0rn5Yi4JPDfnWnPIWhKMcrn9apsyq3qfSgDP+zMVO0cYzWXqeY4H24Mh6fStp2kdSFJUHr9KydSVVR8cn0xQBHFcG7mkl7FvlB9PSriLkqO3pWTYhkC4XjvmtiFvp0FAGvpanDnHOAKvIzGIF1CseoHSq1gCsDMABnHapnf5D0oApt97P9amiUvhcHJqMjL5I4rT0yItI52ghRx9aALMMRHyJjav3jVG+vAZ9q/dBx7Ve1B1trXA+8/Oa5W9ulhYGTluwFAG0SWXc5AHc9hWDqF1HBKwUFm7ZHFNS9Nz98/8BFRXSGZSAo3duOaAM+7vJpAVyAD2Xis5iQ2cc+471p/ZJSw3KFPTrmlXT1lba75b6UAZ1s2WKtnH0qEphiQD05zW1HYiN/8AVq3uaPLQybFhX15HNAGY4Jt8kcD0qsy7nAHToBXS3ELGFVWNcHsQKqz20bqMxhW74FAGLGvzgnPFdPot07Rou7oePzrMjshvOzgAVs6dYn5SoUAenFAHW6ezSRAt1HB96klfYQMdPSoLEFUXofpT7jhs9c+lAE24j5lyT706NtxBOeaqrJx905Izg8Vct8kAjHbj0oAsnITvVS7J247HvVwKWXGOagniOMNxn9aAMt88E81EctnA71pC3Xv/APrpxVY/uoM9uKAOavomcsdp4Fcjq6yvMqhCAB2rvNSVnWQkZPSuI1dEjuTufHHr70AULiKXy1AjOcZ6jmqFvFOCcoa33aIxLtcZKjNRpb5G8Y2joARQBkQPNGDuGCemRVkOSpLYDd6mlTLgkEfyppgDuSwBPXIoAks7iW1clCOeqnkGun0u5S6XEfyvjJU1zAs+Mq2T6EVZgSSGVQRtJPFAHqemXJjjjR+RjB4p9/bCQscfu25z6Vg6ZqGdqOOegbFdBZTh3aNgDk4IoA524g8uRgeoqDZwCB+ldDq1oQDJgDHBrEcY+9xzigCJUO9duBWiymayXHLIcHPpWfwH65YVftm8uM8ZByDQBmTqSSM45qFExkkCtC5iBPynjPWqF2RApZj2xQBBPkHgDHpWJqZIR8j16VpifzVz/Ks3VP8AUt260AVLHGwcfmK0YzyDisuyfKcg1pI+cZHOKAOhtZALVB68053XOMfWs+KUII1OcYq0pzjHQ9xQBIoGetdDpcJitQW+85z+FZFhDvfJ+4tdDC2IVZ+wJAoA57xZdi3ncHhgPkXj0FcU3mXE247iSeWNdH4nH2jUTK/IOCB6cVmKoODngmgBltarFLvbJ9cVpDGOAAMY4FU57iCDln3sP4QRVU6pMrkKcL2wOlAGjP5SD5mC57nrWPNfpE3yIXP4CpZL1mHzndnuKquI5PmHQdaAF+3zvzEiqPTFSxXskUgkmKYzz8o9KpDKptIyPUVJJiYIMZJFAGxeag7bfLKev3Rk1Vl1BlBWWNGPc4qGy2+Ywc5xwMdaZqEeRmPIz6igC5BdwNKQgK5/vVu2JUr8p+X1rjod/wApKk5rf0qR0wcnnjFAHWWSudrLyuf0qwzKJCCoIz2FVtOQ4y2eafI53YY0AWzFGXDFF+tWkUKPlUAVTtn5IJycVdQgrgdaAJYxt3AnJPTpxVd0wSW61P04PSorjBZRQBGrJ1HNU7uY5GwY96tMoUHHJ55qAICcgMSaAOd1QyOjb2P07da4PW4Cl4AehH9a9S1CAtGx2n8BXBeJLZkfzMMQOOnvQBk2MW+UbSCBTr1dzYhHyqO1TWpW3gZyp3P0zVWC8ljOBxu6igBkDOMFc59DVu3u2X/XqCvIOOtRR/upMsOMYxTdoJDA8e9AGvFc29wSIiBj1xzWnaxfxSjI7AiuYtUVl3MvyhjyOO9bum37iUrIQ0fb2FAG2qDYNhIPpmn6TqDW91iXO3d+VNSVXizE24Ht3FRrtY4fqOlAHfOY7m2SQEFZFwcGuZuo/KcqenrmtTw3OPsRglb5M/KeOOak1W3DHBPvQBgYwwwR71YVeOnAFNGAQeTk44qcYVTyTnigCrNGOeTgc1h6lJvkKg5Arcu2227nPPY1zVycsSCcUAVWYxtk9Ki1Q/uDtPGKfcnIJHOO9QSyCSxYE/MooArWX3f6VeWVgQfpWXaNiP19amEpEm7PA/WgDVkuNq5zgAdc1Lpd8zHbIT14NYV1eA4jXj1wasaU2+5iXtnP6UAei2UW2NIwScgMfy6VceXKsQegwPaqukMZojI2QQrAfl1qtc3AjYx5PGSTmgDP1NNzsCRxzk9BXNXV0wOyAEHpv9a2764+0AomSo756/WsSeHk+Xww9O9AFRQSxJyfXNEqsoXnIPSrMUU2cyDBHciphHHzkFn6/NQBnxgk7WGAegqaK1mY/LgD34rRyAigL8wHQU9VYje+1QD1bj/9dAFO309txEjjHtWnDoiJCX81vpUA1SCBjt+fnsDUia0JYchXIz1JxQBLFpVtHJlX6+pq7JpkPlNwG64rLF/ExICHOc/eyP5VYTVRjaqlh060AIdMEiYGAe2as6fpbxuXZs0JqEbMuFKt69a1bWdGiLDJ9D6UAXIQyQKCcPUcqHcpJzmnQM8pGMkdPapByx4BHpmgBIc7h8wANaEDD7oGTVZNu8fJg1ZjYA9Bwe1AE4yw4xn0oZCX5IqQbTGdp5NRhSJgPzoAaY8Dj8ajUEZ6d6knkC8VVkmfqCQKAFdSyEMRg1zOu2IkjkwcY6Z+tbmZS2Nx21l6lG5aQBuoz3oA4yZgB904AohjgUCQg8VmyidZHUuxYH7pY4xU9o7hP3rFgPXNAFm6RJWG1Bg89Pao/s+CAc/SrKXaswTadx70+e6SJAEUls9/SgCA2jgkqwPFJGrIQGGD/OpxJ5uASB3qTZsTk8e9AEUdw8U2YmwehrZs7hJshsI/uetYPloTwpBz71dgR3ZeuB6GgDt9L+SABs49K1GJngBPLLx9a57SbobBHKSGGMEnrW1bTbJ14yuORmgChdQhJgR0YUOfk45Iq9ewt5bAjJUhgR3FZ/PTn60AZ+q58kKaymQ8k961r8lpsHsKoSR8dBigDNuIjg+grJkOyRlI4YYrbuDgcDIrn9WYopI4I5FAFC1mGMfnUskqxozY+YdOaxrOfGTnqakM3nyDaflFAFqJSzAtyT1NdBoUJkv4kC9jk/hWJApJHUe9df4YhSFftD8sSVB9sUAddp5WJXQN8ojIOT04rj9e1DzbgpCWEan3+Y10t47W1kixjMswyx9FI6VzFxCkUpYDOeQf8KAH2SvKMsdnHTvVx4I1wyrg9M+tU7eQq24gEAc54FWZr2M7fLyc9+eKAIZ4lIyHAPvms2eUoSSpY+o71ekZ5GG05z6ioZlWME5zx0IoAoy3MhUKBtJGaYvmkEsXYDjDGlJUsTv7VGs7Ku1F4I6d6AL1rpjTJukI9cVW+wSxOEYnDHjFNju7pGUor7ffNbEHzJGzEFs55zQBY07SomhYOORzyaguIIluWWD72M7e9asMjIhKn9O9UCX+1s/4ZoAzpEeJickc+9bGnPtQFWPNOuo1MYO0DrTrKLbCDjpQBr2ZbkjIHerkaEuCKqWHOACMZrSwAvy544oAFUjAHJpynnA5br06UsfJGOTmnhQGzj/GgCZQQTg8DtQ7jfkHnHelbjpUTqS4JGcflQASoG5wRjn61Xb72e3YVbIJUc9qgJUnk0ARhfmwQNtUtUtzsDqPb/61aMZUOB1zU8sayRlCAQfagDyjXrRoboPGvyuMk88H0qg7KE2g7c9TzzXo+u6WjWwi2jPc4riLzTmidVmGFHIOOtAGYsyqA33iOlSvE8yGSQhB9akazVMbU5+tMa2l2febGeARQBEtyEYAAnHGQcVeW/3DymwV96pNauGJEe8HjgU4W+MMwKjnqKANSALIRsXPPI9K1bJAoxtPPrWRaxsmGQnb61rWk64GT360AXXTyjuXn29KvabeGR9jH5x0PrVSSVSMrgk8VAEMLBoyR6HFAHdMheGJuvy7TWFINjMOnPIrY0Of7VpwDn5l4PvWbq6CN5HGfX6cUAYtyytKTnrVebkev40suTn1zUMrdfTFAFS6HGc/hXK6zKArr14rodRmCqSScgH1rkdVl3qxJ6k0ActHcn/Vr1NbNgMhf1rmdN5fJ55FdTp/GOKANeAcZ9O1dtpsG5LKPHGxSQB1JGa4uDoM4r0zQYVEUFwQMhBj8qAE1jC5PAOQOOwxXO3u1I2eU4GDj3PtWjrE5ivJzKPkTpz1z0Fcxe3T3MrNtwMYAHagCCS7knkwcKg6AVPaTFHOenrVKOMiXKjd2xV6KI4JmxgfwigC39oOR5a5Y+lMaKWTlzgk8DGaaJPL2iNRj61Ik6r8xPB9e1ACrbLszIOO5PemrGmGKgAY44pk12CoKLk9OahjmmmZUChR6igCaWNyhUjPHGauaTbhYz58owDnAGaoQyKXOfnJPUitLTXaVyGTA9qANgiORTs3AAdAKr+dHFuYpk46HtVuFkh3AKOazrnEkkm0gEHpigAa8WVF3oBuOMitSxCmEbSCPWubiV5LrYuAozkdq6O2QhEJUYHp3oA1LT5VYbRj2FXRgMAcc81RtGYH1Here7PJoAmRQD3wakUgMMCo0J2ipE+8cgYoAmUFh0FGAWIOAetNGecU3cAxyOSKAG3D7UJPes+WUjIVQM1ckBOc8455qpMmcYHX9aAGwSsByBkeoq5FM2D938qz8eXkgE+9WbVtoO4ZHrigCxfv5sYOxScc8Vy93bmdMSxgD6V08jptG09eeO9Zs8JDA5oA4a6tpImJU7l+nQVAJyzYIGB/dHNdfdWqNnCc59Kwb/TsF/lAHXIoAW0TzGR8AKOfrTboh5C2xSOcCskmWxUsrbsevapI9SEo2sAPfofpQBcIJRedp7e1QNIUbBByO46VajeOcAbQGA7UeQxOVIIPbrmgCzpd0DhWbvjJHStYpn1K4xwK5w27I37sc56Yrd0GdppPJk7fdoA6TQCbc4IOMAc1Pq6BhIMcYz+lMgQqgIAyKkuG8yIMRz9w/lQBylwBk44P/wBaqM5IzgcYPatG+Vo5ZFIzg4rHuZ9quufxoAxtSlBzyBjP41zV+co5JFX7+53zMgx3rIviBE3Iye+KAOa00fOOO9dXYDIFcpp3Ue1dTYHgevFAG1bqWdEUck4Feq6bHusbaCPBdUC4HcgV5x4ai83V7ZCM8kkfga77w9dbHnkduFzt6elAHJ/EO5dL2MRH92mAeBy2OaoaRH9oj3Pnp+daOqWv2p5XmAKk/Lz+tZto7WcrIQQvT/69AGhLajBMS4Aqq/yEhvxq9JOjIdjZfsQeKypmHmgsDknFACmfcSsQOAOeM1WlBkcHBYjpU8QJJ8rCnGc5obJztO7HPHNAEKscAbvmGBT1nIHoBx0qWOEsQxAU+uKngsoM5bcwHoaAHW06vgBAT3IFb9jC7QZjTHP41DpcFuqFhDxn0rXtZwjFTwvpQBWkDblBXGOtZF2HaY+UCuTW+00ZZywUAetVZwjsMEBOvFAEGkWB3bpFIYn+tbTQmMLtz9KjsWVXB3BhWnIEdc46UAV7TjOOeaugDGSOKhiRB0P196tALgccUANTOQM8VMp+fHamRsnTacfSl3A4xxxigCQde2Kaw+ck9h65qUAHJwcCkCjk9DigCJl+UjHPXNQOgK4YCrEjBRx+IqpLISV7CgB5jUjGKR1CdeQe4qIzDpj8O1K0u4n5VwaAJmVSPlGBUXkByAc0RS4JUrgH0pmQrgbsZ/GgBkloq9H78GqF3YFlO1dy+1aDklM5/Wo0cKM5xzQBzNzpW7K7D9DWJqOklVJjUhuor0GVFk55z6Gsa5slQvhm74BoA4VZJrST94CMda1tNu1m6HDZFX7/AE5JYBuA/wB4VzMsbWdyF+br8poA6rLysGAPHHbNXLO32sHQZYdQKyNIuwSFkbknGa6YqYlUqRnAwQeKANK1nDxZBHy/zqW3UvbynPfNc7NcfZZlkU/IxwR6V02lgS2crAZDIcflQBga2NtzL6HHP4VxWs3BSTAUkMD82RgHiuv8SSbZ3zjOB0+lef69Jk5X0NAGK7/vST1zmqWpSfuG96cz89eKoX0m48UAZ+nkhua6fT3wBk9RzXJWjYYdq6fT3J25x2oA7Xwic6vEdw4Vj9flNdnp0I/s+4OcADJ5rjPCef7Tjz/dPfrwa9Htotlg8Snl1JPuSKAORkm89iQQCeo6/hWFrDFASjruHWpNQvvskrKrASueFz0HrWa26ZyScgjp70AVbW/ePKb8g1rxyiWLA+bnHBrJXT2V/m+UHoB1rYsY1hI2Oox1GaAJTbowHmMy564q3HZxxw7vMKr1AzUtt5A3b25I55qvcXa7SsYDKOhPFADvPhUAAMfbPNRfb9h2KNoPp1rPaSVs44Gewq1ZxpvVm5bHr0oA17HUCiBI1KNnJPWnzTPI37xyVzk1mI7CQDgKOadLOc4Cn5sA0AOlnbkRnJJyeavWbblUOSfeoFiXySy/eNaVhbkNuYcdqANC0AA9/WtNHGPvcGqflESEdPTmrKdMN0oAtREZB4x7GrB2lQBzjkVUtipYgHIzmrfTAz9cUASRtkAA0rH1OKYnselOzuOG9OaAJVbj72T1xQ7ZY9AMHNJj3prNgjPUg45oAryE7zjoDUEuRkn+dW2XIYk1BKoZTnvQBVGMMSfwpVzux3zxzUiKFXPbvzTgq7vlNACsCh4P1qvICGLZyDVySPI46/SoHixt6EelAEAP91sfWoA7ruy2Qe9TbGG7cAKjlGc7evtQA1JsHgnPvTpBvGVz9TULZHDY9c1EZWQgKeKAHmNTw5wTzVG/06G5VtnHbPetJJlYDIyKML8zDqKAONeyeylIZsjPBFaVlqqYWKVgF7Mx6Gruo/vY2RsYIriLgNng/KtAHXTMJCQRgHiuo8KzY0uZZDnYdo57Y4ridJuxeW6xsxV1AGQRkiu/8LRbdOlB4Jzj3GKAOW8WkJeTAdMAgeny153rjYXGeMdq9F8YYNwzAjJH8hXnOucg5x0oA5kyjcQSOtUXfLOSfpT5X2yN+NVt2d3vQBVtzhh9a6TTD0H0rmYj81dDpLdPbFAHofg1PM1e1U9Mnkn2NenNtVZZG4RRk/QV5p4L41BZP7iZFeg6i+dBkYfelbA7nGKAPGtcaSXWZ3HLFsj2Fa+m7Vh+Xk9c0up2KqRIoG7oxqvaSGFyBjZ+lAF6aMTBieD25qoGFuRuOW/nVyS5gSMiPJJqlIqzruPBXtjpQA/7eruEf5R60oaKRiNxxnoKoG1kEhP8B5q/Bb4UFjj+tAF1UQJnI2DH400l3fEKNtxjOOKesJJGCdvGM1oCQQxKAmeaAI49OmS2EjLgH171bsbVJosOvzehPSpY7nzoCk83lxgfjUVnP5UmFHynkMe9AEt3H9mQALg5zgVq2kmVB7dqxtSleWMkvtbHGBTLG4k8g/OxPQ80AdVGN7ZyDinOMYwwFZOnSFlyxxkY6+9aBzkckr0x+NAFi1X5ic85zxV8A7cjj1qhanMmAcHtWlhQACc8UAQmZFkjU79zA4wpI49TjA/GrAK8EHio9il+R+VTIi7c4AoAAeoGfwpVAJJzjg9aUAcYwKMBQeRQBG6gZYmqs8qgA9zU0rDByf8A61UJWDNzkjp6UANMu7IAOBU8MigEdR1+lVPlUgVLkxLzn1+tAFsSqx5OMVGsqscfez6GogNwBHXFVuVb+7+lAF+QgLyBiqnAfLLlfanwz7/kfAFMnyrEAnFAEdyUZ2KKcH0qlKuCMfjVt3AzyKhmUHhjkH1oAhyEwwOB3pjz4bjj6UTwtncjZH92s2d2R/mOB0PHSgCzIwdWbdkd8mub1KMeaNp6+1abzCPJY/Kf15qhdMspXBBJ9qAK2jgxX8Tp9zPzCvXtJ2LCAp+QoSD7ba830my8l1aTJDdcjpXomhMG08bhnaCpJHbHAoA5DxUuAMjk579K861kY3ZzXpXjMBZsA8AdK8x1lgVYg8etAHGXrbZie2TVbdhT3qa+OXOO1VGY7WKmgBqcGtvSX6AdOKxBWrpJ+ce+KAPVPBQy1w2ekdd6z/8AFNxHI3biB+QrgvA5y0ygfeiHX613uo5h0SBPqD9cUAcZqMS+U5bGD/hXIXt0Im8tAOc5zXT6vcZVoUBL9TXJX0TlvMAJJPNAD7K4bftflT61swr9oYBQQOgxWLZQbgC/Q9K6KwYWqK0ijA5BFAFo6cEC7s7z+VDW6xrl2JPX6VJFqG8F1UknpuFV5Xd2Zyyr7CgCWE7sKp9Ogq1EgV+XG/1NZaO2CQTk9KV0lBU4CqR170ASSXJEpAYcHv6VoZ/dK4bdkcYHtWFyjFERWYnOTVyW8khtFChc9/QDFAEsk7ZCSHrTrG4IkdA3X9elUILgSbX2Bju64yKvRbUuxKsYVW4x6UAdNZbY4wrkZHQ1cXgDk/5NVLfEjAqAR/Sr7xsqrgDHagCe0BLZJyQa0M5AIrOs8b8+hrSGdlABnDKcEVOMbMHjmq/Ixj+H1qUZz7UAPXAHHX+dB5Un2NI27byBRncGx/KgCnJ0PNU5WO/GK0HTnrzVKQDzGyAaAIcLjceDnpSvkkck8cU8qC/TrzikkRt2QfwoAUPsQY5OcVG7ZHOPahsrt9KicEAEjmgBSwAG0c96kMuVBfIXpVYsTjjH0odwSUyDgelABOh5MfIqvv4+cEGjz3gcgcqB3okkD84HIoAchwykHjPPpVW9CuxbOR9KjMhRuD/FQrbyewoAy76JgOOR6ispHFtKpkbJ7LiumljRgy4zn2rmdUUx3HH3Mc0AdNburwpJnarKDnFdd4YZn0S6kI4DAfTivMdGv3knW3I+Q/cP4V6x4ciMehSx/wB9d5474oA4/wAanF4xH9wdfpXmWtt8rc/iK9K8ZtmVW6ZX+leX62/DZ96AOOvQN5PvVRjhT2qzdt85981VkP7s8UAHOPetLTOJB25FZ3bk1c04/vRg0AetfD0b9UjTg7kP6c13/iqUQeHPPYLhJc5x14rz34bsBqkbseFQ/qCK7vxjsm0AWvQyNv8A0oA8yhujcO0j9T1B9astbZALbQh7VlWP7qQu5G3PANbiSbwN3XvQBVmWK1wMZA6HHWmmXzVCsCsY6inXaiRiegHTpisq4ucEop70Aaf28W5KQqCPQ9qmSZpsHA+lYsWJEXIJYHoO9aVta3jqpiiIz3NAGlaLwWYn6VDfSh2yGO3oa17TR5niQO/JA3ACp4vDC7gJGcg+pFAHMxSNNtSMED1NWLixaVPKcja3Bx3Fdfb+G7SNSGyc/pReaRbIAItzN069KAOWkiWKNYYwFYd8c1aTasRDOMD05rWbRIpAN6t6cGpRpsNuxVV4A54BoAfpLozBmLk4yBjHetj7RhgTyD61QtrYQrkcAd6n527uOKANK3ZWyQAKuxjIbjjFZNm3zqDWsrDoOB60AMMXOQTzSxR/Nx0pc8c9e1AJDjvQBYI2tx19aUjk9vwqMn0p6uMOOvHagCpcPj6c1Ta4xkYFS3mCD171Q4I4P5UATCYlssBx6U2ObO7fjcScY9M8fjioPu5JPA7U1nG07TzxQBbd16ACmo24nIGPeqTsWG4KSfQVGoudvKMR7CgCy6AKxboeBioZU2jKkH61KBKYwTG35VFJuCgMjHuOKAIpAWXjiquSCwzgdqs5ySPbGKrOoRsL1FACLHvLAffHYVFE+JNrdQaV7hUYBiFY9+KxtQ1BI0fccMvHHegCzqd+kJZc/N344rEkk89sH7pOQSKxTeSXFzukbAzxn0q9CxM6gc/3QOpoAvaZbOl7ERyindn0r2rR336I0vdo8Y+orzKytlSBSQNxGS3vXfeG3z4YcZ5WbBOfagDjfGBw4X0WvL9cblvpXpnjhgt/KmT8oHT6V5XrjjcwoA5u4znmqkv3DzVubBJwc1UnH7tqAHirFi2JV571XHTJqa2+/wCnvQB6l4GfH2hgSCEXkH3ruvELecbZM/8ALJD+a5/rXnnghz5FwAedq8n8a7vUpf3UT5y4RVH4KP8ACgDhdYh2XL4JQE5BwP60lvdqu5G5PatDXsyW+VxleefTFcqBJPNshOCO9AGvczYTCnJ9uatab4fub8gyIUjBznPNavhnS1wGk+Z/U12kMCqqiME+9AGBY6RDa/KqDeP4j1rZtrT5dzcntWilsu/LHLGkc4fAJ+XsKAIoYwh2jv1Jp8h+bPce9G4n68UFScE9KAHRZIJyefeoSuWJI71aG0R8dc801YztLA9+9AEMa8nr0pu35yB096upCx9MdKVYQpHViaAKhRm+XHGelN8oqxABq/tw2c/maRY95PoaAIbdPnBPWtAKMAZBqOKIBs9O/WrKA44HtQBA68jnPHT+tIBgg54xxUzhlOeKjIbaMEbjQBK/I3d6YzfKSD2p4D9GNO8sDcD09KAMy4JYkevpVdomC8VoXCKD0x61GApI55FAFVLcvjNTLbIoyRyfXtVkEAEZwe9MluVVCEI3fWgCMBUG0nGfWo5LqGMdTn0Heqj3Bc5z0qhKGLDoR60Aaf8AaCDJwcUq3yMu0j6VhSOSuARgU5GO0c4oA6ITQSrlwoP51VudMtpgXiYqxzjB71nxSY64NStdiNcls8cAGgDB1yxuYFLgBsZ5FcFqVxJJO4YkBeoPevVfNa7YLIe9ZeseGIr1CRw/ZhQB5pEMlQvOa39IwWUNw6+vpUN1pkmlSFJRnn7341Gbny3UggYoA7C2mAjOSMn7ozXdeHwU8NuD99m8w5ryvR7hri6VSeG6CvV9L+XSpQTgImQaAOC8cn/iY3DZ6hR/46K8r1tsynOa9K8byFrl2DckA/pXl2rMTKeaAMiQ5Y1VuM7Gqw+F71Xuc7W5oAfT4vvjHrTOtKhw44oA9F8CzKGlU91B/Wu41qTy4rRuzJivNvBcuLxQecjGPwr0TxIW/sqEgHKAdPpQBgSg3UxQDK9zntVzTtJFvKwVQF6jmpdAt/NVWZTkj5u/aunjsligVIlxt+VR6D0oAr2cXZecDP0rfs/9WM8tVO3hIGVznvVnO0rj7xoAuEDsahkTk5zzTlbIJIOfSndwWxmgCBAOCRipT2/CnYGD3xzUiJnBYdOKAGRgkAdqmSMAEGnKMDjH0oLHAGc5oAV2x0zTHDP1OPpTlbJxjpQxLHIoAj2jJ4/Wm5I4HFS4B/PpSOO5oAfA2Tz1zVyJTnOf1qnBjIzn1q4o+XvQA18bc4yKRQO3bmnD73PX0pCMYNABjPBweak2nkkAYqPJBx2FKDkHOenegCreck4FQRLwCwGKsTEFs4yahkYrFuA9qAKt5JtJUEZ9c1lSyAZzx+NXLlsckZz71QuPnz/OgBizMMljwTSi4DKRjP41Wcn7pHFMjyOAM5HrQBK6IWxjimMhQev9KRWO7OOPrUwO5cAfjQBD5hRT3+lVtzGQk4Jq5JESDjI/rVXaykg8GgDQtPnkUrgZOTW9alGQKwGBXO2r7SCRkVeS6C5P3fbNADtd06K4t3DqNvb868n1ezktLjnIj6c17LHN50WG5x71z/iDSlni3BM/SgDiPCj4v1dhkJ/hXr+nOG0i6YHgxt/KvKLexk0252SA/PyDXpmiTh/Dec9fk/SgDz/xfIPNJ/2R0+leY6m+Z3x2r0XxlIBPIB0AH8q8zv3DOx5oAptzyTVW74jODzVtunFVLriJqAJARihic/LyaB09qO4NAHTeE5vL1CAnpuGa9euYln0weZggtgCvFdAk2XkX1Fex2dyH0qMnr5m0j6CgCPSC1vIAeFziuutVDLnFcysQ84AcBua6GzYpEFz06UASygoTtHXtijgdvpUxAZSc1XK4PzZPpQBIrcAkVMjbl4PPoKiXlRjv2qeNMDPfvQA9egBOWxn6VIWAHB5qINnOKQ5ODg8HgUASgkE9zSjkcUwHvTkJ74oAcB3zwad754+lGOfenbeMDPrQAwdATxSOOeKlKd1+uMUhHQn+VABGpH+FW0woGTkVAuc8VOBlfmoAY5HHI596QsAO1NkwpAPBPAo25XOSD9KAF3Aj3pyN1BqoC3ms2coGwOKuBfl/WgCCReCePWq9yuY1weasSMGcqCQADmo0AZTySM8GgDMlj+U/pxVJkznjkccV0LRDaT1qBrVS2QtAGLHpzSEFgcGrUemouCwP41rIu0DPUcUMuSBg4oAx5bGPkhMClS0hVOFwa0TEFYkk4PT0FAiXoRx0yaAKK2Y2cfNk96p3Om9ShIb0rdUBH29R2qQqjKc4z2oA45keFiGU8VHvJbqcGuivrUMpLLxWDdQmJ8jOP5UAX9OlBfAJ4OMGthIllxkZUc1zli7B8Dqa6mHKwrjrjtQBx/i2xPll04ZOenapvCkzSeGW3E5+0cD22itDxCm+IDdknqKoaci2umvApwBhx9TQBwXjmTZfXKjtj+VedXLZc123jibdfXBHdv6Vwsx+fNADDVW6P7lvpVk81Vuj+6b6UASRk4ORS01eF/8ArUp6cUAaGkvsuUPHGK9Y0y4/0FVPebIx7rXj9kcSjrXpFhKTYJjrhH/TH9aAO5sRvjL4yV7/AIVejkOeOPSs3SWBs0Y87gDxU0uVLeWM8cUAbcU+88D/AOtUzoCozjIrJtZcHIyfXitWJg+PbrQA+Fctk8Y7VOG+U8dKYy8fKOfeoi3IPpQBKeG469aWPn1GKbz3604FT0HQUAPAHbp1pw6ccds+lNBOOBxTlyzYIYKOpOOfpQBKMn7vWpABjpioQwOeOaN+7rmgCUnJOMc00jBOKYOuCDQTgY54/SgCaNgrDAwO9WkHy5Xpisp5trxqAMlsc+ma0FPP+zQApGG4A4HSmk8HjpRnkE0jbWUjnJ4/SgCFBuByeCc4xU6nIyAcevpUYUKMbTgCnAjacUAQjl5BjvyakVQOBgUxgASeM96UYPTrQArDAOOv0oD5xmk9e9RnvgUATkZ4603b6HNNDbcZzn1pxII6njrQAxwAPofSkOGGQAPpSuMrmonPUYwKAFdRnIA4oV1O70HtULkjBDEY7ev1puM5K9etAE0jqRggAE45HWqF5bZJ4G1vSrCnuScU4jdgnkigDJgszHOOPlPQ46VrecFTHYd6i35zg8jtWfdzFCMcUAOvP9IO0Hr3rLmcJb3TH+7gcVpWrBkdjngVg6s5jgdVGcyDI9sGgDzXxhLm9m69R/KuRkOWNdL4rcNfTEev9K5hsbj1oAQn161Xu/8AVE+1TkVXuuYmoAenSl7U1CSDSnPegCa2OHFd/wCHpPNtY09QU/TIrz+0BdvlzxXdeGIpflTvuDCgDt9KnEUIRjx/XFaKt5gPPSsiW1kTIA4JGMe/NatjBIVBPU8UAWYH9MitW2kCgDocVnxWkgO7v3xVxIm29aALL3JTAjUu3PoAMEDr+NPZ1Leo9aiVHwM49qcYmByPWgCTePyNPJ+TI5bHAJxk0xYWA+Y4NS7WOMHj60APRuF3dcdKN4weCB2pgTcpyenrShSRyfwoAdnnOT0xTs85zUYTOfenhWHfNADi+ATjJ60u7OOetNC9+3vShSBQBBNGZHwcgE7QR1q9bnZbRpjkKFz9BVGdp1ubfyoVdC3zsXwV+gxz+lXHEjEbH28dMZoAl8wD+KjzAc9Kq7zG+2TBOBjFPTDRnGcUASb+560hdwp2ru989KpQCWTy3bJUMQVHp2rQA+Q4oAhdjznApyvkDHFDKfy601UyOKAHb+vI/Gmk4NGxsEEfnQUP5dPegBA4LU5m4zkZppjPXIyaTZzzQA7eMDqO+Khnk2puwSBz1FOcqgwWyfQUgQS8lSdpzz9KAI3cMMgnH86jaTYCBnFWDAACMYHoKilhbp0HNAFbzfm4PFTJLgcHPrUT27DJA+UjtSwwEjocmgCO5kCsTng96ybqYvkn73QYrcntGZMYJ98VTXTWeUD0oAp28myPb0J65rA1qVQrkkDLZH4CurfTmRsHnjrXP+ItKbyTx0jJ/SgDx/XJd1xIxPVqxc9TXQ69YvFI5I4/+tXP7TmgBGOarXR/dtVkg+hqrdAiNs0AdS/hW+j4MZH4H/ChPC1+xwImr9HKKAPgfwv4GvLnexTAU9//ANVemaB4Ma1kiZ+3JA+lfVlFAHzzc6CpVdoGVH50kWliNBn5c9RmvoeigD5/W0VVIP8AOmG22g7ce1fQdFAHz2IETAJHPAB70vkKO+Mdq+g6KAPn0INpwfwpu0EYJGBX0JRQB897PQ/nShRjrzX0HRQB8+gdegNIB7/WvoOigD58A9cZpSOeDwOhzX0FRQB89FDvTB+tW5YiioWK/Mu4YYHjPf0r3qigD57XBZncjHQe1FuRglsZY5x6CvoSigD5/OBkg80oYBTntzXv9FAHz8SD2qM3C+bsKtx37GvoWigD5+bmNih5xxn1pqFnjDKACQPzz6V9B0UAfPlsxO5WIO09cVNhc5x+Ne+0UAeAAKuScZPeo1Plo43AkfNxX0HRQB4DvGCR025GDSAxsF2nqPWvf6KAPAplUREgZOenrzSCL9zujA3E85PTnntXv1FAHg0KIQynt6nmporeM9xj617nRQB4kltCWG5hjP51DfaRFdIRxz3Fe50UAfLfiHwALyCfyz8xUgc+30ri0+E92eMg+3+RX2xRQB8VSfCW7VSQSSPT/wDVWRrnwsvrfT7mbbnYjN19B9K+7KKAP//Z);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Chest radiograph shows hyperperfusion of the right lung with lateralization of pulmonary vascular flow and oligemia of the left lung. Several punctate, irregular vascular structures are seen in the left lung, likely reflecting bronchial collateralization.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Paul Stark, MD.",
"    </div>",
"   </div>",
"  </div>",
"  <div class=\"figure\" style=\"width: 450px\">",
"   <div class=\"ttl\">",
"    Normal chest radiograph",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 371px; height: 324px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Posteroanterior view of a normal chest radiograph.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Carol M Black, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f39_19_40244=[""].join("\n");
var outline_f39_19_40244=null;
var title_f39_19_40245="Breech extraction2";
var content_f39_19_40245=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F78129%7EOBGYN%2F50980&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F78129%7EOBGYN%2F50980&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 474px\">",
"   <div class=\"ttl\">",
"    Delivery of the arms",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 454px; height: 326px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Gentle traction on the pelvis. Note that traction is not applied above the pelvis. Continuation of traction, with rotation as the scapulae becomes visible, sweeping the posterior and then anterior arm free in the process.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: LifeART, Obstetrics &amp; Gynecology. Copyright &copy;2009 Lippincott Williams &amp; Wilkins. All rights reserved.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 474px\">",
"   <div class=\"ttl\">",
"    Delivery of the arms",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 454px; height: 298px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: LifeART, Obstetrics &amp; Gynecology. Copyright &copy;2009 Lippincott Williams &amp; Wilkins. All rights reserved.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f39_19_40245=[""].join("\n");
var outline_f39_19_40245=null;
var title_f39_19_40246="Measurement of ACTH, CRH, and other hypothalamic and pituitary peptides";
var content_f39_19_40246=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Measurement of ACTH, CRH, and other hypothalamic and pituitary peptides",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?39/19/40246/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?39/19/40246/contributors\">",
"     Lynnette K Nieman, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?39/19/40246/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?39/19/40246/contributors\">",
"     Andre Lacroix, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?39/19/40246/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?39/19/40246/contributors\">",
"     Kathryn A Martin, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?39/19/40246/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Aug 7, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Measurements of plasma corticotropin (ACTH) are extremely useful in the diagnosis of both Cushing's syndrome and adrenal insufficiency. In contrast, corticotropin-releasing hormone (CRH) is rarely measured in peripheral plasma or serum because the concentrations are much lower than and do not correlate well with those in the hypothalamic-hypophysial portal plasma. This is because of contribution from nonhypothalamic sources (eg, the gastrointestinal tract). The measurement of ACTH, CRH, and other hypothalamic and pituitary peptides will be reviewed here. The approaches to the diagnosis of Cushing's syndrome and adrenal insufficiency are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?21/25/21913?source=see_link\">",
"     \"Establishing the diagnosis of Cushing's syndrome\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?43/46/44777?source=see_link\">",
"     \"Diagnosis of adrenal insufficiency in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     ACTH",
"    </span>",
"    &nbsp;&mdash;&nbsp;The current commercially available two-site immunometric assays have an analytical sensitivity between 0.6 and 9",
"    <span class=\"nowrap\">",
"     pg/mL",
"    </span>",
"    (0.12 to 19.8",
"    <span class=\"nowrap\">",
"     pmol/L)",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/19/40246/abstract/1\">",
"     1",
"    </a>",
"    ]. However, performance differs between assays and should be considered when interpreting patient results [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/19/40246/abstract/2,3\">",
"     2,3",
"    </a>",
"    ]. Furthermore, the most common platform immunoassay in use in the US gives significantly different results in the critical range of 9 to 118",
"    <span class=\"nowrap\">",
"     pg/mL",
"    </span>",
"    (2 to 26.2",
"    <span class=\"nowrap\">",
"     pmol/L)",
"    </span>",
"    compared with a gold standard immunometric assay [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/19/40246/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Normal values",
"    </span>",
"    &nbsp;&mdash;&nbsp;Plasma ACTH concentrations are usually between 10 and 60",
"    <span class=\"nowrap\">",
"     pg/mL",
"    </span>",
"    (2.2 and 13.3",
"    <span class=\"nowrap\">",
"     pmol/L)",
"    </span>",
"    at 8 AM. The values decrease during the waking hours and are usually less than 20",
"    <span class=\"nowrap\">",
"     pg/mL",
"    </span>",
"    (4.5",
"    <span class=\"nowrap\">",
"     pmol/L)",
"    </span>",
"    at 4 PM and less than 10",
"    <span class=\"nowrap\">",
"     pg/mL",
"    </span>",
"    (2.2",
"    <span class=\"nowrap\">",
"     pmol/L),",
"    </span>",
"    usually less than 5",
"    <span class=\"nowrap\">",
"     pg/mL",
"    </span>",
"    (1.1",
"    <span class=\"nowrap\">",
"     pmol/L),",
"    </span>",
"    within one hour after the usual time of falling sleep. This circadian rhythm in plasma ACTH concentrations is the cause of the parallel changes in cortisol secretion by the adrenal glands and the resulting rhythm in serum cortisol concentrations.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Interpretation",
"    </span>",
"    &nbsp;&mdash;&nbsp;The time of day at which the sample is taken is an important determinant of the utility of the measurement of plasma ACTH, which is best interpreted with a simultaneous measurement of serum cortisol.",
"   </p>",
"   <p>",
"    In evaluating patients with",
"    <strong>",
"     adrenal insufficiency",
"    </strong>",
"    , measurements should be made in the morning, if possible, when plasma ACTH and serum cortisol concentrations are usually at their highest value. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?43/46/44777?source=see_link\">",
"     \"Diagnosis of adrenal insufficiency in adults\"",
"    </a>",
"    .) However, in urgent or emergent evaluation of patients with potential adrenal insufficiency (eg, in the intensive care unit or emergency room), blood samples should be drawn at any time before administration of glucocorticoid therapy.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Morning (8 AM [range 6 to 10 AM]) plasma ACTH is high and serum cortisol is low in primary adrenal insufficiency. Elevated plasma ACTH with a concurrent low serum cortisol at any time can indicate primary adrenal insufficiency.",
"     </li>",
"     <li>",
"      Both plasma ACTH and serum cortisol values are at the low end of the normal range or undetectable in secondary adrenal insufficiency (ie, hypopituitarism or isolated ACTH deficiency). This is also true in tertiary adrenal insufficiency (hypothalamic CRH deficiency), although this is rare and difficult to establish clinically. These values are inappropriately low for the degree of hypocortisolism.",
"     </li>",
"     <li>",
"      In congenital adrenal hyperplasia, early morning plasma ACTH values tend to be high, whereas serum cortisol may be normal or low, depending upon the severity of the enzyme deficiency.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Late evening plasma ACTH and serum cortisol values are of little value in diagnosing primary adrenal insufficiency or congenital adrenal hyperplasia, although evening plasma ACTH concentrations tend to be somewhat high in these disorders.",
"   </p>",
"   <p>",
"    In the different forms of",
"    <strong>",
"     Cushing's syndrome",
"    </strong>",
"    , plasma ACTH and serum cortisol concentrations are most helpful when measured in the late evening, the time at which the concentrations are usually near their nadir in normal persons. These samples must be taken without stress, and this is impractical in most clinical circumstances. Whereas morning values may be within the normal range, there is loss of the normal circadian rhythm in secretion in Cushing's syndrome and the evening values are usually higher than normal. However, for the diagnostic purpose of distinguishing between ACTH-dependent tumors and primary adrenal causes of Cushing's syndrome, ACTH can be measured at any time [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/19/40246/abstract/5\">",
"     5",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?21/25/21913?source=see_link\">",
"     \"Establishing the diagnosis of Cushing's syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In patients with Cushing's syndrome due to adrenocortical tumors, bilateral micronodular dysplasia, or other primary adrenocortical disorders (ie, ACTH-independent Cushing's syndrome), plasma ACTH concentrations are low, often undetectable, but serum cortisol concentrations are high. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?12/33/12826?source=see_link\">",
"       \"Clinical presentation and evaluation of adrenocortical tumors\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?0/45/730?source=see_link\">",
"       \"Cushing's syndrome due to ACTH-independent macronodular adrenal hyperplasia\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?21/35/22072?source=see_link\">",
"       \"Cushing's syndrome due to primary pigmented nodular adrenocortical disease\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      In patients with Cushing's disease or ectopic ACTH syndrome (ie, ACTH-dependent Cushing's syndrome), the late evening plasma ACTH and serum cortisol concentrations are both high. The values for both tend to be higher in the ectopic ACTH syndrome than in Cushing's disease, but there is considerable overlap. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?30/31/31225?source=see_link&amp;anchor=H8#H8\">",
"       \"Establishing the cause of Cushing's syndrome\", section on 'ACTH-dependent Cushing's syndrome'",
"      </a>",
"      .) The morning plasma ACTH levels are often normal, but can be inappropriately elevated for the degree of hypercortisolism.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Pitfalls in measurement",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several factors may influence plasma ACTH assay results:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      ACTH may be unstable in blood at room temperature, is cleaved by enzymes in blood cells and platelets, and adheres to glass and some plastic surfaces [",
"      <a class=\"abstract\" href=\"mobipreview.htm?39/19/40246/abstract/6\">",
"       6",
"      </a>",
"      ]. Therefore, how blood is collected and plasma is prepared and stored may markedly affect the measured ACTH concentration; the severity of this problem varies with the antibodies used in the assays [",
"      <a class=\"abstract\" href=\"mobipreview.htm?39/19/40246/abstract/7\">",
"       7",
"      </a>",
"      ]. In general, it is recommended that ACTH blood samples be drawn into plastic tubes with EDTA and kept on ice until centrifugation, separation, and freezing of the plasma sample.",
"      <br/>",
"      <br/>",
"      ACTH secretion in primary adrenal insufficiency, congenital adrenal hyperplasia, and ACTH-dependent Cushing's syndrome is episodic. Because the plasma disappearance half-time is measured in minutes, measurement of more than two samples may be useful, particularly if the initial result is equivocal. This can be done by obtaining samples at the same time on multiple days or by obtaining samples 30 to 60 minutes apart on the same day.",
"     </li>",
"     <li>",
"      Normal subjects and patients with adrenal disorders may respond rapidly to stress with increased ACTH secretion. For this reason, blood samples should be obtained with indwelling needles or catheters. Measurements in samples that require more than two or three minutes to obtain by venipuncture must be interpreted with caution, if high. For the same reason, it is best not to obtain post-sleep values the first night in the hospital before the patient is acclimated to a new environment.",
"     </li>",
"     <li>",
"      Patients with major depressive disorder, particularly older patients with severe melancholic depression, may have increased plasma ACTH concentrations [",
"      <a class=\"abstract\" href=\"mobipreview.htm?39/19/40246/abstract/8\">",
"       8",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?21/25/21913?source=see_link&amp;anchor=H3#H3\">",
"       \"Establishing the diagnosis of Cushing's syndrome\", section on 'Physiologic hypercortisolism'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      One must be certain that the patient is not taking or has not recently taken glucocorticoids, which can acutely or chronically suppress hypothalamic-pituitary-adrenal function.",
"     </li>",
"     <li>",
"      Two-site \"sandwich\" immunoassays for ACTH use two different monoclonal or affinity-purified polyclonal antibodies. They may not react with proopiomelanocortin (POMC) or forms intermediate between POMC and ACTH [",
"      <a class=\"abstract\" href=\"mobipreview.htm?39/19/40246/abstract/1,9,10\">",
"       1,9,10",
"      </a>",
"      ]. This specificity may be a",
"      <strong>",
"       disadvantage",
"      </strong>",
"      in diagnosing the ectopic ACTH syndrome, in which a large percentage of circulating immunoreactive ACTH may represent incompletely processed or unprocessed POMC (see",
"      <a class=\"local\" href=\"#H7\">",
"       'Other POMC-derived peptides'",
"      </a>",
"      below). POMC concentrations can be reliably measured only with a two-site POMC immunoassay [",
"      <a class=\"abstract\" href=\"mobipreview.htm?39/19/40246/abstract/11\">",
"       11",
"      </a>",
"      ], although this measurement is not widely commercially available.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In addition, excessive concentrations of ACTH fragments, such as ACTH-(1-24), can compete for binding to one or the other of the two antibodies, preventing intact ACTH from coupling to both antibodies and causing factitiously low ACTH concentrations [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/19/40246/abstract/12\">",
"     12",
"    </a>",
"    ]. This is unlikely to be a problem in measuring endogenous ACTH.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     CRH",
"    </span>",
"    &nbsp;&mdash;&nbsp;Like many other peptide hormones, corticotropin-releasing hormone (CRH) is measured by radioimmunoassay [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/19/40246/abstract/13\">",
"     13",
"    </a>",
"    ]. In humans, CRH is largely bound to a plasma CRH-binding protein [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/19/40246/abstract/14,15\">",
"     14,15",
"    </a>",
"    ] and must be extracted by immunoaffinity chromatography or methanol before assay [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/19/40246/abstract/16,17\">",
"     16,17",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Peripheral plasma CRH concentrations range from about 1 to 10",
"    <span class=\"nowrap\">",
"     pg/mL",
"    </span>",
"    (0.2 to 2.2",
"    <span class=\"nowrap\">",
"     pmol/L),",
"    </span>",
"    increasing progressively during pregnancy to as high as 2700",
"    <span class=\"nowrap\">",
"     pg/mL",
"    </span>",
"    (585",
"    <span class=\"nowrap\">",
"     pmol/L)",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/19/40246/abstract/16,18\">",
"     16,18",
"    </a>",
"    ]. The increased CRH in peripheral plasma in pregnant women is presumably produced by the placenta [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/19/40246/abstract/19\">",
"     19",
"    </a>",
"    ]. Most of the CRH is bound to CRH-binding protein [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/19/40246/abstract/20\">",
"     20",
"    </a>",
"    ]. The net effect of the increase in CRH is that maternal pituitary ACTH secretion, plasma ACTH and serum cortisol concentrations, and urinary and salivary cortisol excretion increase during pregnancy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/19/40246/abstract/21\">",
"     21",
"    </a>",
"    ]. This effect is gradual, apparently because the concentration of the CRH-binding protein falls during late pregnancy, resulting in a greater concentration of free bioactive CRH [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/19/40246/abstract/22\">",
"     22",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Despite an early report to the contrary [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/19/40246/abstract/23\">",
"     23",
"    </a>",
"    ], peripheral plasma CRH concentrations do not correlate with plasma ACTH or serum cortisol concentrations or with altered hypothalamic-pituitary-adrenal axis function (eg, in primary adrenal insufficiency or Cushing's syndrome, or during insulin-induced hypoglycemia or",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?15/12/15556?source=see_link\">",
"     metyrapone",
"    </a>",
"    administration). Some investigators reported a correlation between plasma CRH and plasma ACTH or serum cortisol in pregnancy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/19/40246/abstract/24\">",
"     24",
"    </a>",
"    ], but others have not [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/19/40246/abstract/25,26\">",
"     25,26",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Plasma CRH concentrations are also high in the ectopic CRH syndrome, which is the one clinical setting in which measuring peripheral plasma CRH is of value [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/19/40246/abstract/27-29\">",
"     27-29",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     OTHER POMC-DERIVED PEPTIDES",
"    </span>",
"    &nbsp;&mdash;&nbsp;POMC is the ACTH precursor peptide. It is also the source of beta-lipotropin (beta-LPH). In addition, ACTH and beta-LPH are cleaved further to yield alpha- and beta-melanocyte-stimulating hormone (alpha-MSH and beta-MSH), beta-endorphin, and met-enkephalin.",
"   </p>",
"   <p>",
"    There is disagreement about the degree to which POMC is normally processed in the anterior pituitary [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/19/40246/abstract/30,31\">",
"     30,31",
"    </a>",
"    ], and differential processing may take place in different subpopulations of anterior pituitary corticotrophs. Therefore, POMC-derived peptides may not necessarily be released in equimolar concentrations. Furthermore, they appear to be metabolized at different rates, so that one may persist longer than others in the circulation. They are, however, released in concert so that their concentrations change in parallel [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/19/40246/abstract/32\">",
"     32",
"    </a>",
"    ]. Thus, the peripheral plasma concentrations of these hormones provide a direct index of pituitary secretion.",
"   </p>",
"   <p>",
"    Radioimmunoassays have been developed for POMC itself and other POMC-derived peptides, including alpha- and beta-MSH, beta-LPH, beta-endorphin, the N-terminal peptide of POMC, and the joining peptide between the N-terminal peptide and ACTH [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/19/40246/abstract/11,30,33-37\">",
"     11,30,33-37",
"    </a>",
"    ]. These assays have not been validated for routine clinical use. However, studies showing that patients with ectopic ACTH secretion have increased secretion of non-ACTH POMC fragments suggest a potential diagnostic value [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/19/40246/abstract/38\">",
"     38",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    One study suggested that measurement of POMC may serve as a marker of tumor aggressivity in pituitary and non-pituitary tumors [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/19/40246/abstract/39\">",
"     39",
"    </a>",
"    ]. In this report, seven of eight patients with invasive macroadenomas had high plasma concentrations of POMC, compared with undetectable concentrations in all 34 patients with noninvasive tumors. In addition, 16 of 20 patients with ectopic ACTH syndrome had high plasma POMC concentrations; these patients all had malignant tumors. The remaining four patients with undetectable plasma POMC values had bronchial carcinoid tumors (the most frequent indolent tumor causing ectopic ACTH syndrome). Similar findings were noted in another series: high plasma POMC concentrations were found in six of six patients with macroadenomas but not in 27 patients with microadenomas [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/19/40246/abstract/40\">",
"     40",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Measurements of plasma corticotropin (ACTH) are important for the diagnosis of both Cushing's syndrome and adrenal insufficiency. CRH measurements are less useful clinically, but are sometimes used in the evaluation of ectopic CRH syndrome. (See",
"    <a class=\"local\" href=\"#H6\">",
"     'CRH'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    When evaluating patients with",
"    <strong>",
"     adrenal insufficiency",
"    </strong>",
"    , measurements should be made in the morning if possible, when plasma ACTH and serum cortisol concentrations are usually at their highest value. (See",
"    <a class=\"local\" href=\"#H2\">",
"     'ACTH'",
"    </a>",
"    above and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?43/46/44777?source=see_link\">",
"     \"Diagnosis of adrenal insufficiency in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    However, elevated plasma ACTH in the presence of low serum cortisol can be diagnostic for primary adrenal insufficiency at any time of day.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In primary adrenal insufficiency, early morning (6 to 10 AM) plasma ACTH is high and serum cortisol is low in primary adrenal insufficiency.",
"     </li>",
"     <li>",
"      In secondary and tertiary adrenal insufficiency, plasma ACTH values are low or within the reference range (but inappropriately low for the degree of hypocortisolism). Serum cortisol is usually low or at the low end of the reference range.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In the different forms of",
"    <strong>",
"     Cushing's syndrome",
"    </strong>",
"    , plasma ACTH and serum cortisol concentrations can be measured at any time.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In patients with Cushing's syndrome due to adrenocortical tumors, bilateral micronodular dysplasia, or other primary adrenocortical disorders (ie, ACTH-independent Cushing's syndrome), plasma ACTH concentrations are low, often undetectable, but serum cortisol concentrations are high. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'ACTH'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?12/33/12826?source=see_link\">",
"       \"Clinical presentation and evaluation of adrenocortical tumors\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?0/45/730?source=see_link\">",
"       \"Cushing's syndrome due to ACTH-independent macronodular adrenal hyperplasia\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?21/35/22072?source=see_link\">",
"       \"Cushing's syndrome due to primary pigmented nodular adrenocortical disease\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      In patients with Cushing's disease or ectopic ACTH syndrome (ie, ACTH-dependent Cushing's syndrome), the plasma ACTH and late evening serum cortisol concentrations are both high. Plasma ACTH can be within the reference range in the morning, but is usually inappropriately elevated for the degree of hypercortisolism. The values for both tend to be higher in the ectopic ACTH syndrome than in Cushing's disease, but there is considerable overlap. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?30/31/31225?source=see_link&amp;anchor=H8#H8\">",
"       \"Establishing the cause of Cushing's syndrome\", section on 'ACTH-dependent Cushing's syndrome'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/19/40246/abstract/1\">",
"      Talbot JA, Kane JW, White A. Analytical and clinical aspects of adrenocorticotrophin determination. Ann Clin Biochem 2003; 40:453.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/19/40246/abstract/2\">",
"      Lindsay JR, Shanmugam VK, Oldfield EH, et al. A comparison of immunometric and radioimmunoassay measurement of ACTH for the differential diagnosis of Cushing's syndrome. J Endocrinol Invest 2006; 29:983.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/19/40246/abstract/3\">",
"      Wilkinson CW, Raff H. Comparative evaluation of a new immunoradiometric assay for corticotropin. Clin Chem Lab Med 2006; 44:669.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/19/40246/abstract/4\">",
"      Raff H. Immulite vs Scantibodies IRMA plasma ACTH assay. Clin Chem 2008; 54:1409.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/19/40246/abstract/5\">",
"      Klose M, Kofoed-Enevoldsen A, Ostergaard Kristensen L. Single determination of plasma ACTH using an immunoradiometric assay with high detectability differentiates between ACTH-dependent and -independent Cushing's syndrome. Scand J Clin Lab Invest 2002; 62:33.",
"     </a>",
"    </li>",
"    <li>",
"     Orth DN. Adrenocorticotropic hormone (ACTH). In: Methods of Hormone Radioimmunoassay, Jaffe BM, Behrman HR (Eds), Academic Press, Inc., New York 1979. p.245.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/19/40246/abstract/7\">",
"      Besser GM, Orth DN, Nicholson WE, et al. Dissociation of the disappearance of bioactive and radioimmunoreactive ACTH from plasma in man. J Clin Endocrinol Metab 1971; 32:595.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/19/40246/abstract/8\">",
"      Pfohl B, Sherman B, Schlechte J, Stone R. Pituitary-adrenal axis rhythm disturbances in psychiatric depression. Arch Gen Psychiatry 1985; 42:897.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/19/40246/abstract/9\">",
"      Fukata J, Naitoh Y, Usui T, et al. Two-site immunoradiometric assay for adrenocorticotrophin: a cautionary study about the reactivity to its precursor molecules. Endocrinol Jpn 1989; 36:155.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/19/40246/abstract/10\">",
"      Tsuchiya K, Minami I, Tateno T, et al. Malignant gastric carcinoid causing ectopic ACTH syndrome: discrepancy of plasma ACTH levels measured by different immunoradiometric assays. Endocr J 2005; 52:743.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/19/40246/abstract/11\">",
"      Tsigos C, Crosby SR, Gibson S, et al. Proopiomelanocortin is the predominant adrenocorticotropin-related peptide in human cerebrospinal fluid. J Clin Endocrinol Metab 1993; 76:620.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/19/40246/abstract/12\">",
"      Raff H, Findling JW, Wong J. Short loop adrenocorticotropin (ACTH) feedback after ACTH-(1-24) injection in man is an artifact of the immunoradiometric assay. J Clin Endocrinol Metab 1989; 69:678.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/19/40246/abstract/13\">",
"      Nicholson WE, DeCherney GS, Jackson RV, et al. Plasma distribution, disappearance half-time, metabolic clearance rate, and degradation of synthetic ovine corticotropin-releasing factor in man. J Clin Endocrinol Metab 1983; 57:1263.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/19/40246/abstract/14\">",
"      Orth DN, Mount CD. Specific high-affinity binding protein for human corticotropin-releasing hormone in normal human plasma. Biochem Biophys Res Commun 1987; 143:411.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/19/40246/abstract/15\">",
"      Behan DP, Linton EA, Lowry PJ. Isolation of the human plasma corticotrophin-releasing factor-binding protein. J Endocrinol 1989; 122:23.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/19/40246/abstract/16\">",
"      Sasaki A, Shinkawa O, Margioris AN, et al. Immunoreactive corticotropin-releasing hormone in human plasma during pregnancy, labor, and delivery. J Clin Endocrinol Metab 1987; 64:224.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/19/40246/abstract/17\">",
"      Ellis MJ, Livesey JH, Donald RA. Circulating plasma corticotrophin-releasing factor-like immunoreactivity. J Endocrinol 1988; 117:299.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/19/40246/abstract/18\">",
"      Campbell EA, Linton EA, Wolfe CD, et al. Plasma corticotropin-releasing hormone concentrations during pregnancy and parturition. J Clin Endocrinol Metab 1987; 64:1054.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/19/40246/abstract/19\">",
"      Makrigiannakis A, Zoumakis E, Margioris AN, et al. The corticotropin-releasing hormone (CRH) in normal and tumoral epithelial cells of human endometrium. J Clin Endocrinol Metab 1995; 80:185.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/19/40246/abstract/20\">",
"      Salminen-Lappalainen K, Laatikainen T. Binding of corticotropin-releasing hormone (CRH) in maternal and fetal plasma and in amniotic fluid. Clin Chim Acta 1990; 195:57.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/19/40246/abstract/21\">",
"      Goland RS, Conwell IM, Warren WB, Wardlaw SL. Placental corticotropin-releasing hormone and pituitary-adrenal function during pregnancy. Neuroendocrinology 1992; 56:742.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/19/40246/abstract/22\">",
"      Linton EA, Perkins AV, Woods RJ, et al. Corticotropin releasing hormone-binding protein (CRH-BP): plasma levels decrease during the third trimester of normal human pregnancy. J Clin Endocrinol Metab 1993; 76:260.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/19/40246/abstract/23\">",
"      Suda T, Tomori N, Yajima F, et al. Immunoreactive corticotropin-releasing factor in human plasma. J Clin Invest 1985; 76:2026.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/19/40246/abstract/24\">",
"      Sasaki A, Shinkawa O, Yoshinaga K. Placental corticotropin-releasing hormone may be a stimulator of maternal pituitary adrenocorticotropic hormone secretion in humans. J Clin Invest 1989; 84:1997.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/19/40246/abstract/25\">",
"      Jeske W, Soszy��ski P, Rogozi��ski W, et al. Plasma GHRH, CRH, ACTH, beta-endorphin, human placental lactogen, GH and cortisol concentrations at the third trimester of pregnancy. Acta Endocrinol (Copenh) 1989; 120:785.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/19/40246/abstract/26\">",
"      Allolio B, Hoffmann J, Linton EA, et al. Diurnal salivary cortisol patterns during pregnancy and after delivery: relationship to plasma corticotrophin-releasing-hormone. Clin Endocrinol (Oxf) 1990; 33:279.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/19/40246/abstract/27\">",
"      Fjellestad-Paulsen A, Abrahamsson PA, Bjartell A, et al. Carcinoma of the prostate with Cushing's syndrome. A case report with histochemical and chemical demonstration of immunoreactive corticotropin-releasing hormone in plasma and tumoral tissue. Acta Endocrinol (Copenh) 1988; 119:506.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/19/40246/abstract/28\">",
"      Jessop DS, Cunnah D, Millar JG, et al. A phaeochromocytoma presenting with Cushing's syndrome associated with increased concentrations of circulating corticotrophin-releasing factor. J Endocrinol 1987; 113:133.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/19/40246/abstract/29\">",
"      Schteingart DE, Lloyd RV, Akil H, et al. Cushing's syndrome secondary to ectopic corticotropin-releasing hormone-adrenocorticotropin secretion. J Clin Endocrinol Metab 1986; 63:770.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/19/40246/abstract/30\">",
"      Wilson RE, Orth DN, Nicholson WE, et al. Human gamma-lipotropin radioimmunoassay: identification of immunoreactive gamma-lipotropin in human plasma and tissue. J Clin Endocrinol Metab 1981; 53:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/19/40246/abstract/31\">",
"      Liotta AS, Suda T, Krieger DT. beta-Lipotropin is the major opioid-like peptide of human pituitary and rat pars distalis: lack of significant beta-endorphin. Proc Natl Acad Sci U S A 1978; 75:2950.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/19/40246/abstract/32\">",
"      Jackson RV, DeCherney GS, DeBold CR, et al. Synthetic ovine corticotropin-releasing hormone: simultaneous release of proopiolipomelanocortin peptides in man. J Clin Endocrinol Metab 1984; 58:740.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/19/40246/abstract/33\">",
"      Usategui R, Oliver C, Vaudry H, et al. Immunoreactive alpha-MSH and ACTH levels in rat plasma and pituitary. Endocrinology 1976; 98:189.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/19/40246/abstract/34\">",
"      Bertagna XY, Stone WJ, Nicholson WE, et al. Simultaneous assay of immunoreactive beta-lipotropin, gamma-lipotropin, and beta-endorphin in plasma of normal human subjects, patients with ACTH/lipotropin hypersecretory syndromes, and patients undergoing chronic hemodialysis. J Clin Invest 1981; 67:124.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/19/40246/abstract/35\">",
"      Hale AC, Ratter SJ, Tomlin SJ, et al. Measurement of immunoreactive gamma-MSH in human plasma. Clin Endocrinol (Oxf) 1984; 21:139.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/19/40246/abstract/36\">",
"      Pettibone DJ, Mueller GP. Clonidine releases immunoreactive beta-endorphin from rat para distalis. Brain Res 1981; 221:409.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/19/40246/abstract/37\">",
"      Chan JS, Seidah NG, Chr&eacute;tien M. Measurement of N-terminal (1-76) of human proopiomelanocortin in human plasma: correlation with adrenocorticotropin. J Clin Endocrinol Metab 1983; 56:791.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/19/40246/abstract/38\">",
"      Kuhn JM, Proeschel MF, Seurin DJ, et al. Comparative assessment of ACTH and lipotropin plasma levels in the diagnosis and follow-up of patients with Cushing's syndrome: a study of 210 cases. Am J Med 1989; 86:678.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/19/40246/abstract/39\">",
"      Raffin-Sanson ML, Massias JF, Dumont C, et al. High plasma proopiomelanocortin in aggressive adrenocorticotropin-secreting tumors. J Clin Endocrinol Metab 1996; 81:4272.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/19/40246/abstract/40\">",
"      Gibson S, Ray DW, Crosby SR, et al. Impaired processing of proopiomelanocortin in corticotroph macroadenomas. J Clin Endocrinol Metab 1996; 81:497.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 171 Version 2.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0503-61.234.146.186-B86BBD9DD2-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f39_19_40246=[""].join("\n");
var outline_f39_19_40246=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H8\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      ACTH",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Normal values",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Interpretation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Pitfalls in measurement",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      CRH",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      OTHER POMC-DERIVED PEPTIDES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?12/33/12826?source=related_link\">",
"      Clinical presentation and evaluation of adrenocortical tumors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?0/45/730?source=related_link\">",
"      Cushing's syndrome due to ACTH-independent macronodular adrenal hyperplasia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?21/35/22072?source=related_link\">",
"      Cushing's syndrome due to primary pigmented nodular adrenocortical disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?43/46/44777?source=related_link\">",
"      Diagnosis of adrenal insufficiency in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?30/31/31225?source=related_link\">",
"      Establishing the cause of Cushing's syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?21/25/21913?source=related_link\">",
"      Establishing the diagnosis of Cushing's syndrome",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f39_19_40247="Losartan: Pediatric drug information";
var content_f39_19_40247=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Losartan: Pediatric drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_general\" href=\"mobipreview.htm?25/35/26168?source=see_link\">",
"    see \"Losartan: Drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_patient\" href=\"mobipreview.htm?25/26/26021?source=see_link\">",
"    see \"Losartan: Patient drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"block black-box-warn drugH1Div\" id=\"F5709020\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     ALERT: U.S. Boxed Warning",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     The FDA-approved labeling includes a boxed warning. See Warnings/Precautions section for a concise summary of this information.  For verbatim wording of the boxed warning, consult the product labeling or",
"     <a href=\"file://www.fda.gov\" target=\"_blank\">",
"      www.fda.gov",
"     </a>",
"     .",
"    </p>",
"   </div>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F190224\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Cozaar&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F190225\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Apo-Losartan;",
"     </li>",
"     <li>",
"      CO Losartan;",
"     </li>",
"     <li>",
"      Cozaar&reg;;",
"     </li>",
"     <li>",
"      Mylan-Losartan;",
"     </li>",
"     <li>",
"      PMS-Losartan;",
"     </li>",
"     <li>",
"      Teva-Losartan",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list_set htclist drugH1Div drugBrandNames\" id=\"F1022538\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Therapeutic Category",
"    </span>",
"    <ul>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Angiotensin II Receptor Blocker",
"      </span>",
"     </li>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Antihypertensive Agent",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block dos drugH1Div\" id=\"F1022574\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Usual",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?25/35/26168?source=see_link\">",
"      see \"Losartan: Drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Children:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     <b>",
"      Hypertension:",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     Children and Adolescents 6-16 years: Oral:  Initial: 0.7 mg/kg once daily (maximum dose: 50 mg);  titrate to desired effect up to a maximum dose of 1.4 mg/kg/day or 100 mg/day; may be administered once daily or divided twice daily (NHBPEP, 2004; NHLBI, 2011);",
"     <b>",
"      Note:",
"     </b>",
"     Doses &gt;1.4 mg/kg/day (or &gt;100 mg/day) have not been studied (Shahinfar, 2005).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     Adolescents &ge;17 years: Oral: Initial: 50 mg once daily; increase dose to achieve desired effect; total daily dosage range: 25-100 mg/day; can be administered once or twice daily;",
"     <b>",
"      Note:",
"     </b>",
"     Patients receiving diuretics or with intravascular volume depletion: Initial dose: 25 mg once daily",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     <b>",
"      Proteinuria reduction in children with chronic kidney disease:",
"     </b>",
"     Limited data available: Children &ge;4 years and Adolescents: Oral: Initial: 0.4-0.8 mg/kg/day; increase dose if no adverse effects occur and blood pressure remains &gt;90th percentile or proteinuria does not fall &lt;50% of baseline excretion; doses can be increased slowly up to 1 mg/kg/day (maximum: 50 mg/day); dosing based on experience from three retrospective clinical trials (Chandar, 2007; Ellis, 2003; Ellis, 2004)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     <b>",
"      Marfan's syndrome aortic-root dilation:",
"     </b>",
"     Limited data available: Children and Adolescents 14 months to 16 years: Oral: Initial: 0.6 mg/kg/day for 3 weeks (while assessing for adverse events); then gradually increase dose to 1.4 mg/kg/day (maximum: 100 mg/day); dosing based on preliminary results of a small (n=18), nonrandomized, retrospective, clinical study (Brooke, 2008); further studies are needed",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Adults:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <b>",
"      Hypertension:",
"     </b>",
"     Oral: Initial: 50 mg once daily; can be administered once or twice daily; increase dose to achieve desired effect; total daily dosage range: 25-100 mg/day;",
"     <b>",
"      Note:",
"     </b>",
"     Patients receiving diuretics or with intravascular volume depletion: Initial dose: 25 mg once daily",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <b>",
"      Nephropathy in patients with type 2 diabetes and hypertension:",
"     </b>",
"     Oral: Initial: 50 mg once daily; can be increased to 100 mg once daily based on blood pressure response",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <b>",
"      Stroke reduction (HTN with LVH):",
"     </b>",
"     Oral: Initial: 50 mg once daily (maximum daily dose: 100 mg); may be used in combination with a thiazide diuretic",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Dosing adjustment in renal impairment:",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Children: Use is not recommended if Cl",
"     <sub>",
"      cr",
"     </sub>",
"     &lt;30 mL/minute/1.73 m",
"     <sup>",
"      2",
"     </sup>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Adults: No initial dosage adjustment necessary",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Dosing adjustment in hepatic impairment:",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Children: No specific dosing recommendations provided by manufacturer; however, it is advisable to initiate at a reduced dosage.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Adults:  Reduce initial dose to 25 mg/day",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F190196\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Tablet, oral, as potassium: 25 mg, 50 mg, 100 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Cozaar&reg;: 25 mg [contains potassium 2.12 mg (0.054 mEq)]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Cozaar&reg;: 50 mg [scored; contains potassium 4.24 mg (0.108 mEq)]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Cozaar&reg;: 100 mg [contains potassium 8.48 mg (0.216 mEq)]",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F190181\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Yes",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F1022581\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     May be administered with or without food.",
"    </p>",
"   </div>",
"   <div class=\"block sta drugH1Div\" id=\"F1022561\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Stability",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Store at controlled room temperature at 25&deg;C (77&deg;F) in tightly closed container. Protect from light.",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F1022539\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Treatment of hypertension alone or in combination with other antihypertensive agents (FDA approved in ages 6-16 years and adults); treatment of diabetic nephropathy in patients with type 2 diabetes mellitus (noninsulin dependent, NIDDM) and hypertension (FDA approved in adults); reduction of the risk of stroke in patients with hypertension and left ventricular hypertrophy (FDA approved in adults); has also been used to reduce proteinuria in children with chronic kidney disease, either as monotherapy or in addition to ACE inhibitor therapy, and in Marfan's Syndrome to slow the rate of progression of aortic-root dilation",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F190277\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Sound-alike/look-alike issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       Cozaar&reg; may be confused with Colace&reg;, Coreg&reg;, Hyzaar&reg;, Zocor&reg;",
"      </p>",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       Losartan may be confused with locaserin, valsartan",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block arm drugH1Div\" id=\"F190275\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Cardiovascular: Chest pain, hypotension, orthostatic hypotension, first-dose hypotension (dose related)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Central nervous system: Dizziness, fatigue, fever, hypoesthesia, insomnia",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Dermatology: Cellulitis",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Endocrine: Hyperkalemia, hypoglycemia",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Gastrointestinal: Abdominal pain, diarrhea, dyspepsia, gastritis, nausea, weight gain",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Genitourinary: Urinary tract infection",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Hematologic: Anemia",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Neuromuscular &amp; skeletal: Back pain, knee pain, leg pain, muscle cramps, muscular weakness, myalgia, weakness",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Respiratory: Bronchitis, cough, nasal congestion, sinusitis upper respiratory infection",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Miscellaneous: Flu-like syndrome, infection",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Frequency &le; placebo: Abdominal pain, edema, headache, nausea, pharyngitis",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Rare but important or life-threatening: Acute psychosis with paranoid delusions, ageusia, allergic reaction, alopecia, anaphylactic reactions, anemia, angina, angioedema, anorexia, anxiety, arrhythmia, arthralgia, arthritis, ataxia, AV block (second degree), bilirubin increased, blurred vision, bradycardia, bronchitis, BUN increased, confusion, conjunctivitis, constipation, CVA, depression, dermatitis, dysgeusia, dyspnea, ecchymosis, epistaxis, erythroderma, erythema, facial edema, fever, flatulence, flushing, gastritis, gout, hematocrit decreased, hemoglobin decreased, Henoch-Sch&ouml;nlein purpura, hepatitis, hyponatremia, hypotension, impotence, joint swelling, maculopapular rash, malaise, memory impairment, MI, migraine, muscle weakness, myositis, neoplasm, nervousness, orthostatic effects, pancreatitis, paresthesia, peripheral neuropathy, pharyngitis, photosensitivity, pruritus, rash, rhabdomyolysis, rhinitis, serum creatinine increased, sleep disorder, somnolence, syncope, tachycardia, taste perversion, thrombocytopenia, tinnitus, transaminases increased, tremor, urinary frequency, urticaria, vasculitis, ventricular arrhythmia, vertigo, visual acuity decreased, vomiting, xerostomia",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F1022545\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to losartan, any component, or other angiotensin II receptor blockers",
"    </p>",
"   </div>",
"   <div class=\"block pre drugH1Div\" id=\"F6894661\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Precautions",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Use with caution and reduce dosage in patients with hepatic impairment (clearance of losartan is reduced in these patients). Use with caution in patients with impaired renal function; use is associated with deterioration of renal function and/or increases in serum creatinine, particularly in patients with low renal blood flow (eg, renal artery stenosis, heart failure); deterioration may result in oliguria, acute renal failure, or progressive azotemia. Small increases in serum creatinine may occur following initiation; consider discontinuation in patients with progressive and/or significant deterioration in renal function. Hyperkalemia may occur; risk factors include renal dysfunction, diabetes mellitus, concomitant use of potassium-sparing diuretics, potassium supplements, and/or potassium-containing salts; use with caution in these patients and with these agents; monitor potassium closely. Not recommended for use in children &lt;6 years of age or in children with GFR &lt;30 mL/minute/1.73m",
"     <sup>",
"      2",
"     </sup>",
"     (no data exists).",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;\">",
"     Angioedema (although reported rarely) can occur at any time during treatment (especially following first dose) and may include swelling of the face, lips, pharynx, and tongue. Angioedema of the larynx, glottis, or tongue may cause airway obstruction. Some patients who experienced angioedema with losartan previously experienced angioedema with other medications, including ACI inhibitors.",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F1022546\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Drugs that act on the renin-angiotensin system can cause injury and death to the developing fetus. Discontinue as soon as possible once pregnancy is detected",
"     <b>",
"      [U.S. Boxed Warning]",
"     </b>",
"     . Use with caution in volume-depleted patients (eg, those on thiazide diuretics); correct depletion first or use a lower starting dose. Symptomatic hypotension may occur, especially in patients with an activated renin-angiotensin system (eg, volume- or salt-depleted patients receiving high doses of diuretic agents); use with caution in these patients; correct depletion before starting therapy or initiate therapy at a lower dose. Concomitant use of an ACE inhibitor or renin inhibitor (eg, aliskiren) is associated with an increased risk of hypotension, hyperkalemia, and renal dysfunction. Concomitant use with aliskiren should be avoided in patients with GFR &lt;60 mL/minute and is contraindicated in patients with diabetes mellitus (regardless of GFR).",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F190263\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Substrate",
"     </b>",
"     of CYP2C9 (major), CYP3A4 (major);",
"     <b>",
"      Note:",
"     </b>",
"     Assignment of Major/Minor substrate status based on clinically relevant drug interaction potential;",
"     <b>",
"      Inhibits",
"     </b>",
"     CYP1A2 (weak), CYP2C19 (weak), CYP2C8 (moderate), CYP2C9 (moderate), CYP3A4 (weak)",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F190190\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     ACE Inhibitors: Angiotensin II Receptor Blockers may enhance the adverse/toxic effect of ACE Inhibitors.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Alfuzosin: May enhance the hypotensive effect of Antihypertensives.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Aliskiren: May enhance the hyperkalemic effect of Angiotensin II Receptor Blockers. Aliskiren may enhance the hypotensive effect of Angiotensin II Receptor Blockers. Aliskiren may enhance the nephrotoxic effect of Angiotensin II Receptor Blockers. Management: Avoid aliskiren use with ACEIs or ARBs in patients with diabetes or estimated glomerular filtration rate below 60 mL/min. In other patients receiving these combinations, monitor serum potassium, serum creatinine, and blood pressure periodically.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Amifostine: Antihypertensives may enhance the hypotensive effect of Amifostine.  Management: When amifostine is used at chemotherapy doses, antihypertensive medications should be withheld for 24 hours prior to amifostine administration. If antihypertensive therapy can not be withheld, amifostine should not be administered.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Antifungal Agents (Azole Derivatives, Systemic): May decrease the metabolism of Losartan.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Antihypertensives: May enhance the hypotensive effect of other Antihypertensives.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     ARIPiprazole: CYP3A4 Inhibitors (Weak) may increase the serum concentration of ARIPiprazole.  Management: Monitor for increased aripiprazole pharmacologic effects. Aripiprazole dose adjustments may or may not be required based on concomitant therapy and/or indication. Consult full interaction monograph for specific recommendations.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Canagliflozin: May enhance the hyperkalemic effect of Angiotensin II Receptor Blockers. Canagliflozin may enhance the hypotensive effect of Angiotensin II Receptor Blockers.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Carvedilol: CYP2C9 Inhibitors (Moderate) may increase the serum concentration of Carvedilol. Specifically, concentrations of the S-carvedilol enantiomer may be increased.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CycloSPORINE (Systemic): Angiotensin II Receptor Blockers may enhance the hyperkalemic effect of CycloSPORINE (Systemic).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP2C8 Substrates: CYP2C8 Inhibitors (Moderate) may decrease the metabolism of CYP2C8 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP2C9 Inducers (Strong): May increase the metabolism of CYP2C9 Substrates. Management: Consider an alternative for one of the interacting drugs. Some combinations may be specifically contraindicated. Consult appropriate manufacturer labeling.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP2C9 Inhibitors (Moderate): May decrease the metabolism of CYP2C9 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP2C9 Inhibitors (Strong): May decrease the metabolism of CYP2C9 Substrates.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP2C9 Substrates: CYP2C9 Inhibitors (Moderate) may decrease the metabolism of CYP2C9 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP3A4 Inducers (Strong): May increase the metabolism of CYP3A4 Substrates. Management: Consider an alternative for one of the interacting drugs. Some combinations may be specifically contraindicated. Consult appropriate manufacturer labeling.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Deferasirox: May decrease the serum concentration of CYP3A4 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Diazoxide: May enhance the hypotensive effect of Antihypertensives.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Eplerenone: May enhance the hyperkalemic effect of Angiotensin II Receptor Blockers.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Fluconazole: May decrease the metabolism of Losartan.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Herbs (CYP3A4 Inducers): May increase the metabolism of CYP3A4 Substrates. Management: Consider avoiding CYP3A4 inducing herbs in order to avoid therapeutic failure of the substrate. Some combinations may be specifically contraindicated. Consult appropriate manufacturer labeling.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Herbs (Hypertensive Properties): May diminish the antihypertensive effect of Antihypertensives.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Herbs (Hypoglycemic Properties): May enhance the hypoglycemic effect of Hypoglycemic Agents.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Herbs (Hypotensive Properties): May enhance the hypotensive effect of Antihypertensives.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Hypoglycemic Agents: May enhance the adverse/toxic effect of other Hypoglycemic Agents.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Hypotensive Agents: May enhance the adverse/toxic effect of other Hypotensive Agents.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Lithium: Angiotensin II Receptor Blockers may increase the serum concentration of Lithium.  Management: Lithium dosage reductions will likely be needed following the addition of an angiotensin II receptor antagonist.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Lomitapide: CYP3A4 Inhibitors (Weak) may increase the serum concentration of Lomitapide.  Management: Limit the maximum adult dose of lomitapide to 30 mg daily when used in combination with any weak CYP3A4 inhibitor.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Loop Diuretics: May diminish the hypoglycemic effect of Hypoglycemic Agents.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     MAO Inhibitors: May enhance the orthostatic hypotensive effect of Orthostatic Hypotension Producing Agents.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Methylphenidate: May diminish the antihypertensive effect of Antihypertensives.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Mifepristone: May increase the serum concentration of CYP2C9 Substrates. Management: Use CYP2C9 substrates at the lowest recommended dose, and monitor closely for adverse effects, during and in the 2 weeks following mifepristone treatment.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Milk Thistle: May increase the serum concentration of Losartan.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Nonsteroidal Anti-Inflammatory Agents: Angiotensin II Receptor Blockers may enhance the adverse/toxic effect of Nonsteroidal Anti-Inflammatory Agents. Specifically, the combination may result in a significant decrease in renal function. Nonsteroidal Anti-Inflammatory Agents may diminish the therapeutic effect of Angiotensin II Receptor Blockers. The combination of these two agents may also significantly decrease glomerular filtration and renal function.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Peginterferon Alfa-2b: May decrease the serum concentration of CYP2C9 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Pentoxifylline: May enhance the hypotensive effect of Antihypertensives.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Phosphodiesterase 5 Inhibitors: May enhance the antihypertensive effect of Antihypertensives.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Pimozide: CYP3A4 Inhibitors (Weak) may increase the serum concentration of Pimozide.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Potassium Salts: May enhance the hyperkalemic effect of Angiotensin II Receptor Blockers.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Potassium-Sparing Diuretics: Angiotensin II Receptor Blockers may enhance the hyperkalemic effect of Potassium-Sparing Diuretics.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Prostacyclin Analogues: May enhance the hypotensive effect of Antihypertensives.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Rifamycin Derivatives: May increase the metabolism of Angiotensin II Receptor Blockers.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     RiTUXimab: Antihypertensives may enhance the hypotensive effect of RiTUXimab.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Salicylates: May enhance the hypoglycemic effect of Hypoglycemic Agents.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Selective Serotonin Reuptake Inhibitors: May enhance the hypoglycemic effect of Hypoglycemic Agents. Selective Serotonin Reuptake Inhibitors may increase the serum concentration of Hypoglycemic Agents. Management: Consider increased monitoring of glycemic control with concomitant use of a hypoglycemic agent and an SSRI. Dosage adjustments of the hypoglycemic agent may be necessary upon SSRI initiation or discontinuation.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Sodium Phosphates: Angiotensin II Receptor Blockers may enhance the nephrotoxic effect of Sodium Phosphates. Specifically, the risk of acute phosphate nephropathy may be enhanced.  Management: Consider avoiding this combination by temporarily suspending treatment with ARBs, or seeking alternatives to oral sodium phosphate bowel preparation. If the combination cannot be avoided, maintain adequate hydration and monitor renal function closely.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tocilizumab: May decrease the serum concentration of CYP3A4 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tolvaptan: May enhance the hyperkalemic effect of Angiotensin II Receptor Blockers.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Trimethoprim: May enhance the hyperkalemic effect of Angiotensin II Receptor Blockers.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Yohimbine: May diminish the antihypertensive effect of Antihypertensives.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block foi drugH1Div\" id=\"F1022560\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Food Interactions",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Food does not significantly affect the AUC of losartan or its active metabolite. Limit salt substitutes or potassium-rich diet. Avoid natural licorice (causes sodium and water retention and increases potassium loss).",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F190192\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     C (1st trimester); D (2nd and 3rd trimesters) (",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F190207\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      [U.S. Boxed Warning]: Drugs that act on the renin-angiotensin system can cause injury and death to the developing fetus. Discontinue as soon as possible once pregnancy is detected.",
"     </b>",
"     The use of drugs which act on the renin-angiotensin system are associated with oligohydramnios. Oligohydramnios, due to decreased fetal renal function, may lead to fetal lung hypoplasia and skeletal malformations. Use is also associated with anuria, hypotension, renal failure, skull hypoplasia, and death in the fetus/neonate. The exposed fetus should be monitored for fetal growth, amniotic fluid volume, and organ formation. Infants exposed",
"     <i>",
"      in utero",
"     </i>",
"     should be monitored for hyperkalemia, hypotension, and oliguria.",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F1022583\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Blood pressure, BUN, serum creatinine, renal function, baseline and periodic serum electrolytes, urinalysis",
"    </p>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F1022563\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Losartan produces direct antagonism of the effects of angiotensin II. Unlike the ACE inhibitors, losartan blocks the binding of angiotensin II to the AT1 receptor subtype. It produces its blood pressure-lowering effects by antagonizing AT1-induced vasoconstriction, aldosterone release, catecholamine release, arginine vasopressin release, water intake, and hypertrophic responses. This action results in more efficient blockade of the cardiovascular effects of angiotensin II and fewer side effects than the ACE inhibitors. Losartan does not affect the ACE (kininase II) or the response to bradykinin.",
"    </p>",
"   </div>",
"   <div class=\"block phd drugH1Div\" id=\"F6894662\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Antihypertensive effect:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Maximum effect: 6 hours postdose; with chronic dosing, substantial hypotensive effects are seen within 1 week; maximum effect: 3-6 weeks",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Duration: 24 hours",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F1022565\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacokinetics (Adult data unless noted)",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     <b>",
"      Note:",
"     </b>",
"     No significant differences in pharmacokinetic parameters have been identified across studied pediatric age groups (6-16 years) and adult population.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Absorption: Oral: Well-absorbed",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Distribution: V",
"     <sub>",
"      d",
"     </sub>",
"     : Adults:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Losartan: ~34 L",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     E-3174: ~12 L",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Protein binding: Highly bound, &gt;98%; primarily to albumin",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Metabolism: Extensive first-pass effect; metabolized in the liver via CYP2C9 and 3A4 to active carboxylic metabolite, E-3174 (14% of dose; 40 times more potent than losartan) and several inactive metabolites",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Bioavailability: Oral: 33%; AUC of E-3174 is four times greater than that of losartan; extemporaneously prepared suspension and tablet have similar bioavailability of losartan and E-3174",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Half-life elimination:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Losartan:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Children 6-16 years: 2.3 &plusmn; 0.8 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Adults: 2.1 &plusmn; 0.7 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     E-3174:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Children 6-16 years: 5.6 &plusmn; 1.2 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Adults: 7.4 &plusmn; 2.4 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Time to peak serum concentration:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Losartan:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Children: 2 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Adults: 1 hour",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     E-3174:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Children: 4 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Adults: 3.5 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Excretion: Biliary excretion plays a role in the elimination of parent drug and metabolites; 35% of an oral dose is eliminated in the urine and 60% in the feces; 4% of dose is eliminated as unchanged drug in the urine; 6% as E-3174",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Clearance: Adults:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Plasma:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     Losartan: 600 mL/minute",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     E-3174: 50 mL/minute",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Renal:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     Losartan: 75 mL/minute",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     E-3174: 25 mL/minute",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Dialysis: Losartan and E-3174: Not removed by hemodialysis",
"    </p>",
"   </div>",
"   <div class=\"block pai drugH1Div\" id=\"F1022587\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Patient Information",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?25/26/26021?source=see_link\">",
"      see \"Losartan: Patient drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Do not take any new medication (prescription or OTC), herbal products, potassium supplements, or salt substitutes during therapy without consulting prescriber. Take exactly as directed and do not discontinue without consulting prescriber. Medication should be taken at same time each day; may be taken without regard to meals. This drug does not eliminate need for diet or exercise regimen as recommended by prescriber. If you have diabetes, you may be cautioned to monitor glucose levels closely; may alter glucose control. May cause dizziness or lightheadedness (use caution when driving or engaging in tasks that require alertness until response to drug is known); postural hypotension (use caution when rising from lying or sitting position or climbing stairs); or diarrhea. Report immediately swelling of face, lips, or mouth; difficulty swallowing; chest pain or palpitations, unrelenting headache; muscle weakness or pain; unusual cough; or other persistent adverse reactions. This medication may cause injury and death to the developing fetus when used during pregnancy; women of childbearing potential should be informed of potential risk; consult prescriber for appropriate contraceptive measures; this medication should be discontinued as soon as possible once pregnancy is detected.",
"    </p>",
"   </div>",
"   <div class=\"block adi drugH1Div\" id=\"F6894927\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Additional Information",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Potassium content: 25 mg tablets: 2.12 mg (0.054 mEq); 50 mg tablets: 4.24 mg (0.108 mEq; 100 mg tablets: 8.48 mg (0.216 mEq)",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;\">",
"     Evidence from the LIFE study (Dahl&ouml;f, 2002) suggests that when used to reduce the risk of stroke in patients with HTN and LVH, losartan may not be effective in the African-American population.",
"    </p>",
"   </div>",
"   <div class=\"block exp drugH1Div\" id=\"F190202\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Extemporaneous Preparations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     A 2.5 mg/mL losartan oral suspension may be made with tablets and a 1:1 mixture of Ora-Plus&reg; and Ora-Sweet&reg; SF. Combine 10 mL of purified water and ten losartan 50 mg tablets in an 8-ounce amber polyethylene terephthalate bottle. Shake well for at least 2 minutes. Allow concentrate to stand for 1 hour, then shake for 1 minute. Separately, prepare 190 mL of a 1:1 mixture of Ora-Plus&reg; and Ora-Sweet&reg; SF; add to tablet and water mixture in the bottle and shake for 1 minute. Label \"shake well\" and \"refrigerate\". Return promptly to refrigerator after each use. Stable for 4 weeks when stored in amber polyethylene terephthalate prescription bottles and refrigerated (Cozaar&reg; prescribing information, 2008).",
"    </p>",
"    <div class=\"reference\">",
"     Cozaar&reg; prescribing information, Merck &amp; Co, Inc, Whitehouse Station, NJ, 2008.",
"    </div>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      Brooke BS, Habashi JP, Judge DP, et al, \"Angiotensin II Blockade and Aortic-Root Dilation in Marfan's Syndrome,\"",
"      <i>",
"       N Engl J Med",
"      </i>",
"      , 2008, 358(26):2787-95.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?39/19/40247/abstract-text/18579813/pubmed\" id=\"18579813\" target=\"_blank\">",
"        18579813",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Butani L, \"Angiotensin Blockade in Children With Chronic Glomerulonephritis and Heavy Proteinuria,\"",
"      <i>",
"       Pediatr Nephrol",
"      </i>",
"      , 2005, 20(11):1651-4.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?39/19/40247/abstract-text/16133038/pubmed\" id=\"16133038\" target=\"_blank\">",
"        16133038",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Chandar J, Abitbol C, Montan&eacute; B, et al, \"Angiotensin Blockade as Sole Treatment for Proteinuric Kidney Disease in Children,\"",
"      <i>",
"       Nephrol Dial Transplant",
"      </i>",
"      , 2007, 22(5):1332-7.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?39/19/40247/abstract-text/17299000/pubmed\" id=\"17299000\" target=\"_blank\">",
"        17299000",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Dahl&ouml;f B, Devereux RB, Kjeldsen SE, et al, \"Cardiovascular Morbidity and Mortality in the Losartan Intervention For Endpoint Reduction in Hypertension Study (LIFE): A Randomised Trial Against Atenolol,\"",
"      <i>",
"       Lancet",
"      </i>",
"      , 2002, 359(9311):995-1003.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?39/19/40247/abstract-text/11937178/pubmed\" id=\"11937178\" target=\"_blank\">",
"        11937178",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Ellis D, Moritz ML, Vats A, et al, \"Antihypertensive and Renoprotective Efficacy and Safety of Losartan. A Long-Term Study in Children With Renal Disorders,\"",
"      <i>",
"       Am J Hypertens",
"      </i>",
"      , 2004, 17(10):928-35.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?39/19/40247/abstract-text/15485756/pubmed\" id=\"15485756\" target=\"_blank\">",
"        15485756",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Ellis D, Vats A, Moritz ML, et al, \"Long-Term Antiproteinuric and Renoprotective Efficacy and Safety of Losartan in Children With Proteinuria,\"",
"      <i>",
"       J Pediatr",
"      </i>",
"      , 2003, 143(1):89-97.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?39/19/40247/abstract-text/12915830/pubmed\" id=\"12915830\" target=\"_blank\">",
"        12915830",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Hogg RJ, Portman RJ, Milliner D, et al, \"Evaluation and Management of Proteinuria and Nephrotic Syndrome in Children: Recommendations From a Pediatric Nephrology Panel Established at the National Kidney Foundation Conference on Proteinuria, Albuminuria, Risk, Assessment, Detection, and Elimination (PARADE),\"",
"      <i>",
"       Pediatrics",
"      </i>",
"      , 2000, 105(6):1242-9.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?39/19/40247/abstract-text/10835064/pubmed\" id=\"10835064\" target=\"_blank\">",
"        10835064",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Litwin M, Grenda R, Sladowska J, et al, \"Add-On Therapy With Angiotensin II Receptor 1 Blocker in Children With Chronic Kidney Disease Already Treated With Angiotensin-Converting Enzyme Inhibitors,\"",
"      <i>",
"       Pediatr Nephrol",
"      </i>",
"      , 2006, 21(11):1716-22.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?39/19/40247/abstract-text/16909244/pubmed\" id=\"16909244\" target=\"_blank\">",
"        16909244",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      National Heart, Lung, and Blood Institute, \"Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents,&rdquo; Clinical Practice Guidelines, 2011, National Institutes of Health. Available at",
"      <a href=\"file://www.nhlbi.nih.gov/guidelines/cvd_ped/peds_guidelines_full.pdf\" target=\"_blank\">",
"       file://www.nhlbi.nih.gov/guidelines/cvd_ped/peds_guidelines_full.pdf",
"      </a>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents, \"The Fourth Report on the Diagnosis, Evaluation, and Treatment of High Blood Pressure in Children and Adolescents,\"",
"      <i>",
"       Pediatrics",
"      </i>",
"      , 2004, 114(2 Suppl):555-76.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?39/19/40247/abstract-text/15286277/pubmed\" id=\"15286277\" target=\"_blank\">",
"        15286277",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Shahinfar S, Cano F, Soffer BA, et al, \"A Double-Blind, Dose-Response Study of Losartan in Hypertensive Children,\"",
"      <i>",
"       Am J Hypertens",
"      </i>",
"      , 2005, 18(2 Pt 1):183-90.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?39/19/40247/abstract-text/15752945/pubmed\" id=\"15752945\" target=\"_blank\">",
"        15752945",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      White CT, Macpherson CF, Hurley RM, et al, \"Antiproteinuric Effects of Enalapril and Losartan: A Pilot Study,\"",
"      <i>",
"       Pediatr Nephrol",
"      </i>",
"      , 2003, 18(10):1038-43.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?39/19/40247/abstract-text/12920631/pubmed\" id=\"12920631\" target=\"_blank\">",
"        12920631",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Zaffanello M, Franchini M, and Fanos V, \"New Therapeutic Strategies With Combined Renin-Angiotensin System Inhibitors for Pediatric Nephropathy,\"",
"      <i>",
"       Pharmacotherapy",
"      </i>",
"      , 2008, 28(1):125-30.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?39/19/40247/abstract-text/18154482/pubmed\" id=\"18154482\" target=\"_blank\">",
"        18154482",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 13047 Version 44.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-125.39.66.147-ED3CA7AB47-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f39_19_40247=[""].join("\n");
var outline_f39_19_40247=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5709020\">",
"      ALERT: U.S. Boxed Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F190224\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F190225\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1022538\">",
"      Therapeutic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1022574\">",
"      Dosing: Usual",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F190196\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F190181\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1022581\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1022561\">",
"      Stability",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1022539\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F190277\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F190275\">",
"      Adverse Reactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1022545\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6894661\">",
"      Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1022546\">",
"      Warnings",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F190263\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F190190\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1022560\">",
"      Food Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F190192\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F190207\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1022583\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1022563\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6894662\">",
"      Pharmacodynamics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1022565\">",
"      Pharmacokinetics (Adult data unless noted)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1022587\">",
"      Patient Information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6894927\">",
"      Additional Information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F190202\">",
"      Extemporaneous Preparations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_PED/13047\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_PED/13047|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?25/35/26168?source=related_link\">",
"      Losartan: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?25/26/26021?source=related_link\">",
"      Losartan: Patient drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f39_19_40248="Lipoprotein(a) and cardiovascular disease";
var content_f39_19_40248=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Lipoprotein(a) and cardiovascular disease",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?39/19/40248/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?39/19/40248/contributors\">",
"     Robert S Rosenson, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?39/19/40248/contributors\">",
"     James H Stein, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?39/19/40248/contributors\">",
"     Paul Durrington, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?39/19/40248/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?39/19/40248/contributors\">",
"     Mason W Freeman, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?39/19/40248/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?39/19/40248/contributors\">",
"     Gordon M Saperia, MD, FACC",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?39/19/40248/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Sep 5, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most trials of lipid-lowering therapy for the prevention of cardiovascular disease (CVD) focused on patients with elevated LDL-cholesterol levels. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?14/32/14856?source=see_link\">",
"     \"Treatment of lipids (including hypercholesterolemia) in primary prevention\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Although other dyslipidemias, such as an elevated level of lipoprotein(a), also may promote atherosclerosis, interventions directed toward altering these have only infrequently been evaluated in controlled clinical trials [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/19/40248/abstract/1\">",
"     1",
"    </a>",
"    ]. Elevated serum lipoprotein (a), also referred to as Lp(a), is a risk factor for CVD. There is a causal relationship between Lp(a) excess and risk for myocardial infarction (MI). (See",
"    <a class=\"local\" href=\"#H8\">",
"     'Risk factor versus cause'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    This topic will review the genetics, structure and function of Lp(a), as well as its association with atherosclerotic cardiovascular disease. Possible indications for screening and therapy will also be addressed. The association between Lp(a) and aortic valve sclerosis is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?37/24/38279?source=see_link&amp;anchor=H6#H6\">",
"     \"Aortic valve sclerosis\", section on 'Pathogenesis'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     STRUCTURE AND FUNCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Lp(a) is a modified form of low density lipoprotein (LDL) in which a large glycoprotein, apolipoprotein(a) [apo(a)] is covalently bound to apolipoprotein B by a disulfide bridge [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/19/40248/abstract/2\">",
"     2",
"    </a>",
"    ]. The apo(a) chain contains five cysteine rich domains known as \"kringles\" [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/19/40248/abstract/3\">",
"     3",
"    </a>",
"    ]. The fourth kringle is homologous with the fibrin-binding domain of plasminogen, a plasma protein that dissolves blood clots when activated. Because of this structural similarity to plasminogen, Lp(a) interferes with fibrinolysis by competing with plasminogen binding to molecules and cells. This impairs plasminogen activation, plasmin generation, and fibrinolysis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/19/40248/abstract/4,5\">",
"     4,5",
"    </a>",
"    ]. Lp(a) also binds to macrophages via a high-affinity receptor that promotes foam cell formation and the deposition of cholesterol in atherosclerotic plaques [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/19/40248/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     GENETICS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Serum Lp(a) levels are primarily genetically determined. In families without familial hypercholesterolemia, greater than 90 percent of the variability in Lp(a) levels can be explained by polymorphisms at the apo(a) gene locus (isoforms), also referred to as the LPA gene (Online Mendelian Inheritance in Man [MIM] 152200) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/19/40248/abstract/7\">",
"     7",
"    </a>",
"    ]. One important LPA polymorphism is the kringle IV type 2 size polymorphism, which results in a large number of differently sized isoforms of apolipoprotein(a) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/19/40248/abstract/8\">",
"     8",
"    </a>",
"    ]. There is a strong inverse relationship between the size of the apo(a) isoforms and the Lp(a) concentrations [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/19/40248/abstract/7,9-11\">",
"     7,9-11",
"    </a>",
"    ]. A significant proportion (30 to 60 percent) of the population variation in Lp(a) levels is determined by this polymorphism [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/19/40248/abstract/12\">",
"     12",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The distribution of Lp(a) also varies between racial groups. Lp(a) levels are normally distributed in African-American populations; however, Caucasians, Eastern Asian, and Asian Indian populations have Lp(a) distributions that are skewed towards lower levels [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/19/40248/abstract/11\">",
"     11",
"    </a>",
"    ]. According to the Framingham Heart Study, the 90th percentile of Lp(a) levels is 39",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    (1.39",
"    <span class=\"nowrap\">",
"     &micro;mo/L)",
"    </span>",
"    in men and 39.5",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    (1.41",
"    <span class=\"nowrap\">",
"     &micro;mo/L)",
"    </span>",
"   </p>",
"   <p>",
"    in women (units of mass) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/19/40248/abstract/13,14\">",
"     13,14",
"    </a>",
"    ]. Blacks have somewhat higher values than whites [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/19/40248/abstract/15\">",
"     15",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H4\">",
"     'Measurement of serum Lp(a) concentration'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Measurement of serum Lp(a) concentration",
"    </span>",
"    &nbsp;&mdash;&nbsp;Lp(a) initially was identified as a \"sinking\" pre-beta lipoprotein band detected by gel electrophoresis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/19/40248/abstract/16\">",
"     16",
"    </a>",
"    ]. The standard method for measuring Lp(a) is density gradient ultracentrifugation. ELISA techniques are now widely available; however, several of these methods are insensitive, unable to distinguish between apo(a) isoforms, and cross-react with plasminogen, which can result in significant underestimation or overestimation of Lp(a) levels [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/19/40248/abstract/15,17\">",
"     15,17",
"    </a>",
"    ]. A state-of-the art, commercially available assay uses a latex-enhanced immunoturbidimetric method that measures lipoprotein(a) independently of the apolipoprotein(a) size and number of kringle-IV repeats [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/19/40248/abstract/18,19\">",
"     18,19",
"    </a>",
"    ]. Lp(a) levels are stable in individuals with time [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/19/40248/abstract/20\">",
"     20",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     CVD RISK",
"    </span>",
"    &nbsp;&mdash;&nbsp;An association between Lp(a) excess (Lp(a) level above the 95th percentile) and CVD, particularly coronary heart disease (CHD), was initially suggested by relatively small cross-sectional and retrospective epidemiologic studies [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/19/40248/abstract/13,14,21-36\">",
"     13,14,21-36",
"    </a>",
"    ]. The largest prospective analysis (2047 patients and 3921 controls) of the association between Lp(a) excess and incident CHD found an odds ratio of 1.60 (95% CI 1.38-1.85) between the upper and lower thirds of baseline Lp(a) levels after adjustment for traditional cardiovascular risk factors [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/19/40248/abstract/37\">",
"     37",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The best data that summarize the relationship between Lp(a) and CVD come from a 2009 meta-analysis of the individual patient records of over 120,000 participants in 36 prospective studies. In this study the association between Lp(a) and CHD risk was continuous [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/19/40248/abstract/20\">",
"     20",
"    </a>",
"    ]. In the 24 cohort studies in the meta-analysis, the rates of CHD were 5.6 and 4.4 per 1000 person-years in the top and bottom thirds of baseline Lp(a) distributions. After adjustment for multiple traditional risk factors, the risk ratio for CHD was 1.13 (95% CI 1.09-1.18); this is a lower risk ratio than found in the largest single study cited above [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/19/40248/abstract/37\">",
"     37",
"    </a>",
"    ]. The increase in risk with higher Lp(a) was continuous, as has been shown in prior studies [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/19/40248/abstract/20,37\">",
"     20,37",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Lp(a) excess is commonly detected in patients with premature CHD. In one study, for example, Lp(a) excess was present in 18.6 percent of patients with premature CHD, 12.7 percent of whom had no other dyslipidemia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/19/40248/abstract/38\">",
"     38",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Lp(a) is also associated with unstable angina and the presence of complex coronary lesions, suggesting a possible role in plaque rupture and coronary thrombosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/19/40248/abstract/22\">",
"     22",
"    </a>",
"    ]. In patients with an acute coronary syndrome, Lp(a) concentrations are predictive of an increased risk of cardiac death. One study found that among 266 patients with an acute myocardial infarction, a Lp(a) concentration &ge;30",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    (1.07",
"    <span class=\"nowrap\">",
"     &micro;mo/L)",
"    </span>",
"    was associated with a 62 percent increase in cardiac death during a three-year follow-up (29.8 versus 18.6 percent for concentrations &lt;30",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    [1.07",
"    <span class=\"nowrap\">",
"     &micro;mo/L])",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/19/40248/abstract/39\">",
"     39",
"    </a>",
"    ]. Among 197 patients presenting with unstable angina, levels &ge;7.9",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    (0.28",
"    <span class=\"nowrap\">",
"     &micro;mo/L)",
"    </span>",
"    were predictive of subsequent cardiac death (relative risk 2.48).",
"   </p>",
"   <p>",
"    In a systematic review of 40 studies involving 58,000 participants, the relative risk from CHD was 2.08 (95% CI 1.67-2.58) for those with small apo(a) isoforms (&le;22 or fewer kringle IV type 2 repeats), compared to those with large isoforms [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/19/40248/abstract/40\">",
"     40",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Cerebrovascular disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;Lp(a) levels are associated with cerebrovascular disease, a relationship that is stronger in men than in women [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/19/40248/abstract/24,28,41\">",
"     24,28,41",
"    </a>",
"    ]. A meta-analysis that included data from 56,010 subjects with &gt;4609 stroke events found that elevated Lp(a) was a risk factor for stroke, with the strongest evidence coming from prospective cohort studies [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/19/40248/abstract/42\">",
"     42",
"    </a>",
"    ]. In the two available meta-analyses, the range of risk comparing the highest to the lowest tertiles was 1.10 to 1.22 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/19/40248/abstract/20,42\">",
"     20,42",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In a systematic review including six studies that evaluated ischemic stroke as an outcome, the relative risk was 2.14 (95% CI 1.85-2.97) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/19/40248/abstract/40\">",
"     40",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Patients with hypertension",
"    </span>",
"    &nbsp;&mdash;&nbsp;Lp(a) may also play a role in the development of target-organ damage in patients with essential hypertension. In one study, 277 patients with untreated hypertension were compared with 102 healthy controls. Lp(a) levels were the best predictor of target-organ damage involving the kidney, heart, and arterial wall [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/19/40248/abstract/43\">",
"     43",
"    </a>",
"    ]. This relationship was independent of the level of blood pressure. Another independent factor was a higher frequency of low-molecular-weight apo(a) isoforms.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Risk factor versus cause",
"    </span>",
"    &nbsp;&mdash;&nbsp;The continuous positive associations between Lp(a) and CVD risk reviewed above suggest that Lp(a) is an independent risk factor. Evidence that it is causative comes from two gene association studies [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/19/40248/abstract/8,44\">",
"     8,44",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In the first of these, Lp(a) levels, myocardial infarctions, and the frequency of the number of 5.6-kilobase repeats determined by a polymorphism in the Lp(a) gene (which has been inversely related to Lp(a) levels in past studies) were compared in over 30,000 individuals enrolled in three cohorts of Danish citizens [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/19/40248/abstract/8\">",
"     8",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H2\">",
"     'Structure and function'",
"    </a>",
"    above and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?22/18/22823?source=see_link&amp;anchor=H36#H36\">",
"     \"Glossary of common biostatistical and epidemiological terms\", section on 'Mendelian randomization'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The following findings were noted:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Multivariable-adjusted hazard ratios (HR) for MI with increasing Lp(a) levels were 1.2, 1.6, 1.9, and 2.6 events per 10,000 person-years between the 22nd and 66th, 67th and 89th, 90th to 95th percentiles, and greater than the 95th percentile respectively, compared to less than the 22nd percentile. This trend was statistically significant.",
"     </li>",
"     <li>",
"      Mean Lp(a) levels were 56, 31, 20 and 15",
"      <span class=\"nowrap\">",
"       mg/dL",
"      </span>",
"      (1.99, 1.10, 0.71, and 0.53",
"      <span class=\"nowrap\">",
"       &micro;mo/L)",
"      </span>",
"      for the first, second, third, and fourth quartiles of the number of 5.6 kilobase repeats. This trend was statistically significant.",
"     </li>",
"     <li>",
"      The multivariable-adjusted HRs for MI increased significantly as the frequency (by quartile) of the number of 5.6 kilobase repeats. For example, in one of three Danish cohorts, the HR for MI were 1.5, 1.3, and 1.1 events per 10,000 person-years for individuals in the first, second, and third quartiles respectively, compared with individuals in the fourth quartile.",
"     </li>",
"     <li>",
"      A doubling of Lp(a) levels was associated with a 2.2 percent increase in the risk of MI, using a sophisticated statistical analysis.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    A second gene association study evaluated the associations between Lp(a) levels, two common variant chromosomal regions (single nucleotide polymorphisms) near the gene locus that code for apolipoprotein (a), and the presence or absence of coronary artery disease (3145 cases and 3352 controls) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/19/40248/abstract/44\">",
"     44",
"    </a>",
"    ]. The following findings support a causal role for Lp(a):",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The two single nucleotide polymorphisms explained approximately 36 percent of the overall variance in plasma Lp(a) levels.",
"     </li>",
"     <li>",
"      Both variants were strongly and significantly associated with an increased level of Lp(a)",
"     </li>",
"     <li>",
"      Both variants were strongly and significantly associated with an increased risk of coronary artery disease (CAD). Using a meta-analysis technique, the odds ratio for CAD with one variant present was 1.51, 95% CI 1.38-1.66 and for both variants 2.57, 95% CI 1.80-3.67.",
"     </li>",
"     <li>",
"      After adjustment for the Lp(a) level, the association between the presence of the variants and the risk of CAD was no longer present.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The observations from these two gene associate studies are suggestive of a causative relationship between higher Lp(a) and an increased risk of coronary artery disease events. Causality could be proven with a randomized trial showing benefit from a lowering in the risk of events with therapy targeted at reducing Lp(a) levels.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h1\">",
"     MECHANISMS OF CVD RISK",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Atherothrombosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Lp(a) excess may promote atherosclerosis by the following mechanisms:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The VLDL receptor found on the macrophages present in atherosclerotic lesions can bind to and mediate the catabolism of Lp(a) by endocytosis, leading to its degradation within lysosomes [",
"      <a class=\"abstract\" href=\"mobipreview.htm?39/19/40248/abstract/45\">",
"       45",
"      </a>",
"      ]. This could lead to cellular accumulation of lipid within macrophages. Supporting this hypothesis is the observation that Lp(a) is ubiquitous in human coronary atheroma, colocalizes with plaque macrophages, and is detected in larger amounts in tissue from culprit lesions in patients with unstable compared to stable coronary disease [",
"      <a class=\"abstract\" href=\"mobipreview.htm?39/19/40248/abstract/46\">",
"       46",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Binding to the endothelium and components of the extracellular matrix [",
"      <a class=\"abstract\" href=\"mobipreview.htm?39/19/40248/abstract/47\">",
"       47",
"      </a>",
"      ] as well as endothelial dysfunction due to selective impairment of vasodilator capacity of receptor-mediated endothelial stimuli [",
"      <a class=\"abstract\" href=\"mobipreview.htm?39/19/40248/abstract/48\">",
"       48",
"      </a>",
"      ]. The importance of the latter effect is uncertain since Lp(a) may not impair nitric oxide-mediated vasodilation, in contrast to the demonstrated adverse effect of oxidized LDL [",
"      <a class=\"abstract\" href=\"mobipreview.htm?39/19/40248/abstract/49\">",
"       49",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Increased expression of intercellular adhesion molecule-1, resulting in the recruitment of monocytes to the vessel wall and binding to macrophages [",
"      <a class=\"abstract\" href=\"mobipreview.htm?39/19/40248/abstract/50\">",
"       50",
"      </a>",
"      ]. This can promote foam cell formation and the localization of Lp(a) in atherosclerotic plaques [",
"      <a class=\"abstract\" href=\"mobipreview.htm?39/19/40248/abstract/6,51,52\">",
"       6,51,52",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Enhancing the susceptibility of LDL-cholesterol to oxidative modification [",
"      <a class=\"abstract\" href=\"mobipreview.htm?39/19/40248/abstract/53,54\">",
"       53,54",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Interaction with the fibrinolytic and coagulation systems leading to increased tissue-factor mediated thrombosis and inhibition of clot lysis [",
"      <a class=\"abstract\" href=\"mobipreview.htm?39/19/40248/abstract/55\">",
"       55",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    There may also be an association between fibrinogen, apolipoprotein B concentrations, and Lp(a) levels [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/19/40248/abstract/56\">",
"     56",
"    </a>",
"    ]. Also, another study found that the atherogenic effects of Lp(a) may be enhanced or partially mediated through the formation of circulating immune complexes containing Chlamydia pneumoniae-specific IgG antibodies [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/19/40248/abstract/57\">",
"     57",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?24/36/25160?source=see_link\">",
"     \"Chlamydophila (Chlamydia) pneumoniae infection as a potential etiologic factor in atherosclerosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Not all studies have found an association between Lp(a) and atherogenesis. In a cohort consisting primarily of hypertensive patients, Lp(a) levels did not predict coronary artery calcification either in the cohort as a whole or within groups stratified by conventional CHD risk factors [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/19/40248/abstract/58\">",
"     58",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Restenosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The effect of Lp(a) on lipid metabolism, the coagulation and fibrinolytic systems, and the stimulation of smooth muscle cell proliferation suggests that Lp(a) may play a role in restenosis after angioplasty or stenting. However, the data are conflicting [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/19/40248/abstract/59-61\">",
"     59-61",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Myocardial infarction due to vasospasm",
"    </span>",
"    &nbsp;&mdash;&nbsp;The incidence of a myocardial infarction in patients with coronary artery vasospasm is low; the mechanism may be the triggering of thrombus formation and its slow removal due to impaired fibrinolysis. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?3/39/3706?source=see_link\">",
"     \"Variant angina\"",
"    </a>",
"    .) A possible role of Lp(a) in the occurrence of MI in patients with coronary vasospasm was evaluated in one report of 77 patients with coronary spasm, including 16 with a prior MI [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/19/40248/abstract/62\">",
"     62",
"    </a>",
"    ]. The Lp(a) concentration in these patients was higher than in 81 normal controls, but lower than in 177 patients with coronary artery disease. The incidence of high concentrations of Lp(a), defined as &gt;25",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    (0.89",
"    <span class=\"nowrap\">",
"     &micro;mo/L),",
"    </span>",
"    was higher in the patients with coronary spasm who had a MI (56 versus 21 percent in those without an infarction); patients with higher Lp(a) levels had a higher incidence of prior infarction compared to those without high Lp(a) levels (41 versus 13 percent).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h1\">",
"     SCREENING",
"    </span>",
"    &nbsp;&mdash;&nbsp;At present, screening and treatment for Lp(a) excess levels should only be considered for:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Patients with CHD and no other identifiable dyslipidemia",
"     </li>",
"     <li>",
"      Patients with a strong family history of CHD and no other dyslipidemia",
"     </li>",
"     <li>",
"      Patients with hypercholesterolemia refractory to therapy with LDL cholesterol lowering therapies [",
"      <a class=\"abstract\" href=\"mobipreview.htm?39/19/40248/abstract/63\">",
"       63",
"      </a>",
"      ]",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The last recommendation is based upon the observation that in some patients, Lp(a) excess may account for significant component of the LDL-cholesterol level calculated by the Friedewald formula, and that standard LDL-cholesterol lowering therapies do not lower Lp(a) levels appreciably.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h1\">",
"     TREATMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Clinical trials related to the prevention of CHD have not evaluated the effects of specific Lp(a)-lowering therapies, thus all recommendations for treatment are speculative. The primary goal of therapy for Lp(a) excess (Lp(a) concentration above the 95th percentile) is LDL-C reduction to the patient's target LDL-C concentration based upon risk factors (",
"    <a class=\"graphic graphic_table graphicRef82504 \" href=\"mobipreview.htm?11/4/11340\">",
"     table 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/19/40248/abstract/63\">",
"     63",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?10/23/10613?source=see_link\">",
"     \"ATP III guidelines for treatment of high blood cholesterol\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Aggressive LDL-C reduction",
"    </span>",
"    &nbsp;&mdash;&nbsp;Some clinicians recommend treating LDL-C more aggressively in the presence of Lp(a) excess, however the effectiveness of this approach has not been formally studied. In a post-hoc analysis of the Familial Atherosclerosis Treatment Study, elevated Lp(a) levels were associated with progression of coronary atherosclerosis and CHD events ONLY IF the LDL-C level was not reduced by more than ten percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/19/40248/abstract/64\">",
"     64",
"    </a>",
"    ]. In a post-hoc analysis of the Familial Hypercholesterolemia Regression Study of LDL apheresis, Lp(a) reduction did not provide additional angiographic benefit if LDL-C lowering therapy reduced the LDL-C to &lt;130",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/19/40248/abstract/65\">",
"     65",
"    </a>",
"    ]. These studies, although small and not designed to address treatment of Lp(a) excess, provide some evidence that Lp(a) is less important of a CHD predictor when LDL-C has been treated.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Lp(a) reduction",
"    </span>",
"    &nbsp;&mdash;&nbsp;If the LDL-C concentration cannot be reduced to the optimal LDL-C level for an individual patient, use of medications that lower Lp(a) (usually with nicotinic acid) may be initiated. This approach will lower Lp(a) levels and further reduce LDL-C, but this approach has not been shown to improve important outcomes such as death or myocardial infarction.",
"   </p>",
"   <p>",
"    As reviewed below, Lp(a)-lowering is usually accomplished using nicotinic acid, which also reduces LDL-cholesterol and has salutary effects on other aspects of the lipoprotein profile, in addition to Lp(a) reduction.",
"   </p>",
"   <p>",
"    If the decision is made to lower Lp(a) levels, one possible therapeutic goal is to lower Lp(a) cholesterol levels measured by ultracentrifugation to less than 30",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    (1.07",
"    <span class=\"nowrap\">",
"     &micro;mo/L)",
"    </span>",
"    in white patients, a level previously associated with increased CHD risk [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/19/40248/abstract/63,66\">",
"     63,66",
"    </a>",
"    ]; a goal of less than 20 (0.71",
"    <span class=\"nowrap\">",
"     &micro;mo/L)",
"    </span>",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    may be appropriate when Lp(a) protein levels are measured by ELISA. (See",
"    <a class=\"local\" href=\"#H4\">",
"     'Measurement of serum Lp(a) concentration'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h3\">",
"     Lipid-lowering drugs",
"    </span>",
"    &nbsp;&mdash;&nbsp;With respect to lipid-lowering drugs:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Statins and bile acid sequestrates do not reduce Lp(a) levels [",
"      <a class=\"abstract\" href=\"mobipreview.htm?39/19/40248/abstract/35,63\">",
"       35,63",
"      </a>",
"      ]. Lp(a) levels may increase slightly on statins, however this has not been shown to mitigate their beneficial effects on CHD event reduction.",
"     </li>",
"     <li>",
"      Most fibric acid derivatives do not lower Lp(a) levels, except for",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?12/40/12933?source=see_link\">",
"       bezafibrate",
"      </a>",
"      which may produce up to a 39 percent reduction [",
"      <a class=\"abstract\" href=\"mobipreview.htm?39/19/40248/abstract/67-70\">",
"       67-70",
"      </a>",
"      ]. Bezafibrate is not approved for use in the United States.",
"     </li>",
"     <li>",
"      Estrogen replacement therapy (ERT) reduces Lp(a) levels by up to 50 percent [",
"      <a class=\"abstract\" href=\"mobipreview.htm?39/19/40248/abstract/71,72\">",
"       71,72",
"      </a>",
"      ], an effect that was somewhat mitigated by concomitant progesterone therapy in some reports [",
"      <a class=\"abstract\" href=\"mobipreview.htm?39/19/40248/abstract/71-73\">",
"       71-73",
"      </a>",
"      ] but not the PEPI trial [",
"      <a class=\"abstract\" href=\"mobipreview.htm?39/19/40248/abstract/74\">",
"       74",
"      </a>",
"      ]. However, the clinical role for HRT is uncertain and it is not recommended for CVD risk reduction. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?28/36/29258?source=see_link\">",
"       \"Postmenopausal hormone therapy and cardiovascular risk\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Nicotinic acid (2 to 4",
"      <span class=\"nowrap\">",
"       g/day)",
"      </span>",
"      is the most effective therapy for reducing Lp(a) levels [",
"      <a class=\"abstract\" href=\"mobipreview.htm?39/19/40248/abstract/75,76\">",
"       75,76",
"      </a>",
"      ]. In addition to lowering Lp(a) levels, it has multiple, salutary effects on the lipoprotein profile including reduction in LDL-cholesterol, apo B-100, small LDL, and triglycerides, it raises HDL-cholesterol levels and in combination with statins, appears to reduce CHD and CHD risk. Nicotinic acid reduces Lp(a) levels by as much as 38 percent [",
"      <a class=\"abstract\" href=\"mobipreview.htm?39/19/40248/abstract/37,77\">",
"       37,77",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?13/57/14229?source=see_link\">",
"       Neomycin",
"      </a>",
"      (2 to 3",
"      <span class=\"nowrap\">",
"       g/day)",
"      </span>",
"      also lowers Lp(a) levels by as much as 24 percent, but has many side effects and in general should not be used to lower Lp(a) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?39/19/40248/abstract/78\">",
"       78",
"      </a>",
"      ]. Combined therapy with neomycin and niacin lowers Lp(a) and LDL-C levels by 45 percent [",
"      <a class=\"abstract\" href=\"mobipreview.htm?39/19/40248/abstract/78\">",
"       78",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h3\">",
"     Apheresis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The efficacy of Lp(a) apheresis has only been investigated in small observational studies. A 2007 report reviewed many of these studies [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/19/40248/abstract/77\">",
"     77",
"    </a>",
"    ]. The authors suggested that a treatment goal of less than 30",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    (1.07",
"    <span class=\"nowrap\">",
"     &micro;mo/L)",
"    </span>",
"    was reasonable if a patient was receiving apheresis. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?36/25/37274?source=see_link&amp;anchor=H9#H9\">",
"     \"Inherited disorders of LDL-cholesterol metabolism\", section on 'Management'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?10/5/10329?source=see_link&amp;anchor=H2#H2\">",
"     \"Treatment of drug-resistant hypercholesterolemia\", section on 'LDL apheresis'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25929057\">",
"    <span class=\"h2\">",
"     Aspirin",
"    </span>",
"    &nbsp;&mdash;&nbsp;A report from the Women&rsquo;s Health Initiative demonstrated that carriers of a minor allele of apo(a) (rs3798220) had elevated Lp(a), doubled cardiovascular disease risk, and appeared to benefit more from use of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?24/7/24698?source=see_link\">",
"     aspirin",
"    </a>",
"    than noncarriers [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/19/40248/abstract/79\">",
"     79",
"    </a>",
"    ]. After 9.9 years of follow-up, individuals with this minor allele had a nearly doubled risk of major cardiovascular disease events (hazard ratio 2.11, 95% CI 1.39-2.52). However, the risk was more than halved by use of aspirin (HR=0.44, 95% CI 0.20-0.94). The risk was not significantly reduced among non-carriers, and the interaction between carrier status and aspirin use was statistically significant [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/19/40248/abstract/79\">",
"     79",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Lipoprotein(a), also referred to as Lp(a), is a modest, independent risk factor for atherosclerotic CVD events, especially MI. (See",
"    <a class=\"local\" href=\"#H8\">",
"     'Risk factor versus cause'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    There are no clinical trials that have adequately tested the hypothesis that Lp(a) reduction reduces the incidence of first or recurrent CVD events. Therefore, widespread screening for Lp(a) excess is not indicated and treatment of Lp(a) excess should only be considered in specific circumstances, when the treating clinician believes that the possible CVD benefits of Lp(a) reduction or more aggressive LDL cholesterol reduction outweigh the potential risks of therapy.",
"   </p>",
"   <p>",
"    Based upon the available evidence we suggest consideration of targeted screening of the following types of individuals:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Patients with CVD and no other identifiable and treatable dyslipidemia",
"     </li>",
"     <li>",
"      Patients with recurrent CVD events despite adequate risk factor treatment",
"     </li>",
"     <li>",
"      Patients with a strong family history of CHD and no other dyslipidemia",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    When Lp(a) excess (Lp(a) concentration above the 95th percentile) is identified, more aggressive LDL-C targets than those recommended for the general population may be considered. This is based upon the knowledge that there may be modest, excess residual CVD risk associated with high Lp(a) levels. Therapy with a statin or nicotinic acid or both may be needed to achieve these goals. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?2/59/3002?source=see_link&amp;anchor=H13#H13\">",
"     \"Intensity of lipid lowering therapy in secondary prevention of coronary heart disease\", section on 'Summary and recommendations'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The following suggestions for treatment of Lp(a) excess are speculative and await confirmation in clinical trials:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      We suggest the addition of nicotinic acid for individuals on maximal dose statin therapy who have not achieved LDL-C targets (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). If such an approach is chosen, we titrate niacin to the maximally tolerated recommended dose in an attempt to lower LDL-C to target. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?41/14/42217?source=see_link&amp;anchor=H5#H5\">",
"       \"Lipid lowering with drugs other than statins and fibrates\", section on 'Nicotinic acid (Niacin)'",
"      </a>",
"      and",
"      <a class=\"local\" href=\"#H14\">",
"       'Treatment'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We suggest the use LDL-C lowering therapy for individuals with a family history of premature cardiovascular disease whose LDL-C does not make them candidates for a statin based on national guidelines (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). In this situation, we support an optional target of LDL-C &lt;100",
"      <span class=\"nowrap\">",
"       mg/dL.",
"      </span>",
"      A statin is preferred, and niacin may be added if necessary to reach this lower goal. (See",
"      <a class=\"local\" href=\"#H14\">",
"       'Treatment'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/19/40248/abstract/1\">",
"      Rosenson RS. Beyond low-density lipoprotein cholesterol. A perspective on low high-density lipoprotein disorders and Lp(a) lipoprotein excess. Arch Intern Med 1996; 156:1278.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/19/40248/abstract/2\">",
"      Steyrer E, Durovic S, Frank S, et al. The role of lecithin: cholesterol acyltransferase for lipoprotein (a) assembly. Structural integrity of low density lipoproteins is a prerequisite for Lp(a) formation in human plasma. J Clin Invest 1994; 94:2330.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/19/40248/abstract/3\">",
"      McLean JW, Tomlinson JE, Kuang WJ, et al. cDNA sequence of human apolipoprotein(a) is homologous to plasminogen. Nature 1987; 330:132.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/19/40248/abstract/4\">",
"      Loscalzo J, Weinfeld M, Fless GM, Scanu AM. Lipoprotein(a), fibrin binding, and plasminogen activation. Arteriosclerosis 1990; 10:240.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/19/40248/abstract/5\">",
"      Palabrica TM, Liu AC, Aronovitz MJ, et al. Antifibrinolytic activity of apolipoprotein(a) in vivo: human apolipoprotein(a) transgenic mice are resistant to tissue plasminogen activator-mediated thrombolysis. Nat Med 1995; 1:256.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/19/40248/abstract/6\">",
"      Zioncheck TF, Powell LM, Rice GC, et al. Interaction of recombinant apolipoprotein(a) and lipoprotein(a) with macrophages. J Clin Invest 1991; 87:767.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/19/40248/abstract/7\">",
"      Boerwinkle E, Leffert CC, Lin J, et al. Apolipoprotein(a) gene accounts for greater than 90% of the variation in plasma lipoprotein(a) concentrations. J Clin Invest 1992; 90:52.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/19/40248/abstract/8\">",
"      Kamstrup PR, Tybjaerg-Hansen A, Steffensen R, Nordestgaard BG. Genetically elevated lipoprotein(a) and increased risk of myocardial infarction. JAMA 2009; 301:2331.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/19/40248/abstract/9\">",
"      Bowden JF, Pritchard PH, Hill JS, Frohlich JJ. Lp(a) concentration and apo(a) isoform size. Relation to the presence of coronary artery disease in familial hypercholesterolemia. Arterioscler Thromb 1994; 14:1561.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/19/40248/abstract/10\">",
"      Kraft HG, Lingenhel A, K&ouml;chl S, et al. Apolipoprotein(a) kringle IV repeat number predicts risk for coronary heart disease. Arterioscler Thromb Vasc Biol 1996; 16:713.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/19/40248/abstract/11\">",
"      Sandholzer C, Saha N, Kark JD, et al. Apo(a) isoforms predict risk for coronary heart disease. A study in six populations. Arterioscler Thromb 1992; 12:1214.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/19/40248/abstract/12\">",
"      Thanassoulis G, O'Donnell CJ. Mendelian randomization: nature's randomized trial in the post-genome era. JAMA 2009; 301:2386.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/19/40248/abstract/13\">",
"      Bostom AG, Gagnon DR, Cupples LA, et al. A prospective investigation of elevated lipoprotein (a) detected by electrophoresis and cardiovascular disease in women. The Framingham Heart Study. Circulation 1994; 90:1688.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/19/40248/abstract/14\">",
"      Bostom AG, Cupples LA, Jenner JL, et al. Elevated plasma lipoprotein(a) and coronary heart disease in men aged 55 years and younger. A prospective study. JAMA 1996; 276:544.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/19/40248/abstract/15\">",
"      Marcovina SM, Albers JJ, Wijsman E, et al. Differences in Lp[a] concentrations and apo[a] polymorphs between black and white Americans. J Lipid Res 1996; 37:2569.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/19/40248/abstract/16\">",
"      Dahl&eacute;n G, Ericson C, Furberg C, et al. Studies on an extra pre-beta lipoprotein fraction. Acta Med Scand Suppl 1972; 531:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/19/40248/abstract/17\">",
"      Superko HR. Beyond LDL cholesterol reduction. Circulation 1996; 94:2351.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/19/40248/abstract/18\">",
"      Marcovina SM, Koschinsky ML, Albers JJ, Skarlatos S. Report of the National Heart, Lung, and Blood Institute Workshop on Lipoprotein(a) and Cardiovascular Disease: recent advances and future directions. Clin Chem 2003; 49:1785.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/19/40248/abstract/19\">",
"      Marcovina SM, Albers JJ, Scanu AM, et al. Use of a reference material proposed by the International Federation of Clinical Chemistry and Laboratory Medicine to evaluate analytical methods for the determination of plasma lipoprotein(a). Clin Chem 2000; 46:1956.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/19/40248/abstract/20\">",
"      Emerging Risk Factors Collaboration, Erqou S, Kaptoge S, et al. Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality. JAMA 2009; 302:412.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/19/40248/abstract/21\">",
"      Danesh J, Collins R, Peto R. Lipoprotein(a) and coronary heart disease. Meta-analysis of prospective studies. Circulation 2000; 102:1082.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/19/40248/abstract/22\">",
"      Dangas G, Ambrose JA, D'Agate DJ, et al. Correlation of serum lipoprotein(a) with the angiographic and clinical presentation of coronary artery disease. Am J Cardiol 1999; 83:583.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/19/40248/abstract/23\">",
"      Schaefer EJ, Lamon-Fava S, Jenner JL, et al. Lipoprotein(a) levels and risk of coronary heart disease in men. The lipid Research Clinics Coronary Primary Prevention Trial. JAMA 1994; 271:999.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/19/40248/abstract/24\">",
"      Nguyen TT, Ellefson RD, Hodge DO, et al. Predictive value of electrophoretically detected lipoprotein(a) for coronary heart disease and cerebrovascular disease in a community-based cohort of 9936 men and women. Circulation 1997; 96:1390.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/19/40248/abstract/25\">",
"      Wald NJ, Law M, Watt HC, et al. Apolipoproteins and ischaemic heart disease: implications for screening. Lancet 1994; 343:75.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/19/40248/abstract/26\">",
"      Cremer P, Nagel D, Labrot B, et al. Lipoprotein Lp(a) as predictor of myocardial infarction in comparison to fibrinogen, LDL cholesterol and other risk factors: results from the prospective G&ouml;ttingen Risk Incidence and Prevalence Study (GRIPS). Eur J Clin Invest 1994; 24:444.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/19/40248/abstract/27\">",
"      Schwartzman RA, Cox ID, Poloniecki J, et al. Elevated plasma lipoprotein(a) is associated with coronary artery disease in patients with chronic stable angina pectoris. J Am Coll Cardiol 1998; 31:1260.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/19/40248/abstract/28\">",
"      Ariyo AA, Thach C, Tracy R, Cardiovascular Health Study Investigators. Lp(a) lipoprotein, vascular disease, and mortality in the elderly. N Engl J Med 2003; 349:2108.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/19/40248/abstract/29\">",
"      Shai I, Rimm EB, Hankinson SE, et al. Lipoprotein (a) and coronary heart disease among women: beyond a cholesterol carrier? Eur Heart J 2005; 26:1633.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/19/40248/abstract/30\">",
"      Coleman MP, Key TJ, Wang DY, et al. A prospective study of obesity, lipids, apolipoproteins and ischaemic heart disease in women. Atherosclerosis 1992; 92:177.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/19/40248/abstract/31\">",
"      Ridker PM, Hennekens CH, Stampfer MJ. A prospective study of lipoprotein(a) and the risk of myocardial infarction. JAMA 1993; 270:2195.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/19/40248/abstract/32\">",
"      Jauhiainen M, Koskinen P, Ehnholm C, et al. Lipoprotein (a) and coronary heart disease risk: a nested case-control study of the Helsinki Heart Study participants. Atherosclerosis 1991; 89:59.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/19/40248/abstract/33\">",
"      Cantin B, Gagnon F, Moorjani S, et al. Is lipoprotein(a) an independent risk factor for ischemic heart disease in men? The Quebec Cardiovascular Study. J Am Coll Cardiol 1998; 31:519.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/19/40248/abstract/34\">",
"      Nishino M, Malloy MJ, Naya-Vigne J, et al. Lack of association of lipoprotein(a) levels with coronary calcium deposits in asymptomatic postmenopausal women. J Am Coll Cardiol 2000; 35:314.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/19/40248/abstract/35\">",
"      Cobbaert C, Jukema JW, Zwinderman AH, et al. Modulation of lipoprotein(a) atherogenicity by high density lipoprotein cholesterol levels in middle-aged men with symptomatic coronary artery disease and normal to moderately elevated serum cholesterol. Regression Growth Evaluation Statin Study (REGRESS) Study Group. J Am Coll Cardiol 1997; 30:1491.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/19/40248/abstract/36\">",
"      von Eckardstein A, Schulte H, Cullen P, Assmann G. Lipoprotein(a) further increases the risk of coronary events in men with high global cardiovascular risk. J Am Coll Cardiol 2001; 37:434.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/19/40248/abstract/37\">",
"      Bennet A, Di Angelantonio E, Erqou S, et al. Lipoprotein(a) levels and risk of future coronary heart disease: large-scale prospective data. Arch Intern Med 2008; 168:598.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/19/40248/abstract/38\">",
"      Genest JJ Jr, Martin-Munley SS, McNamara JR, et al. Familial lipoprotein disorders in patients with premature coronary artery disease. Circulation 1992; 85:2025.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/19/40248/abstract/39\">",
"      Stubbs P, Seed M, Lane D, et al. Lipoprotein(a) as a risk predictor for cardiac mortality in patients with acute coronary syndromes. Eur Heart J 1998; 19:1355.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/19/40248/abstract/40\">",
"      Erqou S, Thompson A, Di Angelantonio E, et al. Apolipoprotein(a) isoforms and the risk of vascular disease: systematic review of 40 studies involving 58,000 participants. J Am Coll Cardiol 2010; 55:2160.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/19/40248/abstract/41\">",
"      Ohira T, Schreiner PJ, Morrisett JD, et al. Lipoprotein(a) and incident ischemic stroke: the Atherosclerosis Risk in Communities (ARIC) study. Stroke 2006; 37:1407.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/19/40248/abstract/42\">",
"      Smolders B, Lemmens R, Thijs V. Lipoprotein (a) and stroke: a meta-analysis of observational studies. Stroke 2007; 38:1959.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/19/40248/abstract/43\">",
"      Sechi LA, Kronenberg F, De Carli S, et al. Association of serum lipoprotein(a) levels and apolipoprotein(a) size polymorphism with target-organ damage in arterial hypertension. JAMA 1997; 277:1689.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/19/40248/abstract/44\">",
"      Clarke R, Peden JF, Hopewell JC, et al. Genetic variants associated with Lp(a) lipoprotein level and coronary disease. N Engl J Med 2009; 361:2518.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/19/40248/abstract/45\">",
"      Argraves KM, Kozarsky KF, Fallon JT, et al. The atherogenic lipoprotein Lp(a) is internalized and degraded in a process mediated by the VLDL receptor. J Clin Invest 1997; 100:2170.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/19/40248/abstract/46\">",
"      Dangas G, Mehran R, Harpel PC, et al. Lipoprotein(a) and inflammation in human coronary atheroma: association with the severity of clinical presentation. J Am Coll Cardiol 1998; 32:2035.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/19/40248/abstract/47\">",
"      Salonen EM, Jauhiainen M, Zardi L, et al. Lipoprotein(a) binds to fibronectin and has serine proteinase activity capable of cleaving it. EMBO J 1989; 8:4035.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/19/40248/abstract/48\">",
"      Schachinger V, Halle M, Minners J, et al. Lipoprotein(a) selectively impairs receptor-mediated endothelial vasodilator function of the human coronary circulation. J Am Coll Cardiol 1997; 30:927.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/19/40248/abstract/49\">",
"      Schlaich MP, John S, Langenfeld MR, et al. Does lipoprotein(a) impair endothelial function? J Am Coll Cardiol 1998; 31:359.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/19/40248/abstract/50\">",
"      Takami S, Yamashita S, Kihara S, et al. Lipoprotein(a) enhances the expression of intercellular adhesion molecule-1 in cultured human umbilical vein endothelial cells. Circulation 1998; 97:721.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/19/40248/abstract/51\">",
"      Haberland ME, Fless GM, Scanu AM, Fogelman AM. Malondialdehyde modification of lipoprotein(a) produces avid uptake by human monocyte-macrophages. J Biol Chem 1992; 267:4143.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/19/40248/abstract/52\">",
"      Poon M, Zhang X, Dunsky KG, et al. Apolipoprotein(a) induces monocyte chemotactic activity in human vascular endothelial cells. Circulation 1997; 96:2514.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/19/40248/abstract/53\">",
"      Riis Hansen P, Kharazmi A, Jauhiainen M, Ehnholm C. Induction of oxygen free radical generation in human monocytes by lipoprotein(a). Eur J Clin Invest 1994; 24:497.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/19/40248/abstract/54\">",
"      Tsimikas S, Brilakis ES, Miller ER, et al. Oxidized phospholipids, Lp(a) lipoprotein, and coronary artery disease. N Engl J Med 2005; 353:46.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/19/40248/abstract/55\">",
"      Deb A, Caplice NM. Lipoprotein(a): new insights into mechanisms of atherogenesis and thrombosis. Clin Cardiol 2004; 27:258.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/19/40248/abstract/56\">",
"      Braeckman L, De Bacquer D, Rosseneu M, De Backer G. Determinants of lipoprotein(a) levels in a middle-aged working population. Eur Heart J 1996; 17:1808.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/19/40248/abstract/57\">",
"      Glader CA, Boman J, Saikku P, et al. The proatherogenic properties of lipoprotein(a) may be enhanced through the formation of circulating immune complexes containing Chlamydia pneumoniae-specific IgG antibodies. Eur Heart J 2000; 21:639.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/19/40248/abstract/58\">",
"      Kullo IJ, Bailey KR, Bielak LF, et al. Lack of association between lipoprotein(a) and coronary artery calcification in the Genetic Epidemiology Network of Arteriopathy (GENOA) study. Mayo Clin Proc 2004; 79:1258.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/19/40248/abstract/59\">",
"      Desmarais RL, Sarembock IJ, Ayers CR, et al. Elevated serum lipoprotein(a) is a risk factor for clinical recurrence after coronary balloon angioplasty. Circulation 1995; 91:1403.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/19/40248/abstract/60\">",
"      Ribichini F, Steffenino G, Dellavalle A, et al. Plasma lipoprotein(a) is not a predictor for restenosis after elective high-pressure coronary stenting. Circulation 1998; 98:1172.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/19/40248/abstract/61\">",
"      Giovanetti F, Gargiulo M, Laghi L, et al. Lipoprotein(a) and other serum lipid subfractions influencing primary patency after infrainguinal percutaneous transluminal angioplasty. J Endovasc Ther 2009; 16:389.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/19/40248/abstract/62\">",
"      Miwa K, Nakagawa K, Yoshida N, et al. Lipoprotein(a) is a risk factor for occurrence of acute myocardial infarction in patients with coronary vasospasm. J Am Coll Cardiol 2000; 35:1200.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/19/40248/abstract/63\">",
"      Stein JH, Rosenson RS. Lipoprotein Lp(a) excess and coronary heart disease. Arch Intern Med 1997; 157:1170.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/19/40248/abstract/64\">",
"      Maher VM, Brown BG. Lipoprotein (a) and coronary heart disease. Curr Opin Lipidol 1995; 6:229.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/19/40248/abstract/65\">",
"      Thompson GR, Maher VM, Matthews S, et al. Familial Hypercholesterolaemia Regression Study: a randomised trial of low-density-lipoprotein apheresis. Lancet 1995; 345:811.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/19/40248/abstract/66\">",
"      Rader DJ, Brewer HB Jr. Lipoprotein(a). Clinical approach to a unique atherogenic lipoprotein. JAMA 1992; 267:1109.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/19/40248/abstract/67\">",
"      B&oslash;rresen AL, Berg K, Dahl&eacute;n G, et al. The effect of Gemfibrozil on human serum apolipoproteins and on serum reserve cholesterol binding capacity (SRCBC). Artery 1981; 9:77.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/19/40248/abstract/68\">",
"      Jones PH, Pownall HJ, Patsch W, et al. Effect of gemfibrozil on levels of lipoprotein[a] in type II hyperlipoproteinemic subjects. J Lipid Res 1996; 37:1298.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/19/40248/abstract/69\">",
"      Maggi FM, Biasi GM, Catapano AL. Reduction of Lp(a) plasma levels by bezafibrate. Atherosclerosis 1993; 100:127.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/19/40248/abstract/70\">",
"      Bimmermann A, Boerschmann C, Schwartzkopff W, et al. Effective therapeutic measures for reducing lipoprotein(a) in patients with dyslipidemia. Lipoprotein(a) reduction with sustained-release bezafibrate. Curr Ther Res 1991; 49:635.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/19/40248/abstract/71\">",
"      Sacks FM, McPherson R, Walsh BW. Effect of postmenopausal estrogen replacement on plasma Lp(a) lipoprotein concentrations. Arch Intern Med 1994; 154:1106.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/19/40248/abstract/72\">",
"      Kim CJ, Min YK, Ryu WS, et al. Effect of hormone replacement therapy on lipoprotein(a) and lipid levels in postmenopausal women. Influence of various progestogens and duration of therapy. Arch Intern Med 1996; 156:1693.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/19/40248/abstract/73\">",
"      Grodstein F, Stampfer MJ, Manson JE, et al. Postmenopausal estrogen and progestin use and the risk of cardiovascular disease. N Engl J Med 1996; 335:453.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/19/40248/abstract/74\">",
"      Espeland MA, Marcovina SM, Miller V, et al. Effect of postmenopausal hormone therapy on lipoprotein(a) concentration. PEPI Investigators. Postmenopausal Estrogen/Progestin Interventions. Circulation 1998; 97:979.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/19/40248/abstract/75\">",
"      Carlson LA, Hamsten A, Asplund A. Pronounced lowering of serum levels of lipoprotein Lp(a) in hyperlipidaemic subjects treated with nicotinic acid. J Intern Med 1989; 226:271.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/19/40248/abstract/76\">",
"      Guyton JR, Blazing MA, Hagar J, et al. Extended-release niacin vs gemfibrozil for the treatment of low levels of high-density lipoprotein cholesterol. Niaspan-Gemfibrozil Study Group. Arch Intern Med 2000; 160:1177.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/19/40248/abstract/77\">",
"      Keller C. Apheresis in coronary heart disease with elevated Lp (a): a review of Lp (a) as a risk factor and its management. Ther Apher Dial 2007; 11:2.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/19/40248/abstract/78\">",
"      Gurakar A, Hoeg JM, Kostner G, et al. Levels of lipoprotein Lp(a) decline with neomycin and niacin treatment. Atherosclerosis 1985; 57:293.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/19/40248/abstract/79\">",
"      Chasman DI, Shiffman D, Zee RY, et al. Polymorphism in the apolipoprotein(a) gene, plasma lipoprotein(a), cardiovascular disease, and low-dose aspirin therapy. Atherosclerosis 2009; 203:371.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 4566 Version 11.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-58.22.229.50-9649136F8B-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f39_19_40248=[""].join("\n");
var outline_f39_19_40248=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H19\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      STRUCTURE AND FUNCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      GENETICS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Measurement of serum Lp(a) concentration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      CVD RISK",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Cerebrovascular disease",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Patients with hypertension",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Risk factor versus cause",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      MECHANISMS OF CVD RISK",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Atherothrombosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Restenosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Myocardial infarction due to vasospasm",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      SCREENING",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Aggressive LDL-C reduction",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Lp(a) reduction",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      - Lipid-lowering drugs",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      - Apheresis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H25929057\">",
"      Aspirin",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"CARD/4566\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"CARD/4566|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?11/4/11340\" title=\"table 1\">",
"      ATPIII LDL goals",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?10/23/10613?source=related_link\">",
"      ATP III guidelines for treatment of high blood cholesterol",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?37/24/38279?source=related_link\">",
"      Aortic valve sclerosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?24/36/25160?source=related_link\">",
"      Chlamydophila (Chlamydia) pneumoniae infection as a potential etiologic factor in atherosclerosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?22/18/22823?source=related_link\">",
"      Glossary of common biostatistical and epidemiological terms",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?36/25/37274?source=related_link\">",
"      Inherited disorders of LDL-cholesterol metabolism",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?2/59/3002?source=related_link\">",
"      Intensity of lipid lowering therapy in secondary prevention of coronary heart disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?41/14/42217?source=related_link\">",
"      Lipid lowering with drugs other than statins and fibrates",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?28/36/29258?source=related_link\">",
"      Postmenopausal hormone therapy and cardiovascular risk",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?10/5/10329?source=related_link\">",
"      Treatment of drug-resistant hypercholesterolemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?14/32/14856?source=related_link\">",
"      Treatment of lipids (including hypercholesterolemia) in primary prevention",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?3/39/3706?source=related_link\">",
"      Variant angina",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f39_19_40249="Child abuse: Evaluation and diagnosis of abusive head trauma in infants and children";
var content_f39_19_40249=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"5\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Child abuse: Evaluation and diagnosis of abusive head trauma in infants and children",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?39/19/40249/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?39/19/40249/contributors\">",
"     Cindy Christian, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?39/19/40249/contributors\">",
"     Erin E Endom, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?39/19/40249/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?39/19/40249/contributors\">",
"     Daniel M Lindberg, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?39/19/40249/contributors\">",
"     Jan E Drutz, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?39/19/40249/contributors\">",
"     Douglas R Nordli, Jr, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?39/19/40249/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?39/19/40249/contributors\">",
"     James F Wiley, II, MD, MPH",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?39/19/40249/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Feb 26, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;More than 40 percent of deaths from child abuse occur among children younger than 12 months of age [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/19/40249/abstract/1\">",
"     1",
"    </a>",
"    ]. Abusive head injury is the most common cause of death as the result of child abuse. Infants frequently present with nonspecific clinical features without a history of trauma. As a result, as many as 30 percent of children with abusive head injury may be misdiagnosed at the initial evaluation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/19/40249/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Identification of abusive head injury can be life-saving. In one chart review describing missed cases of abusive head injury, four of five deaths might have been prevented if the inflicted mechanism had been recognized during previous evaluations for symptoms related to head injury [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/19/40249/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Cranial injury may be inflicted by blunt force trauma, shaking, or a combination of forces. The constellation of injuries associated with this mechanism has been referred to as the \"shaken baby syndrome\" (SBS), the \"infant whiplash syndrome\", the",
"    <span class=\"nowrap\">",
"     \"shaken/impact",
"    </span>",
"    syndrome\", or more simply, as \"inflicted or abusive head injury\". For many young infants, crying may be a trigger for the shaking episode, suggesting that the caretakers' response to prolonged crying may be an effective target for prevention strategies [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/19/40249/abstract/3-5\">",
"     3-5",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H24\">",
"     'Prevention'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    The significance of the diagnosis (with regard to morbidity, child protection, and criminal prosecution) may be similar, regardless of whether injury resulted from direct blows or from shaking. In addition, much of the evidence to support the mechanism of injuries that result from shaking is retrospective and indirect. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?32/13/32985?source=see_link&amp;anchor=H4#H4\">",
"     \"Child abuse: Epidemiology, mechanisms, and types of abusive head trauma in infants and children\", section on 'Mechanisms of injury'",
"    </a>",
"    .) Some experts have suggested that the term \"shaken baby syndrome\" be replaced with a more generic term such as \"abusive head injury\" or \"inflicted neurotrauma\", allowing for consideration of multiple mechanisms of injury in any child. Generic terms, such as \"head injury\", also serve to distinguish the diagnosis of injury from the investigation of how the injury occurred [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/19/40249/abstract/6,7\">",
"     6,7",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The evaluation and diagnosis of abusive head injury in infants and children will be presented here. The epidemiology, mechanisms, and ophthalmologic aspects of abusive head injury in children, management of suspected child abuse, and the initial evaluation of severe traumatic brain injury in children are reviewed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?32/13/32985?source=see_link\">",
"     \"Child abuse: Epidemiology, mechanisms, and types of abusive head trauma in infants and children\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?20/7/20602?source=see_link\">",
"     \"Child abuse: Eye findings in children with abusive head trauma (AHT)\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?4/9/4250?source=see_link\">",
"     \"Initial approach to severe traumatic brain injury in children\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?24/19/24890?source=see_link\">",
"     \"Physical abuse in children: Diagnostic evaluation and management\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     CLINICAL FEATURES",
"    </span>",
"    &nbsp;&mdash;&nbsp;The clinical manifestations of abusive head injury are often nonspecific. Furthermore, a history of trauma usually is not forthcoming and external signs of injury (such as bruising of the skin) may be minimal or absent.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     History",
"    </span>",
"    &nbsp;&mdash;&nbsp;The symptoms for which caregivers most often seek medical attention for children with abusive head injury include seizures, breathing difficulty, apnea, and lifelessness [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/19/40249/abstract/8-13\">",
"     8-13",
"    </a>",
"    ]. In comparison, in a population-based series describing the clinical features of children with inflicted and unintentional head injury, reasons for seeking care for those with unintentional head injury included local swelling following injury, parental concern for children who were asymptomatic, and lethargy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/19/40249/abstract/9\">",
"     9",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    No history of a traumatic event was offered in 64 to 97 percent of cases of abusive head injury described in several retrospective series [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/19/40249/abstract/9,10,14,15\">",
"     9,10,14,15",
"    </a>",
"    ]. In one of these reports, the absence of a history of trauma had a high specificity (0.97 [95% Cl 0.83-1.0]) and high positive predictive value (0.92 [95% Cl 0.78-0.98]) for abusive head injury [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/19/40249/abstract/10\">",
"     10",
"    </a>",
"    ]. Other historical features that are typical include attributing the injuries to resuscitative efforts and a changing or developmentally incompatible history [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/19/40249/abstract/9,10\">",
"     9,10",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Accurately determining when an injury occurred can be difficult, since the traumatic event is infrequently disclosed and initial symptoms may be nonspecific. However, a retrospective review describing cases where perpetrators admitted to abuse noted that 91 percent of children developed symptoms immediately after the injury [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/19/40249/abstract/16\">",
"     16",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Finally, a history of previous abuse",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    investigation for maltreatment is common among children who have sustained abusive head injury. Retrospective series have reported that over 60 percent of victims of abusive head injury may have a history",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    clinical evidence of previous abuse [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/19/40249/abstract/8,17,18\">",
"     8,17,18",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Physical examination",
"    </span>",
"    &nbsp;&mdash;&nbsp;Children with abusive head injury may have physical findings ranging from a normal neurologic examination, to nonspecific signs related to brain injury (such as vomiting and altered mental status), to profoundly unstable vital signs (apnea, bradycardia) requiring resuscitation. This is illustrated in the following reports:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Two retrospective series reported that occult head injury was diagnosed on screening neuroimaging studies in 37 and 29 percent of children being evaluated for child abuse who had no neurologic symptoms [",
"      <a class=\"abstract\" href=\"mobipreview.htm?39/19/40249/abstract/19,20\">",
"       19,20",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In a retrospective series describing infants who were evaluated for complaints that were not initially recognized as the result of abusive head trauma, 65 percent were described as irritable [",
"      <a class=\"abstract\" href=\"mobipreview.htm?39/19/40249/abstract/2\">",
"       2",
"      </a>",
"      ]. An abnormal mental status was reported for 35 percent of children and 56 percent were vomiting.",
"     </li>",
"     <li>",
"      A retrospective report noted that 39 percent of children with abusive head injury required cardiopulmonary resuscitation at initial presentation [",
"      <a class=\"abstract\" href=\"mobipreview.htm?39/19/40249/abstract/9\">",
"       9",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The majority of children with abusive head injury initially have an abnormal neurologic examination [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/19/40249/abstract/8-10\">",
"     8-10",
"    </a>",
"    ]. Many children have no external signs of injury (35 and 40 percent in two reports) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/19/40249/abstract/8,9\">",
"     8,9",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h3\">",
"     Retinal hemorrhages",
"    </span>",
"    &nbsp;&mdash;&nbsp;Retinal hemorrhages are frequently noted in children with abusive head injury (60 to 85 percent in retrospective series) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/19/40249/abstract/8,9,15,21\">",
"     8,9,15,21",
"    </a>",
"    ]. The extent of retinal hemorrhages is generally correlated with the severity of intracranial injury and neurologic impairment [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/19/40249/abstract/21\">",
"     21",
"    </a>",
"    ]. Among abused neurologically normal children whose intracranial injuries were diagnosed with screening neuroimaging, retinal hemorrhages were uncommon [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/19/40249/abstract/19,20\">",
"     19,20",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Although retinal hemorrhages have been reported in other conditions, those associated with abusive head injury are characteristically numerous, involve multiple layers of the retina, and extend beyond the posterior pole to the peripheral retina (",
"    <a class=\"graphic graphic_picture graphicRef69754 \" href=\"mobipreview.htm?38/62/39919\">",
"     picture 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/19/40249/abstract/22,23\">",
"     22,23",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H16\">",
"     'Differential diagnosis'",
"    </a>",
"    below.) Injury to the eye as the result on abusive head injury is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?20/7/20602?source=see_link\">",
"     \"Child abuse: Eye findings in children with abusive head trauma (AHT)\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h3\">",
"     Cutaneous bruising",
"    </span>",
"    &nbsp;&mdash;&nbsp;Children with abusive head injury may have cutaneous bruising, particularly around the face [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/19/40249/abstract/11,24\">",
"     11,24",
"    </a>",
"    ]. Suspicious bruising patterns such as linear strap marks or bruises over the buttock also raise concern for inflicted injury among children with a nonspecific presentation. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?25/54/26473?source=see_link&amp;anchor=H10#H10\">",
"     \"Physical abuse in children: Epidemiology and clinical manifestations\", section on 'Bruising patterns'",
"    </a>",
"    .) However, in one retrospective series describing children with abusive head injury, 54 percent had no bruising noted at initial presentation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/19/40249/abstract/8\">",
"     8",
"    </a>",
"    ]. Bruising in non-ambulatory infants is rare, and any bruise to a young infant should raise concerns of either trauma or a bleeding diathesis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/19/40249/abstract/25,26\">",
"     25,26",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     Associated injuries",
"    </span>",
"    &nbsp;&mdash;&nbsp;Children with abusive head injury frequently have injuries to other organ systems that are typically associated with abuse. In two retrospective series, 22 and 23 percent of children with abusive head injury also had rib fractures [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/19/40249/abstract/8,9\">",
"     8,9",
"    </a>",
"    ]. Long bone fractures were reported in 23 and 29 percent of cases. In one of the reports, 4 percent of children sustained an abdominal injury [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/19/40249/abstract/8\">",
"     8",
"    </a>",
"    ]. Cervical spinal injury may be more common in children with fatal injuries [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/19/40249/abstract/27\">",
"     27",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Injury to the cervical spine as the result of abusive head injury is uncommonly recognized, but possibly more common than reported [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/19/40249/abstract/28,29\">",
"     28,29",
"    </a>",
"    ]. In a large retrospective series describing the clinical characteristics of children with abusive head injury, 4 percent also had injury to the cervical spine. Spinal magnetic resonance imaging is the best method for detecting these injuries [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/19/40249/abstract/30\">",
"     30",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     EVALUATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnosis of abusive head injury requires a high index of suspicion. The signs and symptoms may be mild and nonspecific (eg, vomiting, poor feeding, irritability, or lethargy) or severe and even life-threatening (eg, apnea or other breathing abnormalities, coma, seizures) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/19/40249/abstract/2,11,31\">",
"     2,11,31",
"    </a>",
"    ]. Although children who present with serious head injury usually can be readily identified, subtle injuries may be missed. Once the diagnosis is suspected, a careful evaluation must be performed to identify supporting clinical features and exclude other diagnoses.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Laboratory studies",
"    </span>",
"    &nbsp;&mdash;&nbsp;Children with abusive head injury are frequently ill-appearing with nonspecific clinical features. There is often no history of trauma. The following laboratory studies may provide specific diagnostic information:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Complete blood count, a platelet count, and coagulation studies may indicate an underlying bleeding disorder, although coagulopathy (as evidenced by decreased hematocrit, lower platelet count, and mildly prolonged prothrombin time) has been reported in children with parenchymal brain damage as a result of inflicted injury [",
"      <a class=\"abstract\" href=\"mobipreview.htm?39/19/40249/abstract/32\">",
"       32",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Cerebrospinal fluid (CSF) should generally be obtained if meningitis is a serious consideration and whenever a lumbar puncture can be safely performed, primarily to exclude infection as a cause for nonspecific symptoms. (See",
"      <a class=\"local\" href=\"#H16\">",
"       'Differential diagnosis'",
"      </a>",
"      below.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Xanthochromia",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      red blood cells in CSF may indicate intracranial injury. In one retrospective series describing children with abusive head injury who had a lumbar puncture performed, CSF was bloody in 83 percent of cases [",
"      <a class=\"abstract\" href=\"mobipreview.htm?39/19/40249/abstract/11\">",
"       11",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Preliminary evidence suggests that CSF and serum measurements of biomarkers of brain injury (such as neuron-specific enolase, S100B [a calcium binding protein found in astrocytes], and myelin basic protein) may have future utility as screening tests for infants with nonspecific symptoms who are at high risk for abusive head injury [",
"      <a class=\"abstract\" href=\"mobipreview.htm?39/19/40249/abstract/33,34\">",
"       33,34",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Electrolytes, liver function tests, and a urinalysis should be performed to identify metabolic abnormalities and injuries to other organ systems.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Imaging",
"    </span>",
"    &nbsp;&mdash;&nbsp;Neuroimaging is an essential component of the evaluation of children with suspected abusive head injury. In addition to establishing the diagnosis, imaging may provide documentation of the extent and timing of injuries. The initial studies should include unenhanced computed tomography (CT) and a skeletal survey. Magnetic resonance imaging (MRI) is preferred for infants who are asymptomatic, but require neuroimaging after non-cranial injuries are identified. MRI should be done in follow-up for patients with abnormal CT findings. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?22/40/23178?source=see_link&amp;anchor=H11#H11\">",
"     \"Approach to neuroimaging in children\", section on 'CT applications'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?13/30/13802?source=see_link&amp;anchor=H8#H8\">",
"     \"Orthopedic aspects of child abuse\", section on 'Skeletal survey'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h3\">",
"     Computed tomography",
"    </span>",
"    &nbsp;&mdash;&nbsp;We recommend unenhanced computed tomography (CT), with brain and bone windows, as the preferred imaging modality for the initial evaluation of children with suspected inflicted head trauma [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/19/40249/abstract/35-39\">",
"     35-39",
"    </a>",
"    ]. CT is readily available and reliably identifies injuries that require immediate intervention. Subarachnoid hemorrhage, large extra-axial hemorrhage (eg, subdural or epidural hemorrhage), and mass effect are best demonstrated on CT. Other injuries that are frequently identified include cerebral ischemia, cerebral contusion, skull fracture, and scalp hematoma. However, early signs of brain edema or diffuse axonal injury may not be apparent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/19/40249/abstract/40,41\">",
"     40,41",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Extra-axial fluid collections may be high",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    low density on CT scan. These descriptions of collections should not be used to date injury, as mixed collections can represent acute injury (eg, representing mixing of blood and CSF) or both acute and chronic bleeding. MRI allows for better estimation of the ages of intracranial blood products [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/19/40249/abstract/41\">",
"     41",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H12\">",
"     'Magnetic resonance imaging'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    A systematic review of 21 observational studies analyzed CT findings in 2353 young children hospitalized with closed head injury, including 38 percent with abusive head trauma [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/19/40249/abstract/42\">",
"     42",
"    </a>",
"    ]. The following CT findings were significantly associated with abusive head trauma compared with unintentional head trauma:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Subdural hemorrhage (68 versus 23 percent, respectively); additional characteristics of subdural hemorrhage significantly associated with abusive head trauma included multiple hemorrhages with differing density, interhemispheric or posterior fossa location, and extension over the convexity of the brain",
"     </li>",
"     <li>",
"      Hypoxic-ischemic injury (24 versus 8 percent, respectively)",
"     </li>",
"     <li>",
"      Cerebral edema (39 versus 18 percent, respectively)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In contrast, the frequency of subarachnoid hemorrhages was",
"    <strong>",
"     not",
"    </strong>",
"    significantly different following abusive head trauma compared with unintentional head trauma. Epidural hemorrhages were significantly associated with",
"    <strong>",
"     unintentional",
"    </strong>",
"    closed head injury rather than abusive head trauma (17 versus 4 percent, respectively).",
"   </p>",
"   <p>",
"    Subcortical abnormalities on head CT may also be a strong marker for child abuse. In one prospective, multicenter observational study of 54 children under three years of age not included in the systematic review described above, a head CT with findings at the subcortical level, including swelling, hypoxic-ischemic changes, brain shift, or hernia was highly associated with abusive head injury (OR 36; 95% CI: 6-209) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/19/40249/abstract/43\">",
"     43",
"    </a>",
"    ]. Patients with subcortical changes were also significantly more likely to acutely present with seizures, acute encephalopathy, signs of herniation, respiratory distress, or circulatory compromise.",
"   </p>",
"   <p>",
"    Imaging with CT or MRI may also be useful in the evaluation of children who are at high risk for child abuse, but have a normal neurologic examination and no evidence of head injury. In a retrospective series describing children with suspected child abuse (rib fractures, multiple fractures, facial injury, or age &lt;6 months), screening neuroimaging identified occult head injury in 37 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/19/40249/abstract/19\">",
"     19",
"    </a>",
"    ]. Skeletal survey alone would have missed 5 of the 19 patients, and retinal hemorrhages were not seen in any of the patients who had an ophthalmologic examination.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h3\">",
"     Magnetic resonance imaging",
"    </span>",
"    &nbsp;&mdash;&nbsp;Noncontrast magnetic resonance imaging (MRI) is superior to CT for documenting the pattern, extent, and timing of head injuries [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/19/40249/abstract/44\">",
"     44",
"    </a>",
"    ]. T1, T2, and fluid attenuated inversion recovery (FLAIR) sequences must be performed in order to characterize the nature and timing of hemorrhages and other fluid collections. MRI may also demonstrate small extraaxial hemorrhages, parenchymal contusions, evidence of shearing injury, and posterior fossa abnormalities missed by CT [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/19/40249/abstract/12,36,40,45\">",
"     12,36,40,45",
"    </a>",
"    ]. Diffusion-weighted images (DWI) and apparent diffusion coefficient (ADC) mapping help to identify hypoxic-ischemic injury in the acutely injured child [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/19/40249/abstract/46\">",
"     46",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    MRI may not be available urgently and may be difficult to perform for a child who is unstable. In addition, it is relatively insensitive for the identification of subarachnoid blood and fractures. Consequently, MRI is typically obtained two to three days after the injury [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/19/40249/abstract/36\">",
"     36",
"    </a>",
"    ]. MRI should be done as a follow-up study for abused infants and children who have abnormal initial CT scans.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h3\">",
"     Skeletal evaluation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Children with abusive head injury often sustain other injuries. (See",
"    <a class=\"local\" href=\"#H7\">",
"     'Associated injuries'",
"    </a>",
"    above.) In addition, identifying injuries that are pathognomonic for child abuse (such as posterior rib fractures and metaphyseal fractures) substantiates the inflicted mechanism for the head injury. Consequently, we recommend that all children with suspected abusive head injury receive a skeletal survey [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/19/40249/abstract/39\">",
"     39",
"    </a>",
"    ] (",
"    <a class=\"graphic graphic_table graphicRef82510 \" href=\"mobipreview.htm?15/14/15595\">",
"     table 1",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?13/30/13802?source=see_link&amp;anchor=H13#H13\">",
"     \"Orthopedic aspects of child abuse\", section on 'Fracture patterns'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?13/30/13802?source=see_link&amp;anchor=H6#H6\">",
"     \"Orthopedic aspects of child abuse\", section on 'Radiographic evaluation'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Ophthalmologic examination",
"    </span>",
"    &nbsp;&mdash;&nbsp;Children with suspected abusive head injury should have a funduscopic examination, preferably by an ophthalmologist, to identify retinal hemorrhages and other eye injuries. Non-ophthalmologists may have difficulty performing an adequate examination and thereby fail to identify injuries that, although not pathognomonic, suggest inflicted injury [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/19/40249/abstract/47,48\">",
"     47,48",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Wide-field retinal imaging permits photographic documentation of the extent of any retinal hemorrhages present and may be useful for forensic purposes but, when performed, should be interpreted by an ophthalmologist [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/19/40249/abstract/49\">",
"     49",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Establishing an abusive mechanism for any injury is essential for the protection of the child and any other individuals who could be exposed to similar injury. Making the correct diagnosis may be life-saving. On the other hand, the consequences of misdiagnosis of inflicted injury are serious, including disruption of a family (as the result of placement of children in foster care) and false accusations that could lead to criminal proceedings.",
"   </p>",
"   <p>",
"    In children with intracranial injuries, no single physical finding definitively identifies abusive head trauma. However, features that are most predictive of child abuse have been demonstrated in two meta-analyses of observational studies:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In a meta-analysis of high quality studies, each of the clinical findings listed below were strongly associated with abusive head trauma [",
"      <a class=\"abstract\" href=\"mobipreview.htm?39/19/40249/abstract/50\">",
"       50",
"      </a>",
"      ]:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Inadequate history (eg, no history of trauma, or a history that is inconsistent with the severity of physical findings)",
"     </li>",
"     <li>",
"      Apnea or seizures on presentation",
"     </li>",
"     <li>",
"      Fractures of the ribs, metaphyseal region, or long bones",
"     </li>",
"     <li>",
"      Retinal hemorrhage(s)",
"     </li>",
"     <li>",
"      Subdural hemorrhage",
"     </li>",
"     <li>",
"      Skull fracture with associated intracranial injury",
"     </li>",
"     <li>",
"      Cerebral ischemia on neuroimaging",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Using only the injuries identified and",
"      <strong>",
"       not",
"      </strong>",
"      other components of the history, an analysis of six studies with a total of 1053 children with intracranial injury estimated the probability for abusive head trauma when different combinations of clinical features were observed [",
"      <a class=\"abstract\" href=\"mobipreview.htm?39/19/40249/abstract/51\">",
"       51",
"      </a>",
"      ]. The probability for abusive head trauma increased with specific findings and when more features were present as follows:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Intracranial injury (ICI) alone &ndash; Lower probability",
"     </li>",
"     <li>",
"      ICI and long bone fracture &ndash; Moderate probability",
"     </li>",
"     <li>",
"      ICI and retinal hemorrhage &ndash; Higher probability",
"     </li>",
"     <li>",
"      ICI and rib fracture &ndash; Higher probability",
"     </li>",
"     <li>",
"      ICI and any three of the following: apnea, bruising, long bone fracture, retinal hemorrhage, rib fracture, or seizure &ndash; Higher probability",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Individual observational studies also suggest that abusive head trauma is more likely in children with the combination of intracranial injury on neuroimaging and one or more of the following clinical features:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Past history of child abuse or neglect, in the patient or a sibling [",
"      <a class=\"abstract\" href=\"mobipreview.htm?39/19/40249/abstract/52\">",
"       52",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Intra-abdominal injury, especially hollow viscus injury or pancreatic laceration [",
"      <a class=\"abstract\" href=\"mobipreview.htm?39/19/40249/abstract/53\">",
"       53",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Oropharyngeal injuries, such as frenulum tears or pharyngeal lacerations [",
"      <a class=\"abstract\" href=\"mobipreview.htm?39/19/40249/abstract/10\">",
"       10",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Additional extracranial injuries that are not explained by the history provided (eg, head and neck bruising or other cutaneous findings). (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?25/54/26473?source=see_link&amp;anchor=H7#H7\">",
"       \"Physical abuse in children: Epidemiology and clinical manifestations\", section on 'Clinical manifestations'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Thus, combinations of clinical features can accurately identify patients with a high likelihood of abusive head trauma.",
"   </p>",
"   <p>",
"    A thorough evaluation by a multidisciplinary team (social worker, nurse, physician with expertise in child protection) should be performed whenever there is a suspicion that an injury is inflicted. Additional information often can be identified to support or refute the diagnosis. A reasonable medical suspicion that an injury was inflicted is sufficient to make a preliminary diagnosis of abusive head injury and refer the case to social service and law enforcement agencies for further investigation. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?35/5/35927?source=see_link&amp;anchor=H3#H3\">",
"     \"Child abuse: Social and medicolegal issues\", section on 'Reporting suspected abuse'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    During the initial evaluation of a child with suspected abusive head injury, the harm of repeated injury caused by missing an abusive injury is more significant than the harm of false accusation. The clinician must maintain a low threshold for suspecting abusive injury and reporting it to child protective services. The purpose of subsequent investigation by social service and law enforcement agencies is to identify evidence that substantiates or refutes the medical indications of abuse.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h1\">",
"     DIFFERENTIAL DIAGNOSIS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Accidental injury",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although many of the clinical features of accidental and abusive head injury are similar, the abusive mechanism is often suggested by a combination of historical features and specific injury patterns [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/19/40249/abstract/54\">",
"     54",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A history of a traumatic event has been consistently present among children with accidental head injury in retrospective series that have compared children with inflicted and accidental head injury [",
"      <a class=\"abstract\" href=\"mobipreview.htm?39/19/40249/abstract/9,15,55\">",
"       9,15,55",
"      </a>",
"      ]. Furthermore, the absence of a history of trauma is highly specific for abusive head injury [",
"      <a class=\"abstract\" href=\"mobipreview.htm?39/19/40249/abstract/10\">",
"       10",
"      </a>",
"      ]. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'History'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Retinal hemorrhages have been observed in some children with head injuries from accidental mechanisms [",
"      <a class=\"abstract\" href=\"mobipreview.htm?39/19/40249/abstract/9,15\">",
"       9,15",
"      </a>",
"      ]. The hemorrhages are typically fewer in number and less extensive than those reported with inflicted injuries [",
"      <a class=\"abstract\" href=\"mobipreview.htm?39/19/40249/abstract/22,23\">",
"       22,23",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?20/7/20602?source=see_link&amp;anchor=H19#H19\">",
"       \"Child abuse: Eye findings in children with abusive head trauma (AHT)\", section on 'Differential diagnosis'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Subdural hematomas occur in association with accidental injury. However, they are more common with abusive mechanisms [",
"      <a class=\"abstract\" href=\"mobipreview.htm?39/19/40249/abstract/42\">",
"       42",
"      </a>",
"      ]. In addition, mixed density subdural hematomas are noted more frequently with inflicted injuries. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?32/13/32985?source=see_link&amp;anchor=H8#H8\">",
"       \"Child abuse: Epidemiology, mechanisms, and types of abusive head trauma in infants and children\", section on 'Subdural hemorrhage'",
"      </a>",
"      and",
"      <a class=\"local\" href=\"#H11\">",
"       'Computed tomography'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Birth trauma",
"    </span>",
"    &nbsp;&mdash;&nbsp;Retinal hemorrhages and subdural hematomas have been noted in asymptomatic newborns. Both occur more commonly with instrumented deliveries [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/19/40249/abstract/56,57\">",
"     56,57",
"    </a>",
"    ]. These subdural hematomas are often small, located in the posterior fossa or at the tentorium, and are usually resolved by one month of age. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?20/7/20602?source=see_link&amp;anchor=H19#H19\">",
"     \"Child abuse: Eye findings in children with abusive head trauma (AHT)\", section on 'Differential diagnosis'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?32/13/32985?source=see_link&amp;anchor=H8#H8\">",
"     \"Child abuse: Epidemiology, mechanisms, and types of abusive head trauma in infants and children\", section on 'Subdural hemorrhage'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Among symptomatic infants with subdural hematomas, those with a perinatal etiology often have a history of birth trauma and are younger than those with abusive head injury [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/19/40249/abstract/58\">",
"     58",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Apparent life-threatening event",
"    </span>",
"    &nbsp;&mdash;&nbsp;In two prospective series describing infants who had apparent life-threatening events (ALTE), 2 percent were diagnosed with an abusive head injury as the cause of the ALTE [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/19/40249/abstract/31,59\">",
"     31,59",
"    </a>",
"    ]. Children with ALTE as the result of inflicted head injuries must be urgently identified because injury often occurs repeatedly and can be fatal. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?30/34/31272?source=see_link&amp;anchor=H6#H6\">",
"     \"Apparent life-threatening event in infants\", section on 'ALTE and child abuse'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Bleeding disorders",
"    </span>",
"    &nbsp;&mdash;&nbsp;Intracranial hemorrhage (ICH) can occur in children with severe bleeding disorders (such as hemophilia) spontaneously or following an injury. Retinal hemorrhages in children with bleeding disorders are usually small in number and are typically confined to the posterior pole. Laboratory abnormalities pinpoint the nature of the bleeding problem (",
"    <a class=\"graphic graphic_table graphicRef67121 \" href=\"mobipreview.htm?36/13/37084\">",
"     table 2",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?3/40/3722?source=see_link&amp;anchor=H6#H6\">",
"     \"Approach to the child with bleeding symptoms\", section on 'Relevant laboratory tests'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?20/7/20602?source=see_link&amp;anchor=H19#H19\">",
"     \"Child abuse: Eye findings in children with abusive head trauma (AHT)\", section on 'Differential diagnosis'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Among boys with hemophilia, ICH occurs most often in the neonatal period [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/19/40249/abstract/60\">",
"     60",
"    </a>",
"    ]. ICH is uncommon in immune thrombocytopenia (ITP). (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?1/18/1322?source=see_link&amp;anchor=H5#H5\">",
"     \"Clinical manifestations and diagnosis of hemophilia\", section on 'Central nervous system'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?23/17/23833?source=see_link&amp;anchor=H4#H4\">",
"     \"Clinical manifestations and diagnosis of immune thrombocytopenia (ITP) in children\", section on 'Clinical manifestations'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Other diagnoses",
"    </span>",
"    &nbsp;&mdash;&nbsp;Glutaric aciduria type 1 is a metabolic condition that shares some clinical features with abusive head injury. Case reports have described children who present with acute subdural hemorrhage or chronic subdural effusions that were mistakenly attributed to child abuse. Glutaric aciduria is diagnosed through urinary and laboratory screening; treatment can prevent further deterioration. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?7/46/7914?source=see_link&amp;anchor=H33#H33\">",
"     \"Organic acidemias\", section on 'Glutaric aciduria type 1'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Other conditions that can cause ICH",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    retinal hemorrhages such as meningitis, cerebral malaria, galactosemia, hypertension, intracranial aneurysms, and hemophagocytic lymphohistiocytosis are rare and can be identified by laboratory and radiological testing.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h1\">",
"     MANAGEMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;The management of infants and children with suspected abusive head trauma is similar to that of other patients with suspected inflicted injury. The medical issues are addressed first, followed by additional evaluation for occult injuries or injuries inflicted at an earlier time. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?4/9/4250?source=see_link\">",
"     \"Initial approach to severe traumatic brain injury in children\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?43/37/44633?source=see_link\">",
"     \"Elevated intracranial pressure in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Consultation with a multidisciplinary team (eg, social worker, nurse, physician with more extensive experience in the management of child abuse) is recommended, if such a team is available. The safety of other children in the home must be ensured by local Child Protective Services. Reporting cases of suspected child abuse to Child Protective Services is discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?35/5/35927?source=see_link&amp;anchor=H3#H3\">",
"     \"Child abuse: Social and medicolegal issues\", section on 'Reporting suspected abuse'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h1\">",
"     OUTCOME",
"    </span>",
"    &nbsp;&mdash;&nbsp;Mortality rates in series of cases of abusive head injury range from 13 to 23 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/19/40249/abstract/11,61-63\">",
"     11,61-63",
"    </a>",
"    ]. In a survey of cases identified between 1994 and 2000 from a traumatic brain injury surveillance system in Colorado, the mortality rate for children younger than three years of age with intentional traumatic brain injury was 17 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/19/40249/abstract/64\">",
"     64",
"    </a>",
"    ]. Several clinical features are correlated with fatal child abuse. As an example, in an observational study of 386 children managed with abusive head trauma at multiple children&rsquo;s hospitals, fatal outcomes were significantly associated by adjusted analysis with an initial Glasgow coma score of 3, 4, or 5; retinal hemorrhage; intraparenchymal hemorrhage; or cerebral edema [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/19/40249/abstract/63\">",
"     63",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Among survivors, the initial morbidity from abusive head injury is significant. In one retrospective chart review of 364 cases, death occurred in 19 percent as a direct result of the head injury; among survivors, 55 percent had persistent neurologic deficit and 65 percent had visual impairment [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/19/40249/abstract/8\">",
"     8",
"    </a>",
"    ]. Only 22 percent of the survivors were felt to be \"well\" at the time of discharge, without identified health or developmental impairment.",
"   </p>",
"   <p>",
"    Follow-up studies of children with abusive head injury suggest that, although some patients may initially improve, long-term neurocognitive functioning is poor. This is illustrated in the following reports:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Among a group of 13 patients with nonaccidental head injury who were followed over a period of 4 to 14 years (mean seven years, two months), six children initially appeared to have a full recovery [",
"      <a class=\"abstract\" href=\"mobipreview.htm?39/19/40249/abstract/65\">",
"       65",
"      </a>",
"      ]. By the end of the study, 11 of the 12 survivors had been diagnosed with abnormalities ranging from psychomotor delay, intellectual disability (mental retardation), and learning disabilities to blindness, seizures, tetraplegia, and hemiparesis.",
"     </li>",
"     <li>",
"      In another report, 25 children with abusive head injury were followed for a mean of 59 months with neurologic, behavioral, and social assessments [",
"      <a class=\"abstract\" href=\"mobipreview.htm?39/19/40249/abstract/66\">",
"       66",
"      </a>",
"      ]. Among these children, 68 percent had abnormalities noted on follow-up, 36 percent of which were classified as severe. Identified abnormalities included motor (60 percent), visual (48 percent), speech and language impairment (64 percent), and epilepsy (20 percent). Behavioral disturbances were noted in 52 percent of children. Many of the behavioral problems developed in the second and third year of life. Outcomes correlated with severity of injury, but not with age at injury or mechanism of injury.",
"     </li>",
"     <li>",
"      An observational study of 39 surviving patients found that 17 had normal development, 17 had mild to moderate developmental delay, and 5 had severe impairment. Cerebral ischemia on initial head CT or MRI was associated with long term impairment [",
"      <a class=\"abstract\" href=\"mobipreview.htm?39/19/40249/abstract/41\">",
"       41",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Radiologic sequelae of shaking injury include infarction, cerebral atrophy (generalized or asymmetric), encephalomalacia, hydrocephalus, and chronic subdural hemorrhage [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/19/40249/abstract/67-70\">",
"     67-70",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h1\">",
"     PREVENTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The implementation of strategies for the prevention of abusive head injury is recommended by the AAP Committee on Child Abuse and Neglect [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/19/40249/abstract/35\">",
"     35",
"    </a>",
"    ]. Nevertheless, the development of effective strategies is a challenge. Several types of programs have been studied.",
"   </p>",
"   <p>",
"    Primary prevention efforts, which target a broad population, have included large scale public education campaigns and hospital-based education programs [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/19/40249/abstract/71,72\">",
"     71,72",
"    </a>",
"    ]. In one report, a short, intensive education program describing the dangers of violent infant shaking and providing alternative responses to persistent infant crying was administered to parents of newborns before hospital discharge [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/19/40249/abstract/72\">",
"     72",
"    </a>",
"    ]. There was a 47 percent decrease in the number of cases of inflicted head injury in the region during the study period as compared with the six-year control period.",
"   </p>",
"   <p>",
"    Secondary prevention programs, directed toward a specific subset of the population at risk for child maltreatment, have demonstrated some success. In one study, prenatal and early childhood home visitation significantly reduced the number of verified reports of child abuse and neglect in the group that received the intervention compared with the group that did not [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/19/40249/abstract/73\">",
"     73",
"    </a>",
"    ]. However, the effectiveness of this type of program in preventing abusive head injury has not been specifically studied.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Abusive head injury is a common cause of death, particularly among children younger than 12 months of age. The diagnosis is often missed at the initial evaluation because clinical features are typically nonspecific and there is frequently no history of trauma. As a result, the child may not receive prompt treatment for the current injury and is at risk for later, potentially fatal, injuries.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      There is typically no history of trauma among children who have sustained an abusive head injury. As many as 60 percent of children have been previously physically abused. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'History'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The neurologic examination is abnormal for most children with abusive head injury, although some may be asymptomatic. Retinal hemorrhages are common (though not pathognomonic) and correlate with the severity of injury. Some, but not all, children have cutaneous bruising, particularly around the face. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Physical examination'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Laboratory evaluation should include CBC with differential, platelet count, and coagulation studies. Cerebrospinal fluid (CSF) should generally be obtained whenever a lumbar puncture can be safely performed, primarily to exclude infection as a cause for nonspecific symptoms when meningitis is a serious consideration. CSF is typically xanthochromic",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      bloody in children with abusive head trauma. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Laboratory studies'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We recommend that computed tomography (CT) and a skeletal survey be performed initially for all children with suspected abusive head injury. Magnetic resonance imaging (MRI) provides additional information regarding the extent and timing of injuries. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Imaging'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The diagnosis of abusive head trauma is aided by the presence of additional clinical features in children with intracranial injury including a history that is inconsistent with physical findings, retinal hemorrhages, fractures, unexplained bruises, apnea, and seizures. A thorough evaluation by a multidisciplinary team should be performed whenever there is suspicion that an injury is inflicted. Subsequent investigation by social service and law enforcement agencies may substantiate the diagnosis of abusive head injury. (See",
"      <a class=\"local\" href=\"#H15\">",
"       'Diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Abusive head injury must be differentiated from accidental injury. Other diagnoses that must be excluded include birth trauma, bleeding disorders, and other rare conditions such as glutaric aciduria type 1. (See",
"      <a class=\"local\" href=\"#H16\">",
"       'Differential diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Initial management must address the safety of other children in the home as well as the medical condition of the injured child. (See",
"      <a class=\"local\" href=\"#H22\">",
"       'Management'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The morbidity and mortality for abusive head injury is significant. Mortality rates as high as 23 percent have been reported. The majority of surviving children have permanent neurologic impairment. (See",
"      <a class=\"local\" href=\"#H23\">",
"       'Outcome'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The development of successful prevention programs has been a challenge. In one report, a short, intensive education program describing the dangers of violent infant shaking and providing alternative responses to persistent infant crying administered to parents of newborns before hospital discharge appeared to be effective. (See",
"      <a class=\"local\" href=\"#H24\">",
"       'Prevention'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     Administration for Children &amp; Families. Child Maltreatment 2010. Annual Report, US Government Printing Office; US Department of Health and Human Services, Washington, DC 2010 available at file://www.acf.hhs.gov/programs/cb/pubs/cm10/cm10.pdf (accessed April 11, 2012).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/19/40249/abstract/2\">",
"      Jenny C, Hymel KP, Ritzen A, et al. Analysis of missed cases of abusive head trauma. JAMA 1999; 281:621.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/19/40249/abstract/3\">",
"      Krugman, RD. Fatal child abuse: analysis of 24 cases. Pediatrician 1983-1985; 12:68.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/19/40249/abstract/4\">",
"      Barr RG, Trent RB, Cross J. Age-related incidence curve of hospitalized Shaken Baby Syndrome cases: convergent evidence for crying as a trigger to shaking. Child Abuse Negl 2006; 30:7.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/19/40249/abstract/5\">",
"      Reijneveld SA, van der Wal MF, Brugman E, et al. Infant crying and abuse. Lancet 2004; 364:1340.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/19/40249/abstract/6\">",
"      Richards PG, Bertocci GE, Bonshek RE, et al. Shaken baby syndrome. Arch Dis Child 2006; 91:205.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/19/40249/abstract/7\">",
"      Christian CW, Block R, Committee on Child Abuse and Neglect, American Academy of Pediatrics. Abusive head trauma in infants and children. Pediatrics 2009; 123:1409.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/19/40249/abstract/8\">",
"      King WJ, MacKay M, Sirnick A, Canadian Shaken Baby Study Group. Shaken baby syndrome in Canada: clinical characteristics and outcomes of hospital cases. CMAJ 2003; 168:155.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/19/40249/abstract/9\">",
"      Keenan HT, Runyan DK, Marshall SW, et al. A population-based comparison of clinical and outcome characteristics of young children with serious inflicted and noninflicted traumatic brain injury. Pediatrics 2004; 114:633.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/19/40249/abstract/10\">",
"      Hettler J, Greenes DS. Can the initial history predict whether a child with a head injury has been abused? Pediatrics 2003; 111:602.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/19/40249/abstract/11\">",
"      Ludwig S, Warman M. Shaken baby syndrome: a review of 20 cases. Ann Emerg Med 1984; 13:104.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/19/40249/abstract/12\">",
"      Duhaime AC, Christian CW, Rorke LB, Zimmerman RA. Nonaccidental head injury in infants--the \"shaken-baby syndrome\". N Engl J Med 1998; 338:1822.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/19/40249/abstract/13\">",
"      Johnson DL, Boal D, Baule R. Role of apnea in nonaccidental head injury. Pediatr Neurosurg 1995; 23:305.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/19/40249/abstract/14\">",
"      Ettaro L, Berger RP, Songer T. Abusive head trauma in young children: characteristics and medical charges in a hospitalized population. Child Abuse Negl 2004; 28:1099.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/19/40249/abstract/15\">",
"      Bechtel K, Stoessel K, Leventhal JM, et al. Characteristics that distinguish accidental from abusive injury in hospitalized young children with head trauma. Pediatrics 2004; 114:165.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/19/40249/abstract/16\">",
"      Starling SP, Patel S, Burke BL, et al. Analysis of perpetrator admissions to inflicted traumatic brain injury in children. Arch Pediatr Adolesc Med 2004; 158:454.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/19/40249/abstract/17\">",
"      Ricci L, Giantris A, Merriam P, et al. Abusive head trauma in Maine infants: medical, child protective, and law enforcement analysis. Child Abuse Negl 2003; 27:271.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/19/40249/abstract/18\">",
"      Oral R, Yagmur F, Nashelsky M, et al. Fatal abusive head trauma cases: consequence of medical staff missing milder forms of physical abuse. Pediatr Emerg Care 2008; 24:816.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/19/40249/abstract/19\">",
"      Rubin DM, Christian CW, Bilaniuk LT, et al. Occult head injury in high-risk abused children. Pediatrics 2003; 111:1382.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/19/40249/abstract/20\">",
"      Laskey AL, Holsti M, Runyan DK, Socolar RR. Occult head trauma in young suspected victims of physical abuse. J Pediatr 2004; 144:719.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/19/40249/abstract/21\">",
"      Morad Y, Kim YM, Armstrong DC, et al. Correlation between retinal abnormalities and intracranial abnormalities in the shaken baby syndrome. Am J Ophthalmol 2002; 134:354.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/19/40249/abstract/22\">",
"      Adams G, Ainsworth J, Butler L, et al. Update from the ophthalmology child abuse working party: Royal College ophthalmologists. Eye (Lond) 2004; 18:795.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/19/40249/abstract/23\">",
"      Wygnanski-Jaffe T, Levin AV, Shafiq A, et al. Postmortem orbital findings in shaken baby syndrome. Am J Ophthalmol 2006; 142:233.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/19/40249/abstract/24\">",
"      Tung GA, Kumar M, Richardson RC, et al. Comparison of accidental and nonaccidental traumatic head injury in children on noncontrast computed tomography. Pediatrics 2006; 118:626.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/19/40249/abstract/25\">",
"      Sugar NF, Taylor JA, Feldman KW. Bruises in infants and toddlers: those who don't cruise rarely bruise. Puget Sound Pediatric Research Network. Arch Pediatr Adolesc Med 1999; 153:399.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/19/40249/abstract/26\">",
"      Labb&eacute; J, Caouette G. Recent skin injuries in normal children. Pediatrics 2001; 108:271.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/19/40249/abstract/27\">",
"      Hadley MN, Sonntag VK, Rekate HL, Murphy A. The infant whiplash-shake injury syndrome: a clinical and pathological study. Neurosurgery 1989; 24:536.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/19/40249/abstract/28\">",
"      Ghatan S, Ellenbogen RG. Pediatric spine and spinal cord injury after inflicted trauma. Neurosurg Clin N Am 2002; 13:227.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/19/40249/abstract/29\">",
"      Choudhary AK, Bradford RK, Dias MS, et al. Spinal subdural hemorrhage in abusive head trauma: a retrospective study. Radiology 2012; 262:216.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/19/40249/abstract/30\">",
"      Feldman KW, Avellino AM, Sugar NF, Ellenbogen RG. Cervical spinal cord injury in abused children. Pediatr Emerg Care 2008; 24:222.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/19/40249/abstract/31\">",
"      Altman RL, Brand DA, Forman S, et al. Abusive head injury as a cause of apparent life-threatening events in infancy. Arch Pediatr Adolesc Med 2003; 157:1011.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/19/40249/abstract/32\">",
"      Hymel KP, Abshire TC, Luckey DW, Jenny C. Coagulopathy in pediatric abusive head trauma. Pediatrics 1997; 99:371.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/19/40249/abstract/33\">",
"      Berger RP, Kochanek PM, Pierce MC. Biochemical markers of brain injury: could they be used as diagnostic adjuncts in cases of inflicted traumatic brain injury? Child Abuse Negl 2004; 28:739.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/19/40249/abstract/34\">",
"      Berger RP, Dulani T, Adelson PD, et al. Identification of inflicted traumatic brain injury in well-appearing infants using serum and cerebrospinal markers: a possible screening tool. Pediatrics 2006; 117:325.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/19/40249/abstract/35\">",
"      American Academy of Pediatrics: Committee on Child Abuse and Neglect. Shaken baby syndrome: rotational cranial injuries-technical report. Pediatrics 2001; 108:206.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/19/40249/abstract/36\">",
"      Section on Radiology, American Academy of Pediatrics. Diagnostic imaging of child abuse. Pediatrics 2009; 123:1430.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/19/40249/abstract/37\">",
"      Demaerel P, Casteels I, Wilms G. Cranial imaging in child abuse. Eur Radiol 2002; 12:849.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/19/40249/abstract/38\">",
"      Datta S, Stoodley N, Jayawant S, et al. Neuroradiological aspects of subdural haemorrhages. Arch Dis Child 2005; 90:947.",
"     </a>",
"    </li>",
"    <li>",
"     American College of Radiology. ACR appropriateness criteria.  Suspected physical abuse - child. file://www.acr.org/~/media/ACR/Documents/AppCriteria/Diagnostic/SuspectedPhysicalAbuseChild.pdf (Accessed on August 06, 2012).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/19/40249/abstract/40\">",
"      Sato Y, Yuh WT, Smith WL, et al. Head injury in child abuse: evaluation with MR imaging. Radiology 1989; 173:653.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/19/40249/abstract/41\">",
"      Foerster BR, Petrou M, Lin D, et al. Neuroimaging evaluation of non-accidental head trauma with correlation to clinical outcomes: a review of 57 cases. J Pediatr 2009; 154:573.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/19/40249/abstract/42\">",
"      Kemp AM, Jaspan T, Griffiths J, et al. Neuroimaging: what neuroradiological features distinguish abusive from non-abusive head trauma? A systematic review. Arch Dis Child 2011; 96:1103.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/19/40249/abstract/43\">",
"      Hymel KP, Stoiko MA, Herman BE, et al. Head injury depth as an indicator of causes and mechanisms. Pediatrics 2010; 125:712.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/19/40249/abstract/44\">",
"      Barnes PD, Robson CD. CT findings in hyperacute nonaccidental brain injury. Pediatr Radiol 2000; 30:74.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/19/40249/abstract/45\">",
"      Alexander RC, Schor DP, Smith WL Jr. Magnetic resonance imaging of intracranial injuries from child abuse. J Pediatr 1986; 109:975.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/19/40249/abstract/46\">",
"      Suh DY, Davis PC, Hopkins KL, et al. Nonaccidental pediatric head injury: diffusion-weighted imaging findings. Neurosurgery 2001; 49:309.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/19/40249/abstract/47\">",
"      Morad Y, Kim YM, Mian M, et al. Nonophthalmologist accuracy in diagnosing retinal hemorrhages in the shaken baby syndrome. J Pediatr 2003; 142:431.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/19/40249/abstract/48\">",
"      Kivlin JD, Simons KB, Lazoritz S, Ruttum MS. Shaken baby syndrome. Ophthalmology 2000; 107:1246.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/19/40249/abstract/49\">",
"      Minns RA, Jones PA, Tandon A, et al. Prediction of inflicted brain injury in infants and children using retinal imaging. Pediatrics 2012; 130:e1227.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/19/40249/abstract/50\">",
"      Piteau SJ, Ward MG, Barrowman NJ, Plint AC. Clinical and radiographic characteristics associated with abusive and nonabusive head trauma: a systematic review. Pediatrics 2012; 130:315.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/19/40249/abstract/51\">",
"      Maguire SA, Kemp AM, Lumb RC, Farewell DM. Estimating the probability of abusive head trauma: a pooled analysis. Pediatrics 2011; 128:e550.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/19/40249/abstract/52\">",
"      Goldstein B, Kelly MM, Bruton D, Cox C. Inflicted versus accidental head injury in critically injured children. Crit Care Med 1993; 21:1328.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/19/40249/abstract/53\">",
"      Trokel M, Discala C, Terrin NC, Sege RD. Patient and injury characteristics in abusive abdominal injuries. Pediatr Emerg Care 2006; 22:700.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/19/40249/abstract/54\">",
"      David TJ. Non-accidental head injury--the evidence. Pediatr Radiol 2008; 38 Suppl 3:S370.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/19/40249/abstract/55\">",
"      Feldman KW, Bethel R, Shugerman RP, et al. The cause of infant and toddler subdural hemorrhage: a prospective study. Pediatrics 2001; 108:636.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/19/40249/abstract/56\">",
"      Hughes LA, May K, Talbot JF, Parsons MA. Incidence, distribution, and duration of birth-related retinal hemorrhages: a prospective study. J AAPOS 2006; 10:102.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/19/40249/abstract/57\">",
"      Whitby EH, Griffiths PD, Rutter S, et al. Frequency and natural history of subdural haemorrhages in babies and relation to obstetric factors. Lancet 2004; 363:846.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/19/40249/abstract/58\">",
"      Hobbs C, Childs AM, Wynne J, et al. Subdural haematoma and effusion in infancy: an epidemiological study. Arch Dis Child 2005; 90:952.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/19/40249/abstract/59\">",
"      Pitetti RD, Maffei F, Chang K, et al. Prevalence of retinal hemorrhages and child abuse in children who present with an apparent life-threatening event. Pediatrics 2002; 110:557.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/19/40249/abstract/60\">",
"      Klinge J, Auberger K, Auerswald G, et al. Prevalence and outcome of intracranial haemorrhage in haemophiliacs--a survey of the paediatric group of the German Society of Thrombosis and Haemostasis (GTH). Eur J Pediatr 1999; 158 Suppl 3:S162.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/19/40249/abstract/61\">",
"      Reece RM, Sege R. Childhood head injuries: accidental or inflicted? Arch Pediatr Adolesc Med 2000; 154:11.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/19/40249/abstract/62\">",
"      Keenan HT, Runyan DK, Marshall SW, et al. A population-based study of inflicted traumatic brain injury in young children. JAMA 2003; 290:621.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/19/40249/abstract/63\">",
"      Shein SL, Bell MJ, Kochanek PM, et al. Risk factors for mortality in children with abusive head trauma. J Pediatr 2012; 161:716.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/19/40249/abstract/64\">",
"      Sills MR, Libby AM, Orton HD. Prehospital and in-hospital mortality: a comparison of intentional and unintentional traumatic brain injuries in Colorado children. Arch Pediatr Adolesc Med 2005; 159:665.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/19/40249/abstract/65\">",
"      Bonnier C, Nassogne MC, Evrard P. Outcome and prognosis of whiplash shaken infant syndrome; late consequences after a symptom-free interval. Dev Med Child Neurol 1995; 37:943.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/19/40249/abstract/66\">",
"      Barlow KM, Thomson E, Johnson D, Minns RA. Late neurologic and cognitive sequelae of inflicted traumatic brain injury in infancy. Pediatrics 2005; 116:e174.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/19/40249/abstract/67\">",
"      Sinal SH, Ball MR. Head trauma due to child abuse: serial computerized tomography in diagnosis and management. South Med J 1987; 80:1505.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/19/40249/abstract/68\">",
"      Cohen RA, Kaufman RA, Myers PA, Towbin RB. Cranial computed tomography in the abused child with head injury. AJR Am J Roentgenol 1986; 146:97.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/19/40249/abstract/69\">",
"      Feldman KW, Brewer DK, Shaw DW. Evolution of the cranial computed tomography scan in child abuse. Child Abuse Negl 1995; 19:307.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/19/40249/abstract/70\">",
"      Gilles EE, Nelson MD Jr. Cerebral complications of nonaccidental head injury in childhood. Pediatr Neurol 1998; 19:119.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/19/40249/abstract/71\">",
"      Showers J. \"Don't shake the baby\": the effectiveness of a prevention program. Child Abuse Negl 1992; 16:11.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/19/40249/abstract/72\">",
"      Dias MS, Smith K, DeGuehery K, et al. Preventing abusive head trauma among infants and young children: a hospital-based, parent education program. Pediatrics 2005; 115:e470.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/19/40249/abstract/73\">",
"      Olds DL, Eckenrode J, Henderson CR Jr, et al. Long-term effects of home visitation on maternal life course and child abuse and neglect. Fifteen-year follow-up of a randomized trial. JAMA 1997; 278:637.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 6610 Version 10.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0503-190.111.122.2-BE0BA8F269-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f39_19_40249=[""].join("\n");
var outline_f39_19_40249=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H25\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      CLINICAL FEATURES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      History",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Physical examination",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      - Retinal hemorrhages",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      - Cutaneous bruising",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - Associated injuries",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      EVALUATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Laboratory studies",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Imaging",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      - Computed tomography",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      - Magnetic resonance imaging",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      - Skeletal evaluation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Ophthalmologic examination",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      DIFFERENTIAL DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Accidental injury",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Birth trauma",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Apparent life-threatening event",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Bleeding disorders",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Other diagnoses",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      MANAGEMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      OUTCOME",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      PREVENTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"EM/6610\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"EM/6610|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?38/62/39919\" title=\"picture 1\">",
"      Dome shaped hemorrhage",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"EM/6610|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?15/14/15595\" title=\"table 1\">",
"      Standard skeletal survey",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?36/13/37084\" title=\"table 2\">",
"      Test results bleeding disorders",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?30/34/31272?source=related_link\">",
"      Apparent life-threatening event in infants",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?22/40/23178?source=related_link\">",
"      Approach to neuroimaging in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?3/40/3722?source=related_link\">",
"      Approach to the child with bleeding symptoms",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?32/13/32985?source=related_link\">",
"      Child abuse: Epidemiology, mechanisms, and types of abusive head trauma in infants and children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?20/7/20602?source=related_link\">",
"      Child abuse: Eye findings in children with abusive head trauma (AHT)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?35/5/35927?source=related_link\">",
"      Child abuse: Social and medicolegal issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?1/18/1322?source=related_link\">",
"      Clinical manifestations and diagnosis of hemophilia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?23/17/23833?source=related_link\">",
"      Clinical manifestations and diagnosis of immune thrombocytopenia (ITP) in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?43/37/44633?source=related_link\">",
"      Elevated intracranial pressure in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?4/9/4250?source=related_link\">",
"      Initial approach to severe traumatic brain injury in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?7/46/7914?source=related_link\">",
"      Organic acidemias",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?13/30/13802?source=related_link\">",
"      Orthopedic aspects of child abuse",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?24/19/24890?source=related_link\">",
"      Physical abuse in children: Diagnostic evaluation and management",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?25/54/26473?source=related_link\">",
"      Physical abuse in children: Epidemiology and clinical manifestations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f39_19_40250="Squamous cell carcinoma erythronychia";
var content_f39_19_40250=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F85607%7EDERM%2F85606%7EDERM%2F85608%7EDERM%2F85609&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F85607%7EDERM%2F85606%7EDERM%2F85608%7EDERM%2F85609&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Longitudinal erythronychia secondary to squamous cell carcinoma",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 433px; height: 540px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 560px\">",
"   <div class=\"ttl\">",
"    Invasive squamous cell carcinoma of the nail",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 540px; height: 530px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAISAhwDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwDYhACdOaYj7CQc88dKtERKjfP90elVWbzMHGAB1qmeinchVsPxyadKq7dxzR9xs4FJJuKcg4NTcoiKmTgY2jnFRy7diqBzmpVwARnHFREZIUEcUmUhYoyX47damXEknHCio9235V61Ih2RMP4jTBkc8m5zxwOgqLv7UE5AFB+UY9akZG5yP61LGoVd5P4UzjPsKcFJUs4x6U0NiFvmye9O25GeaUDjoM+tSIQFoRLZX4OR0HelY4Py9KdKBng4pmQM5OMUxp3J94CdMt2qsMls7af5gK/KBiiMnv8ArS3HsSBBjJ4HqKY7AjjjFObJ4JqL7rd8igQ9TtGTTTIFbGBio3fPzNzimFgzYA6ihDSHTOeMMT7VGQz4x3GMVMkLFWJIIHOOlNXPYYxTtcpMWONlUkkADrShvL4AyT3NSK2Thjg/TOasboAhJGSB1xVJLcTZWSN5MddtW3iEcgU5X5cgVJDc2yqTh844PSof9bIZGOA3c0WXQm7bFOQOCCO/NRDcZMEEA06QqTsByfUcU9HK7VJ+760hj2kSGP5V5qBV81ywYlj7cVFPPuPyj8cVJbg7Cd2PajcdrItpE+xSuDUM4ymG61GzMh5Zj9Kftyww3y9cmgVrEJTgAjA7GnqoBALVOp7tgr6ntSjyGOVcDHr3osgbIxjIBB/CpEYg9MUzeFY54FSpIpPzcik1cQp9RkU7GeeBQG9vlprMR9KTRIjjHQ1GCd3PBFSEgDikUHqOtIpCkZ5JpMgkYpV+7x1powGApAPU0pNNI5pTjGDQIXOegpCeaBjHBprUmSTIfxpWzTIzT2xis2iSPIzg1NGfzqIjPWnr+lCuY1tiypqQHmoVNSoa0R573JB704UzmnCmSx6dqmXrUIPpUiZpgWoz+VWojyKpRntVmJvxoA0YjVpTlaoxGrUZJWmmIjnHBxzWNerjNbc3Q1kXo61ohM5fUU61zl8ME10+pcZrl9QOM1qjNmRK20+4qs0pzxio7yba2KoNcHccH9arcm56swCMF7mnAny3IA9OlOm+/wAjjHX1qMt5bL+eK57n0K1IyMxkucEdKaSxGT09KkuJPNbcBjPakIPln8qgq5XI4/HmmsCqFj17YpRnIFErHGCP/r0FEaHpnmllfnjpTAScA9BTWyGwRSGPDfMMDJpsgJAHalQ5fGcH1pjE7vpTBCge/HrT3PApoODzjFOkI+XtTExRzg/yoJ59u1NUgHngetKx2+nsaRI2TOBzmo2OT7U52yOCKYSEzk5pMtAWUDA6+9PDkjk0zaHHB5FL0TBpoZKBxyw/xpjEE4GaRen+NNAIJB496BWEyN2DkmmrkMSTgCnbgrZXGaeGGGMgXPQZpoq4wLNcPlRuI4I6VOD5cP71AXB4NReeYoSEIJ9fSoCxYqS5J7gmq2CzZeAK4KgMp796eQCOcYNU4mcFgOD6k0jPjnd1NArFxlUKCp5pvmAEAkkjtVKN268nmrJfK4wAx6tRvqO1hGba2eh9KbuJ3bmBHTk9KUom0/Ng+tJ9n837pBHc0hpoTzeQIyN397rVoTEIRtBYd+lRQWpD4Vd2Tx9abczZkYMvl7eCM5zRsFk3ZFlZ1fgR/vOwzUUk43HjY3oaqqzFh65yCKsPIB99cnux70XDlsxPMZhluP5UK655xSLjb325yaV4QvzA/KfWgqyLBb5R/FTVfacDGDUG8qfl71YjZWUEnmjclxsPWRqkEoOQx+lQZB4zj2qMnDADt1qSeW5bDjinK4249aqhuGxTkk6HNILE/Pejrz3pY5lCkNyPT0qNm54waXoSOVsfQ0u7I55pgI2+9C8HrRYCQcnkUhoBx0p2QRS2Exo4+lTBuMCoKcrc89KloholNKpGcGmqfelb1HFTsTKN1YmQ81OvuearRnPTNTL+daJnmTjyuxMKcPypg/OnA+9MzHjFSKfSogT1qQdaAJ0PSrMZqohwanQ80wL8bEVciNZ8R6VbjNAiaboeayb3vWpIeKy7wcHNaIRzOpHAOa5HVGxu45rr9T43ZrjNYJAPStYmUjlNSm2uRk1kvcfN1qfWJCGPPFYLz/N3rR6ER1Poqbcx34GTTBCzMuepqa6jIAK/Kg61FM65QA/Ljk965H5n0S8hk+1MKo+buc0dFxzk0j7RkIM89TSBkY96SZVtCEkqTjAFNmPGKXgN/WmsSTxQVYjxg5PSkJ9PWnHuG6U1U3ZpIoaThifypMdyc570rYDe31pOnTGKAGN97+opdwAA645obOOcAVH7EcUXAmLEmkOOeOaYrY4NKPfpTCwoGTkVEVy1TFxgY69/eoSeTj8qWgIenfjFNY45796QEswwQozgn0prfLI67gxB6jpQUPLdDziljJJApm7ChQc89PSnqVQZ/iNNCH4GGLA9e1RttIJGB2HNIzEtjnHYU0gA9OO9WCGbTtJOaYMkAH8KnJ3KVAOB0FRqMEHt2pItMlCggcc4oZS2FPWnE8cj8KepLAISMHocU9xDI1CI2G5PY9aRSW4IP1qx9nUNgEM5GcU6BYwfmzkdeKYXICmOGySRUsUe1AWGOeasptdwI0LEnio75FRFAmDMAS2Og9qCU+gySVCRlmU/7PekkMGB+7csPvFjgVUjO4YbPBp+SSQeUpal8pKssW8lYmDdgOlQuHODgkeppMY5Q8n9KuwRgrukYLGO54BNFmx6R1I7dGKDcMZq0I41TD5XHpyKS5WSIAH+Lnj0quqt3OB70E/FqSFUKnb0HX1pgiCnIGVNKU45wfehZF7Z3dwaTGSMmRkDJpPvMVYAsOfeo2mJPHGepqJdxOM5OeD60gsWQgBPOM1Gww/HShWJOG+9TmYZ5XilYkUDqSODSkgY9KRWyPmH4elPVfTGKVhXFjYA4bP19Kd/F7dqiAP4inZIosJok47inDFRc8HFOU1ImSEc5pmMHjJqSmnt0osQCtnjpU2M9ulVwdp5qYNnpUWEKh2tjNWVPv8AhVQnBHap424pxOPEQ6lgHpUgqFDx1qQGqRxjx2x1p6nmox9aeDzTETKeamQ4NV19qmQ0wLkZOatxGqMZ5q1EaBFt+VzWdeDg1fBytUrscHiqQjl9TXrXF6ypw1d3qa8GuN1ePg+lbQMpnnOsoSWz0rAZee9dZq8f3uK5uRMORW6Rkn3Poy7R3RWYjaB2qicMw28LU9y5bahJ3Y6dqYhSNTnrXFdNn0sVZDZQVQA9KaEHl5xihm3EFj8o709pV2YTknrSK1KykqckZz0JpAMtnPPtUgUsenTtTcbWyKRVyI/Ox7YHSlG1OwOaV+p2jk96bgYOaAI2XrmmkYT6VLt6nBz6UyQAEDFAyFmBHPJoDcdcU9toGOKYFyeOlIYwg5ofcF60/OCRjrQMk8g49KB3IskGg/L0HPvTpsbu1NBCnNAx0mFAGcMRmougO3FK53k44+tC4465xVBawgb2+b370quWznA+lKVOQx5pTgg5wDTSDQEXoCacwII9KFzgHOB3PapGjAXdvXb65piejGKfmwKdlWYgLx6mjmP7i5PbNPWKVhukG09cetNLsBZt4baeJyXCOgyRnr9KZiNVYwgsvTcwxUJwWA4DDselIvmBjnpnt0FUFrdR6LtILE7hzSoGmY8nr19aRA2ckE5FPiQgksCD3FCQMewjRDgYOMZzVF13Fjuq8VDFtoJH8qJbVAykZ2kfkaLXBNIgt/LKqJwVGeWxnIqUPCzkBGKA8CmzxlMKfudA1ESshyrMp9RQPfUf59vG+4R+Z7dhSTXck2MqAg/h7VEsa78MCRSthTwfoR3od2KyvcWN5UGA/wCHXAqYuuwluueKiLHZswvucc0vbkDFIBzvvA4AHt3pjrnjjPpT1OBtABB56c0EDrS3HchYYGV4PegtvX37VKVLnAGSajlHAGOR1qfQaYqS78GVQzL0PQ/jUhkDnDLz7Diq6EhhxnHGDTucnrmkDSuS/KGAGR7U/cVPynGahUqfrTg+V57UEslDEv7mpMZGD1qANn2qWN+Peglj9uDxz7UhGKcTuowWFJkjQ3ZqXJpjAhuKM80gaHNxj1pyHimk5FNzz9Kl6kk7cilhfBx3qIPSrw1TsZ1I3iX0NPB59KhRsVKDxVnlSVmSg05Tx9KjU96cDzzTETKfepkIqBT6ipUx2poRajParMben61TjNWozzQBdU8VXuR8pqWI8U2ccVSEc/qS5Vs1yOqx8HHWu1vlyCK5XU4/velbRIkefavHktmuVnjxK3NdtrEfXjn0rlLhP3proitDm1ue4SOTJvHJI/Koynft3NPOGUkD86M5XA7dTXnn1K02I5WzEEUYXv6mmodvA609geKaV74xQUKueQo5PUntSOqiMjILZ60uOPl/E1Fn5jycUCsK5AiG3rTFXjJ6UrZzwuB71Hu3DAzQ2Ow5nB4AxUDnP0qQ4wB1NRPhSOxNIaQ0r6DrSnrhqUH5sClCjPPIpjIzz0NKGOecU5hjODUbA4obAQ4zUec/LgAZpz5BBo2nIzQNCBSfu09QMHnp3qeNMtzxUchRWwBTFfoNZcLnHFNA6549TQZcHGMj0pgkY5BAwelCZVmTu6GLyhuDY544quYxkAc0oZVGCCKdwegJPbNVYErDUB7ZxUxubgKEEnyjpTRO4jZQq5PU45pFBBweTTG/MciDGT97vTk3Rk7M474p3lFWyTjHfOaa2Qd3IzTWgr3LluNyYwadLH8yk8YODUEJKx8H5quI4Me7aN2ckk9apPoZy0Yj4CjAG5ec45pwUvtEsvDDGVHT2xSshdc4ySeiio0Ql93JQdVHWmybjzHGx2s25V4GOv1xTWRQApI9sHt60qRKXIXdkKSfr71YiTzFAQDcPbrVJibKhUFSNu7+6cdagljZV3eWACeMVdfgEAqq5qPDbOqhc9M1LKUiEJ5iBipz0z2phxtOB04qyUbPJVmPNMkj2lgRjjjFSNS1KucYIzQXwOTzTnU4Ix+NM2YqLFp3FV8HIbHtTW+Zic/nTeSB2AoJIbIOCRSBCA46n8aVuMcU3nPP5UFsYFJlDunI/GgOQD0waaeMfkaQg4OBQBYjGQ3IGBmlQk8iq6Eg8+lORiORSuS0W1bB55p8bjNVd+f/ANdLuwR6UrkuJafqO9Jjimq+RxTl6UybDAccGlB2nikcHr0phPvSCwobmng8e9QE4NSq2RwKzaJZcgbI461ZWs+3cg4xV1Tx61UXoeZXhyyJgeKeDxUaninA9KowJl7VMpquvT2qVD607iLKHkVZjNVUNWIvamBdjp0v3c1HEfepW+7TQjIvRkHiuY1NR83p/KusvBwa5jVB1xzWkWTJHD6un3q5K5UeaeM/jXaauuM+lcjcj98ev4V0QOWSsewFwUCgfjTC2CVU8etNyFXtzTVJBrgPq0iVemcjFDFc/wCyajGW4xSkhGBIyfSmIcxBOeiioHJzwODT5GJ7celRBs/IPvH1oGgkLE8tzjFN3Z4HP4USjEmBzSDC855pXGKqgfWonVhISXyvYY6VKeQOmDTWICigEMHAOPxp/HHYUzcc4X8acFoTHcTAA9fWmcZ4JqTBJIxUbq2BjFAIQLvJ28kVLGmT7ikjToRnnrVhVAb/ADzVCZHJ8o579qpk5Y55q1MTnGelV265fj6UhxIzjcSQPQU0t8+3j/CnfxHAwPekZcHNCLQg6jNKQe/Ap4HIzjBqQrxxVCuQoDnOSTT9uOO1OyMDGOPSnLncPT3pgxY0bA54qUxZHGacnzgkdM0+NuqkHPYirRk5WIsEZJ+lTwyKqjPOeMVBdNtGAevFUyzEYJ71DlYhyujdjmXDbDnA5C9qY91EgByckdTWOEJf5d3PTFWIi0YAYBkHY9qfO2Qy3bz+ZLtTIyetSG+iUyBcBl4x61WNy6giFFUA8tjmq20MpHRs5z04o5mid9yytyJJMKffHvVpRjy/MXg8nturNjXkEU+Z2fCplVHTLZxSUu5TZqmBQdyAsGPGf1qBUL7gGPA6nuPSqZupG2lsfKMDAq9HPFMAWcIxHK4/lV8yYKTW5H/G2fQYIqGZRuOB71ZXBPzfhjuabMuQ2OmPSky1MobQCSB3zzSyr8oIz78VNINsYBGcjoKiA4G7PPSpZopEJLbsZIB4ofcjEEYI4NPZeOATULjnHX0NQy07gdzDIP1p6FWibe53j7ox1qNh0weDziiPp05x0oTK3RJhkMZ6kjOOuKcFPAIK1DtIA7DrxUis3ynPTgUmJh+dICfWgnk0wDr1zUjRPHIc+1WEfnr1qkOB7U+J8Ec1VxOJdPPeo2XB9cUqOOhoYjOaNzMjPIzQp9elKT6UwnpxxSaEywjYYY6VdibK8VmA5FXLZjjk1KdmceIjdXLqkcVIPyqFSetSKau5wMlX8jUqmoFzwOtSqfegRaQ9MVZQ96pxnPIq3F1piRciPQVMc7eahi/SrHVeetMRnXfQ1zWpjrXTXg4IFc3qY4bH51cWJnFawPvZFcddEiY4Ars9Z4DAVxV1zM3P6VtFmEo6nrbEZwOlTQIGPPQdahGCfapJGZUCg4yMn3rk2PpX2BwN2Bx7imSABwM0m7AGM7jRIMBcnJHajoNCk4Vuc4qpMTsHl/ez1qc5IO38ajPQDvQxoZgqgHc96cB05pztwMjnFRgnjmhDWo9uvHSkYcjPSlAz6DFJjJoAbs44p+McGgjHFNI6c0CFwQCQcUxRvFDnK4zz6VNDHwNzc0INgUED0ps0mOlTuyqMDg1Ulxxk0wjqRF/mz3PelGM8ilKf3elIBjrimWMHX0FL1Y+9PAAJz3pAuSxGfYUAMxhfegnI680SY7ZB70qY2HPrTSAbu5wOop5Ycqxw1NwAwweRQUV3x096AJ4c8ZHIqfO3BXG7rmq8J6qSQRUhPIwefWqMKjI52zKWkA9SKjU72VVUDHUdae4X+Ln1xToygOIFbzD0qLXM7ly1aPGx0HmA9TS3McbSHYBk9QO1W7Gz4WST7w6qRVm4jVVZo1/eEfKAOta201MHNKWhkJbsR0IA9aY0eCdwwatzzvwHTY3cVO4ijVQ0TKWXILGpsh8zRnRRMSMDP0pZQG42gfTrV6K6MZBVAMUyKFblmBYK3JHvSa7D5nuyhJbFdvO4Edqa8RHX8vWtZLXy1kK7XZPvKfT/ABqGWYfdVF2H+IjODTsHPfYzQ8isCCc1b84GMcEP3B6H6Uht3DfcJJ6UeUwB3DHrmlqi1JDfN8z7o6djU7Wx8hZY8MvQgHkGqzKwIwOlTQvgbSQvcMf60rjcmtiIxlpCMEkelV5IuTtGeK0jcxBVCxsHHVgetVctk4G5evvUuxcajRVETeXnbkevpTQnytwfatG3UFXDSmIEHGRxmnRoJmCtsztPOOuKOpftjM2kg5YDnHNKUIk2nBPseK0HmR1xHBGp75GaqyRAliikLkcUFKpcib5Dh16ckd6iDZAOOKs+Rl25CkDjPequHDMD1qGXFpiK3zMKFbkGkXg80YwfxoNCwjdxzUykEVVBxUqOBjPQ1RDQ5utNyO9PY5NRyDByKCGODYPNTQSbW+tV+DnpSqxBGKhqxjON1Y2I2+WpQeap28m5asr7HrVJ9jy5x5XYmX07VKntUANSqfxFMgtR+4xVuLHFU4utXIqaAuxVY/hxVeLoKsdBTJZn3nANc5qZ68V0t30Nc1qf8VUgZxWtHhv5VxV2P37c4rttaGcmuKuh++bitUyGkmeuWygt25pLht0rAHpwKiWTZilx8pbdg1zXPoba3HDr9O9MyxOeoFIAce9SKjnhQaB6AP8AVs3bpTNoC5Pfil3sRt4AzzUbjeeDQAxmz97p6UqkgZxjmkb7xp0hyFAoGH3+lOA2jkY9qE6c80rHB5NAmRluQRTWYkk45/lSMQDzmm9Wz2oGkSRjJ6ZNWlXJzxx1qsuN2AetWD8q+9NCYSEE8VA/XqKcR0PPvQMevNARVhgxtxTGIxlRU2NqHPBNVyQc8gUyhGbkH2qaJBhWPaq4xnkjFWY5AFYdeOtNeYPTYrnkkMM85yKdAQC3y5yMetPb5C4IxxxRBGZFbH3gMimJ7EQGGzyKsBVK7gKhCnOecVIzAp8vDUrkyY6TblCuMngigEZ5xntVc5z1+tTIcgcZ96SdzGWoOoJz1JqS2jdHMgOwDgtRgY3DrU3M1oqZC4bjHeqRm2aLTLIAoYE8DOepqw7C1T90A5Prniq1g6QbyVSRF4wRk5qG81Yyfu4V2IO561pfQx5NbItreRO+ZkUOegHNRX0ZnClSSR0z29qoxO0xIIXd79TUkkTqmTIVGO1CBx5dhUtJOjDB96l2iHCliWI7dqorO24/vSe2c0u/5ssc0tCrPqaTK8qFgA3949Kp7QgwFJbPIPQin2k4DkEsoPcVeUxyAB2jJ7HvRa5N3Eprb3DKJEOxfrjFRyRzYw+7bnqeQavS2UwDFCcnkf8A1qfA8oUxzY24/Ok13DmM1QOhqRIlmICnDHpuPWnSjLkFdozTUiLPhSPbNRYtsbLZ7dpZgD0PtUZgaNM5Hpwe1XWtLjaSE3qOTg5/GoEUwlWkQhTwMjrQ15CUr9SBg8igOWwOmafFDGzYdzGSpx7ntUsZYOWVMg5GPSozyAGAGOlSVdkbQeUFJcE56D+dJJAyc53A9xUoUcce1PMe3Ib9DRYfMzOKN+HpTZMlskDAGK0HQEA46VC8QbpzU2saRnYouhYAr0pjDnmrRQqTgcVGU3DJ60G8ahAD6+lKDjgVI0TDGRUUgIOKDSLuTK2SKc3TGKgQnOKlDcEUIJIaOKcDj8aY3WjNDMpIt2zgNWhG2Rx1rGU4PWtC1l3Ckt7HDiIdS8p5qZTyagX2qaM/lVHEW4jzVuKqcfOMVchPNNAXoenpVgfdqtFVkH5aYiledD/Oua1McGulu+QevFc5qIyDTQHFayOG75rjbtSZ2IrttXXIbjiuRugPOOQaq5NtT0hB0BNPmI2hR2qE8Dk/hSrnqfxrK59APUkN0qQ3GIzjOTxUKkk4puF2qGP6UA7C4xywOMdqE4PHT1pu/JPpTg3BA5J5+lADDjFK3Uc9KVVLL8o/+vTT0NAyQMOvU1GzZznp3pM/KOlJ1oCwEZb2pQNtID1FOHPX9KLDDcRghRTwxb71BXABFOGCOeKaQhAwGRyaAMjqM0oHGTzUqqSOcYzVJA7DNhwcjjFUWU7uDxmtNzlDxwPWqTriQnGADTa7hFkJQjk9M1d06NHkZX6AZzUEvouSDVqyikaFgrBSepNNbkzloGsuGlQIoHy/5zTLJAWQrhT396W8REjZmbIUbc+tM0uRfNWMtgnge9HUhy9zQdebYyUUgEdaqLyM1e1W2ZSzgHrWbGSDkdKzk9TOLurkzEADFKh6UYzzjIpoVs4B5oS1AnDdqkkCxxIo5YnPFVwjgZPHuavWkRmYM4+VT1rRIh2Wo6RktIfLwzOw3c1RTdNISAB3+lXZpFe4IZHfnrjgVYihiV8ICCR3qkTeyuV7ZNpG4ZIrRS3V1IJ+WohAQamZGKj5yMdMU1czk7ldrCLfwr/hSmyjYDAYEdc1oSAmNJI+cdacdmwyM4Uds07Ec7M6O2CMDjrxRJbAEZUfWtONVmizDIrGlkhfysSDmlYOZmfbSTwcxyMB6HkVNcXr4J8pTnrSsh4FKYtyEcGlqgbT1ZVju4H4lUo3TIqTyYnc+Wyn6HkioZrdSTxg1X+ysOY35/KkXZPZliS3uLZ8oZFXsQaUXEkilZH3+m7tUlrdXMCCORRIn+12olmSRsGDnPUdaduwr9yFXGMSDAPcdqfb3Hlu0bbWibuex9ae1mXOYWU54w3BFPTTbgruJQYP41Fgbj1KrQtkBeV6gjvUbDa3OQRV17eSDaglBJHQ8YqGSB26vmk0NMgxnjH60fMOV4X17mrccZQEnbtx/HjikSa1ztkPHqFOBRoPmKPk7jyRuJ4qCWEKxxgHNbbXVqh/dLuXgZx0qOcROCbaSOV/4lbjP0pOKY1Now2JHDDI9ajliHUcg1qGGOZTgeUR1B6GoLizkiVWRt2eaSTNo1bbmcUz0470i+p61NyST39Khbg89aR0qVwNNPFPI6ECmsc/ShgxFOQetT2r7Hxmq445PWlyQcjrUsynFSVjfjOVFWI/Ws+zk3oMVfj/ACprU8ma5XYtQ9RV2LrVKI5Iq5Fx9apEF2HrVodKqw1ZSmIqXfQ1z2pDhq6O5Hymuf1EdeKY7nHasud1cldJ++Ndlqo6+tctcJ+9Pam2LS52e7eTnoKUHnjpUCnjjpUvPqMdayWp7499vAB+tNk4YdcU0AsMY/OkOSoJ/AUxgc4PGGqWPCqS1MJ7nHHah1dwvHB546UvQQ9ZMKQvGenNRZ69amjZUOWGVHBxUBKmQlfu54pgiRflzkZ9s01ulBwzcdDQxwM47dKEC1G52kD1pyn5uMU1FyelSRrkHIpjH8lTTh05HWmk/KAAacGwCCB9aoARweOvpVpZIwgDqCfUVWVQcHpmlYEEKMVSIdmXpADCqxNvPJJrNmB81gep9K07BI5I5Y3Jx3qhNGqljuJANEiIys7EcMYzjPPpUl08luoWPoRyfSnWyERtMwwg/Op7m4g8pGXlRyxPQ0nsRKd2ZJnLGMAeZj+E9K1Uit0kEzpt+UED3rKF0s8xMShVHC7R1qdBcTNsml2RjkcUCmn6G2kiXkTqv3QOc1jy2TxSkL8wPetaaHytPhe3B8zbnPrTLdvPUb1xJScddTGMrK62M1I32/dO0damjT5Ay9c1rNbBcKAfWp7eyDLuI4FWog6plRWklwwLD8K14tO2xruI5/hq3E0cOBgbscCuV1fVbo6g6RtsCnHFU7RJjzVXZHQS2yGIhQF/pVATQ+YyAncvrWXbandkgM6kdyaV7wSNu2gMOCR3pc1ylRktGbyIhAbqO9QXMgSNnwQF6ZrL07VGtt0bJvUnPWjUdRe7wqoETOcU+ZWEqUuY0rPVo5UeN4yrkcAd6yNQumuCBgqq9vWoI8hgw4IomU+Znsealt2NY04xd0S2l1Lbyb42xkdK0INWm+1q8vzRkYx6Vj9jxyKcrZx7Uk7FSgn0OoF/bSsBu2ueMHirn2fEe5h97pg1x7neNx61JDdSoV+dsDtmrTMHR7M6R4McNux7iohCrE4YCsa8vJ5kGZW2/wB3PSqEcrK3LN9c0pNBGk7bnVpbOCDuOKkMOWx8hYd8VzzahdImxJ221AJ5JcmSZyfrQg9k+50/ksvzCMk+qnIpvnyLhVhbaTk7jwDWFZ3k1nKrI7FP4kJ4NX5NaLgfuQOeee1BLpv1HXjM9yGmUshHO0dqWLE8MkattA6DpkUz+0YSpIEgI+6p5z+NN/tLc+TGu30HFSHK7WsTB41GySPORxzzUDKpXcoIoluiznoVPTjpTopYgMSbgfVaB6rUcn2fySJIv3g6MGxVN4FMjFSB9a1Y7aORf3ckUqYzydrAfSqjxx4JWVSAe9FgUjOmWURMiMSpOdpqsmoPFiOdCADgEdq1HRTn5v8A69UJ4lbO8Z96zlF7o1jJPcdHPHISr4Izwwp8lrGSdrE+nvWPJugkBXLJWtpkq3EqojbXPIye9Sm9mW7x1iQvA6J86EY7mqx6cVp3UjvujcnIODms0ja/zdKqxrTk2tSItSj0pr8HihWGalltF7T5dsm1u/StuM8A1zKMUdWHauhsnDxg596FoediYWdzQi7Vbi6j1qnH+dXIj0qjjLsXFWV6VViPFWl+lAiC56c1hagODW9cdDWJfjiqQzktUHXiuYnQiU4Ga6zUl65rmpwPMNMDoYwSQF5JpSCXK9D0ppZl2svHbilJ+YEDk9azPcuPUHzQpx6UyQFXYZyQaHyuCGOTTlbahON2evtRcZCxy2AKkLcKoBHqKSMYyzEECgtly2MDsKS0GPuCAgjHXrUZ4Uep9KRVJyx6mhzyAB0piHAdu9O5ycHjFJyv1x2pRznHWiwLUenDD1605TknNMQDHPWnRAk+wpoBSABknvSg8EA59eKlKCVBjgr+tMVvKyRww9RT2EmAUgjcCPbFPXDTAdvTvSRSNLICSSa0dLSBXLsCzg9x0qomc5cqHvavAiuuRvHSsl1aSfyzgBTzW1qN7Cg+VjuPGT2rIS3aQgqcoeSRTb10MYyb1ZHI2/C5JQnoKqancIQsQXhew7/Wr2ozRWiHYPmxgZrn4lkkdpepPJx2qGa01fU6fRbSCSBpUXlccelWp7YeaqnG3tVPQbh4AwOMOMEVoSXKltzJuB79xW6SsctRvnLZO218ojLDoazXkCuCowe+O1Sm5WP5cmqrSxj52II9KmT1FCNi9HdjZyCfepkuZQAE4Brn31Bg+1FGB3NNmvZ5EA3hR6CkmaexbNue4ihG95l3Hrz0rmriTzZ2k6kmmScjnk1GhzUt3OinTUdS2OFyAPpTP4iAevNNVvm4oY4HuKGirCDIcH9anz0qIEbQacpJ78UITLCA4pXHyetQxuTkVMgLDFPch6EeOc+vrQExnHTNG5ec9RQr5fkjmkBLGu5SOveo2XHB5qVTtYY71FMdr0CJlxJCRkcc1FJFwCKZHKQTg/hVlWGOQeaaYtmRKpIGRg01Vw3BqfGODzTW29hzQFxMHGKQDAqQdKGBBoAjXjHNOU4PB4pGwDjNISMelJhuTKSetPV8jHeq6sM//WpxYg4pisT7iGPanBsqPaq+/g0+N+aLktEwfnmmSYYc9aazY5pmec5oFYhkXaDgAj0NZh3w3SvHkMOeK12IzUE6Ajd/nFTKKki4ytuSmf7UhkX/AFo5ZT3p9uiTAkgbsVjNI8UwKk4q5ZM0cpckhTyBUXdy7NLQS4Xa5HpUGce1SSyFmcsCCaqtL2OMU2zaOqLAPArV0iXOUJ5FY0ZJHIq1ZSeXcqex4NQzKtDmidZDjirkWMiqNu4Kg5qysoUc1Z5XKzRiPParKsABzWSLkDvSG796ZSpNmhcSrtNY162QfWnyXO4Hmqc0m4mlc1VBsx7+PdmsWW0y5OK6WVN2eM1D9lz6Um2zVYYzNykA+gpQQD1qMkBFB4NIpzz1zQd6LCHeTuJz7U3GWOCcCgriIMKdCrcDHXvQIi3HftFLLlT1GTREmZCTx75pJMbyxPFIbeoqjLBemOtPkwWDKQe1Ro21Mnr0pEPNAiZ+OM/jUipsQlu4qFSeAPWpZ3LkgkEAcYpiGoeDUsbEn2qJB8hpykBOnNNDsWnQRxj+83P0qFgWySc04FnVA3OOntVqOARhZH+6386e5HNyi2kO2LeR1qzxaW+5vvN2oj3bN0mMA5AqlqrSZRieG9DxTbsYO8nYhjP2u5UvyM4xWvdJsTbGAoUZrnxL5H7xGwRUGuatK1utupxK4+Zh2FHNoV7NyaSK15cR3UxLE8GpbTggY+U1Us4EMYcsM56d60IcLkY5xx7URRpLTREkMrQyZjPyk8CtCW7W4ICgJxzWcELFVHQd8VaSEYweh71ormMkt2Me4K5Ef0JquRjnrup0xAcgdqiLYIOaTNIoQ5BqRFLDmmFs84FORsg81K0L6Aygkg/nVRW+cgVYOfWqzf63ApFxLEZAJzUjL8pwM1Ah59KtKmV4obuTLQrKcgj9KnhIxzTFiJBPpRGPmweMUr2E3clXAfNWEcBhzwaqyZD4zT4z04q7kMZP/rT70oI288kU+6XdhhUaLlWFK409CYN37VLKFxnsaqZwozUindEQelITQ1XCv7VbfBhDis5uuO1W4TmJx1xTTE+4+OQVJtHOfTtVQnnNToSwHNO4MenIxSng9KaMg0/kr15FADGGQcUwrUg9KYc0Ahqnmg5HP60HrThk5z0pAMweSaVSQfagdSD+tI5G729cU9xDyT1yaVWJXNJHhl29+1IMq/PTvSYrDzz2pvUc07ofagjH0oJsVZYA2cDPtUtn++glgUD7Qg3Ie+BUmARioAWt51njOHX9aRafQimO+EOzjd0I96yLiZUJZiMjtWhrEoeUSQcRuM49DXL3s5iLeaprOTtuddGLZbstcWW5MMgC46Vtq4IyDz615s86i8DxE8nqK7PSbppUCue1RzWKlBW0O10663wjJyRVzz+1c7p0uJSvStftnFVF6HIqCvcnaY54NMMrHvxUainAeoOao2VNIfuYjIpvPc09VzTtnFBVkhqZqUKMU1Ux2qVV4/8ArUDsciDkjOOalTjqKhHHI6GnqQGxnrU3IuWHyNv93FO3YiY5PtSDGdvXiot2Btx1qiVqTK0YtwMfvCetDFFhI25Y9/SoW6fezzxSFiWA7Utx21FxwB3xmpEiYEuRheKaw/e4FWSxNsF3dD0oSE2+hXT73WpB80hBogG45/nSEgOee9Md+hJGcAg/pSqeOelQg9Qaf0AANFxMtxzRqMOKe0zELxmP0qjkZzgEilV2HynrnNO5DiaMkqunlKNp6mqeovjy4x90DNOgYi4G/HJ5qLU3DSAIPlXinJ3RCWpVcogDyYKr82PWsMO89y8r/wAR6Vcv3LFQOVB6etQ26jOcYzSir6nRHTUswoFAOcZq9AAWGTgVXAGF2jpUy9K0uZS1LpljQ/dzimvKWBC8DvVYnApyOOmaq5HKhHHtUZHHuKe7ccGoQ2Mg1LsaLYa596dDICODxVaZu1RRuQ1SaqN0aBbnnrUE3yuGApyk46UrjK8j6GkydhUOTuHSr8DcVmRHA78VdgcgE4o2ImTO21iB37VAvEnA96WZsgHvUe7kY7UmyFsT3QywIpqAkVO/zQg02MZ44piT0FI3R1EODVlU3DHIqBh8xGeadwTGHkEU6InBHY05hjB7VGp+fj+dIq5G4weantTg89OlNlwO1NRiCAKLg9iYggkUisQePyp0mNobHWot2DyD9apiRMrHqeKnQjjuKpGXAqeFwVzRew2iVl57Ypr8ipDhgODRgbfegkhx1AH4UqjijjODSjg4FF7DGSDByKNufrUpANMGOlMRGDtbPrUhBP0prjByORTh93OaWwxUztwOakEZk+6OfT1pirtwfWpUYoQQeRUkshIwcGo5UzViTlieKaVyMimIx7sFVYEfL1+lYupW63MO9SCen0rqLiLcpBFYdxbRxeZuyA3I9zUSWljpozscbPapb3J8oEjORXRaSyyRxv0ccEVlakshuE2rwec1sWEeyJCp5Hf1rB3vY7Zr3bm1bsFkDc9a6GH50B7Yrm06Z71u6VJvhAz0rRbnJcuKpNOC4Bp+PpTiMVoFxFHpUgHr0pqin0DDHQAigDHGTQW7YxTeTQUkcfH8ygNipAgEinPFU45BtH9atWrLgllJ9PrUaMxd0SmTLEjimb8nA596jL4wCOaXI3ZBI4ouNIeD8xFOA3HnrUS5GGz1qUcOBzk0xMVTiSrDkvGSGUBeaqAgOR3qZRuiIA5ovoJiRyADJPPrTs8jjIqFuAvHWrUeCihjj3oDYJPmfIHX9KeRhR6CogQZWweOlKGweR1poB0YyT7U0MWYkdKk+WPIY9RxUJO1D6Ggm5cg+dk4596pXAAnZAeMk9asWr8njnbgVU2FzluFz8x9Ke4loyhcqVneM5zjNLCvHoRU+o5fUZGIwDjoaainOKtKxpfQljBxTxyaao7U8UMgPrTQ3NOOMc1Hu54oGiQgVXc/PzUm/wBagkbnrSY0MYZJNRp98U6QHNRYO7IpX1NUaKYx7U44KmoIiWA9PWpUXFNmTI0461Ojdu1RFdr+xpwHz9aklslB3A0QpuH0601RzirFtheCazbszNsnCjycHqKYmFPPWlRwWK0YCnmqTuTe2hMpHeq0y5kyBUyketJgbqbYkxqLlcGo9mD0qzgbvWnbM0FKVirMMLUQOOtXJFG3kVWZMHHOKE2UpXFmJ8kbTx61TDsrnPIq/sJQqwqs6belUtRpiHkZFLC+CQaZGSeDQRtfNBXkX0YsvBqQHJwetV7duPrU/Q96ZLQ1wQcUmORUrDPPamY4pgLgHpTSDnFPXnmhhyDQgI8HGaEzkg9KmVetMA2kfWh9xAoKkHt9alTnpSFQRkU6MAjkc1Nweo11yKAOKlUdjSEYagkhkXg+lUby2WQMPatMjI6VGyAnGOKBxdjir20CSlG4HUGrFom1cYrY1GyEnzY+Yd6orHgYAO4Vm463O1VeaNmS8BeO9aWjvhylZa5K4q1ZtsnVug6VJGx064pw6c1BG+UBzUoOfpWqYWHj6Up6dKbnv600nnmgaH/WkJx1ppam5z3pFI4ISbuenY1ajk5ArPicDkjr6VcU5iyMcVBmy0CWba3IzSyAAcHOarxMcj1qxINuCB1FAtmOUErgke1APQj0xUYONu7jNSKwVSOqjvTt1Ex0bjZkYz71ZtjtQkHkcnNZ7NtGFHFTpKfJ2qRyKExNaFjfFPhcbTnORTJGMbbDS6ewXJYZOMCi8R/MD4zmqtoJb2Aghx6HkVde3KwiVug61UYD92GOCOea1mnX7OygjBFC2Jk3pYzUUzSn6VL9hl8sEjgmr2nxxAbmdd/TrWpHZ+cCofcD6HpVqJnKpZ6HOovkSfN0ArKV5ZL9Y0/1Q5YHv9a3vEUQtAIwPm6msDTfMSOW4kX7zYX3qVuaxd48xd1MRtMoRQGxlqgVcHrS5LtuJyadjHTrVXGlZWGnjn0pd2PqaaRg8flS9vSi4CMcCoiecc81IT14xUbdRmkxoUcj096ZIv409SeaV8kYpXsGxEVyMfrTAmT9KkTk4qdY+KQ+awRAAD0p5FCqR0qXYcVW5m2QsM0w8Hnr7VJ0z0zUeTk561nJ2JJB2OafnK5HWoh1/Wn9OKyk7ksdG3zD0q1cf6sEVnqeffNXVPmQ471cWRLcjSXGKsCQMvFZ5TD1JGcHrVodrl1GBPNWSuBnJxVFCM/N0rUj2vbEDpVEyuiqxGeKgdalAw5zxillTk0hrRjrbaUZjzVO5IDnZxUyMYwV9agkXjPXPWqiWlqQ2xDTbT3pbgbZCB2qNfklDUsxJYkUFLcs254HPSrDHp2rNgZgTjtV3dlcmhFtFoDMeR+NNI4HTmmwNkMKDk4Pp0oItqKMA1K6/IDUR681IMlcdqaY2NUAgZ/SiQYbn8aQcEj9Kc2cc0wJEGVIPWkjGD1pqHBp44bipYh2MNmhxmnMOBS5yBSuSRD8qCM0HANBPBz3oHYikjDA5rIu4CjkrnFbYyVPSq9zEHUjijcqEuVmGOCPSpl456UskZViAKSPIPSsrWOi+ht2Um+FfWraGsnT5MMQe/StMHIq0y1qibdx700kYpmcHrSbqY0rD856/lSEnPFM3U0k+n60mOx57bMMfPnirsbnGByO4rLJxJmrkcgIz3qDNovIepBGKsM2NuT2qgrZ5HrU/mEgdeKES0SOSWG49BQGIBx1JpAykHJ57UiZYFV7HrQgJT8wAHUCpI1wVyeoqBHKtyafv+Q4zup+YmTozR8KMr61euZCturg/Oowc1mbyuwdqkaUybkPQcU09CGupYjxcEFjhhVsOrKYxwD8vNULGVYt7MN3YGrJZpGV1HC1SJluXJ9PSK2Em4gj3rS0e6aGMqGGQMj3rPd3ubMgZyp6VPZWFx9picpiIj5qtLXQxk7xtJlHXC9xLNMx4245rOsmlFqIpMbVXj8a6DXYVUxxqN0e7JrDuHzduq8JnAFK1jWDvGw5V4pSMHpT1XjJpG+9QykyKTApi9MUsp5poIGOalsbFcc1CwyeuTT2kH1qNnyeKltCQ9RinHpUKuc4p5BNPmAbnDDmrKuAgNQrHxmlx2zRoJu5YVxU3mjZjiqKYXr1qXqKExNA55571FIehpWzS43DmlJXF5ijnFPHvUaYAxjFTJio5bksbtAPHerNqQOM8UqwlgDUogIIYVS0ZDKlym2U8Go1+9V64i3gdMioDEAQapNDixxwy9OKtWEoGVNVVX5cfpRCSjg000DV0Xp0IbcKTcDinGQMnqarZPNGxKFl6mom5GBSuWzUa8nAouzRFeVc0icrippAM47VAODgUywGA9XI8MuKpMDnNWbd8g+lHUpliFtjEd6mqqD8/NWRyBg0CkhxGVzTozimA5yBSr1piHMAHzzTzypHakYZXPahBmquIYPlapAdue9NIw3JqULuXpUgx0Z3L1FNXj8DTYztbGac5+YHHWkw6jXHJppIHpzTjz1qPPOKlgkOz6dKRuc0gNHXnPNCuFilexHBYdaogjPHetWf5hWbINrZxSZpB9CS1bbMM45rXVsqDWGrYIb3rWhfcgNEXqbw10LHvSEjBwaYG44pCao0sOJ/GjIpmex7UpJHSgZ51c9cjqadbuMYPWluVGSB1qqH2v7VnJGdtDVVuOO9WIzgjn8qz42JwatxtkgngUIhlraCGbIHt3NMU4GCe9NKkswz+NCn5MdxRsLcsSBcgg8Y60RZO4DrmmO+QvGMDipo3G/ITr3NBN9AWNmAPUDrimA7XIHPagOVRsZAJ60sABbeenqKAH4/hU8/zresoUaIbjggdK54yjzgcDjitSxuBuYux2HgH0q4OxlUTsbmnwCMtzhz93PSrv2mVYxuVVPT2qj56rGG6/Q1SvtQV9ioGBzzW1zn5XJ6kms3MiR/PjJOPlrFC/MW6Z5rVvHF1AGjX65qjOmF4qJ6M2horCK/BGaaeW70xCd1TsvyZqUWnYrynioCT2qxIuRzSRRbl6c1LuO+hTYk8ChV44PNXGtScmlhtypwRUhzIggjLHBFXxb/ACZp8UeDV1lATmgyczN2YJxVdvvkVclYDpVcjPNVHQaZC6856H1p6qfXrTmGRT4xxTsPmGlRSEYNSMuQe1MI4ocSb3IpMryDwaW3DGTODUqx7xjH51dgt8Lk0LQluyJoQcVOAOaYowKkiBLfWlYzZGV6gimvGParTpg/Wo3jOeKF5AmU2XbmmgAZyKndSM1DIM1Vikx6cjimgfNSRA4ApxyG5pNWGQzKfTNQgkGr+0EVC8fzcUykyFhuHueDUckYBBHNXFiGBTpLfKZobKUikUytRxHa2AavCLjFUpYystJMqL6FsgEA4Oaki+7ioo1JUfSnxHGRVJj3JRwe9KcZpP4qc4wAemaYiRSNpGM01Tjr0poOe9JKgcbd2Bmi4Ez4K5ogODzThHui4zkVEODzih9xD5BtfIFDH5eKHOcf1pAMr70mOwgOQCMU1xg56ClTvQ3SpBDKQnB4px6Z/nTSeKkBr1SlXPpVx84GagCneMUnqCKRBBq/ZPlMelR3sJVlYdD1ptq22TFC0ZtCV2X+/vQT+dMBo75rXodA7I707I74qPvzTgT2pDOBlAJJNUJsAnjNac6AA4PNZsy5B/pUPQmLRNby7l5PSr8LjA9PWsaBtj9citOGUBcHpU2uRNGhFgltrY46mkB4PNQ71JGzOMU4MNpOMmncixZIxGpJBGaVT+8wO1VmJMa9evanx5SbLcA8Um9RFqBQ7Shu3QZ61ZgVY942nG3vVNTtkPlgE45piTsC/mZIPWqvbclpsIxvJUfeHWpWl8mIqpyaZG6xzAgcN2qWQCUyKBjHIoV7A3rqaelSFxgk8jjnvUSZe6IcEY/WqdlMEjPJyD1q/Delw5KgnoDirTvYzkrN2J4nxKy5+UHGKLkEg/WqfmYk3MCGq6i+au7k0pMl6O5SBKydKmDlvl9aSePDdKbbq4cZ6VCY2+o5lIPIq1p8efxpJoyQKu6bFgCqIctCZbUEc1WmhwxwK1iuB0zUDRgtk0MyUmUkjwc0kvAwKuvHhD6Vn3DbWoSC9ypInzU0xipweM0hI21pYu5CEyDxzQnHtTlbJwPypSCT6UguIg3H3pjpg1IilacyE9ae4XEgA21YjkBGB/Oqy+lMztc9s0C3NBTkZqxCRms9JMcZ5qeCQ5/SpaIZoyYwDTB8woPzRg85qNSQfSlbUlDJlxx0qsw5Aq1J8xyaj2e2astMYicA46090BUY69qUccA1KFyuetDC5XQdQe1RuvPFWNvzHikkjOOBUFJjQOBUxA8v+dNjGVxVgR5TiluK5WjXJqvewcgitCJMHBFOnj3LnFLYpSszPgj+Xk/rUZG2UjqKvRpg47VDcxbWBFMtSuMIG6nkZj96YOD0zQpq0UIuMDPWnNjimg4PSlzwO1CZRYiYDv8AnUcow3H4UiHpikl69qGJbiHJ6elEL5znqOtOGMc1Cp2ykD60Me48HDEdKcSMY65qOQ/OKlVCyFsjioFewym5FIT3FIFLHgZobGwKsRu7Cp7WEsdzCn2sbDcCMqRyKuBdg9Km3UycuhTv4FNu5HVRmsQMQ4PbvWpq05ChAeD1rK6jBol2Nad0rmgpJXNOFV4X+T39KmVqpO52LXUfkYx3ozim96Me9Mo4iRSetUbgYz3rQl61SlGc5FJohFTbzwKmtpDwB1xUbngioUfa2M1LsN6o2YpM4B4qYcktn/8AXWfC2QGH4VcRu/epbMnoS5Pl8YFSqw3oeMdKrKCc9MVKMmIHPSqQiy3y3CFTjPenusbSOGOWfvUMjr5SYyxPU06cbJoyfukZo0IGuxCrjovBqQnBSXJ98VXbatwMNlCM1ZjcNC0RHHY4pIHoJjbMdnQnNaEMyeVg4Hv71lpKqSbXIx0BpZCSy/3fWqTE1fQ1ZIXMPmZDZ7itTS0LQ88tWHbFtvzOQPStTRrpRIy9BVbsxnexauLcFqdHa4wcdKvMquc9atRx/uxUqJi52KTW+Y+e9WLOLYOgqULkVLEvqKd7EtjZBjmom9qszqStRKpoEQENgg1n3ad8Vslfl6VQuUFNaAnqZR6Uz2qxImGNN2e1Wi7kCrhuetTrg4pClPCnjikxXGY+YYqVh8uaNuOakC5ShA2UyMNxmo2XmrbxnvUDrxnvmmNEY61IjGlVMc0u3FDA07Rt6bTzxTXUhiKbYOFbBqxKAWyBSZBXwe4ozVjy9y5qF1xTHccoDKTipEHGD0qOPI+lTR/hSFciI+alKClI+apVXNTYorxjBIFWY+BzUbLg9KcgJBoAbn95U7LmPOaqtkvVlW+XFJoH3I0Tnio7qPgVZH3qS4Hy5oKT1Morg0mecdqsTJg1AwKn+tUjZO5H0NBNITzzR2plkiHGKdKR96olODzT5OgoAVT2HNQSZDhvQ1LGc0y568cUnsC3B26UqkkH+lJtLKOv1FWbeHcPYc1BLdkRRRluccVfhhAA46VJDEoHAqbAHahIylMiChTUV3KIo2LHAAqeQgDJPFc5qV39onCqf3a/rTbsOEXNkErtLMXbvTWHy4zj3py+lKwwvP6Vle+507aDrU9QatAe9Z8TFZMHkVeD/nWkGmjem9LEgoBphfJ460mT2qmaHHzYzVaUDac1YlbP1qux55oMkVJVBGDVN157VffvzVV1BNSaJjrSXa+1jx25rRV+eOD7VikEHIOKvW027GRgik2ZyRpqCeh/CnxHgrgZz1qukgyDnBxUgISRSCOaViCQZaMHPIpx3PGH6/jREU8yTILZ6U2E5DIOfxoshXHMjPACoyR0qax3FsPkHtmiwI3tGxxSSEJdIQSR709ncTfQh8pvNZAMkHg1aiYqgEg5zSkFLzeBhDTblgRu3DBNGwnK+heiOW+Vhx/DVcmS3uN4B2k5qvAXjkyM1JcXL7cvggcmiTVtCOV3Ojsr4OoBbmtu3uFKYJrzgXcm4Mp2gdqv22uNGQsgI+tCqLZmM6D6HepIvrUqvk8HiuTt9YhfGWH4mtS31BCow4xRdMxcGtzdb5lIOMUqICM1mreZXqKkF78vv2qybFuTAOB1qjdL1zUiT7hk80lwwcfrVJC2Mx0+bpQq8U+XHUUin9KaKGlPWgL6dqcSMYpp4NDARkJHFWLdeMVCKsWx555qU1cGR3CYbpVR09q1bnayDjFUXXvTe4JkSRkj0ppWrVvgfeomCE5wM+1Va6C5Ha/e9avsPlBFUAQh4q1FMHGCelITJ4yMc1HKpPNSblXApcjac00F7FdPfrTwcYz0z2qN2Ck+lM3hiPSkwLD81LCRtqu8gCj27U+0bd97pUsZJJSIamkRCOKaI170WC5C2M5pwHy+wqQhc9qeqDFFguQxt83NSSfMoFKYxil2ZBNK3Qd0VXTJ6VXlh56VpKg6ZpHiBFCVilOxhujDPHSkwfWteSDPbiq5twPpTvY1VRGcmd9SkEjpxVj7NhsjpVmC23jGKY3URQhUlqnktWfGMYFXFt1RsVMdip1pEOp2KFrDkHIxirNugTOe9MEwjPGOarzXQTlmVR9akHeRoF0XqevaoHnABYkBB3Nc3qGoS3BKW5Kp3buarhpGQi5kdl7DOaTZrHDt6s0dUv8A7Qwihb93/Ew7mqGBtBHSmqMHp9KmRcjp1qG77m6ioKyBOT1/OiTkY9aUgj6elIT70aCImyOnWrAfI61A3Q4p0Jyo6U4s1pFhTzUg6Dg1GtOrRGpxsnUgdKhY9f8AGpmBPfNQSAjjFDM0Qyc+uKgYgn2qV+mKgf0pajIpOf6UQy7G7YPrQ+KgbAOfSpJZsxvwOuDzVgnfGCOorItJ+Qrc+laET5GMnn0FD00JLYbaRg59qkjbEhGcZGeKrAgp0+YGn7xsz0PrQItROkdyDnIPrUd2xEo4x6UyY7gjjPHUU53EqqTkbaL6WEl1LSsZYdw5x1+lQtlotyjhTSQSkIwXlewpUum2lSoweCKLqxNrPQQTsIjjoKaz+ZGd2c96njgXDNkAY6VUDqpKqDz61L10DToQySEIAACKacvjI4xxU6RbyTjjNR3G9X4Hy1MolpkSrnncVqX+0HtwFRqhl4VSc1XlGcEZIqVcqye5sRa7Oq5Pb3q9aeJGJG8da5QOSwHarqRArTcmtjOVOHVHYxeIIT1OM+9XY9WhdQVb9a86kRicDqO1MW4ljO0kgVUapm8NF7M9MF3G38QqWN1bkEV5xHfTbSQ/StKx1mRcB2Naqae5lLDNbHbsOuCBURYjvWBHrDZ+Y1JJqTZGKTqRZl7ORt+ZUsEoBrnjqJAOaVNUx0pc6HyM6iWYFAM1WeUYIrn5dZ2jg0Qam0w7gGq50L2UjcEuOpxTWuFUckVkvKSM9ce9V5XLIezVLmCga0t2p6EHPpSR3iqcVkafJlikpq5JagtlTxU8zeqKcEtDR+3J/ex9alW+UjG8VliyaTBA96zNQimhbKEg+lV7Sw1TjJ2R0kk4PO4VH9sQfxDP1rnbczyJ8xYH0pqw3Bl4DEZ603MpUV1Z1STh16jPpmrEUhGMVjW0MjJyf1p8olh6bqEyORbG2ZSe+eKVZSfUVgrqEqL8yE49RQ2s4X7uDTTD2T7G+shB61ItzgEVzkWpuVyQcGnnVsD7vFCYeyZ0KXCtyaf546Zrm49YiJxjBobWYwxXbzRzW3D2Mux06Shj71NvI5Nc3barE2MnbV+O73j5XBH1oUiXSaNRnBGKgDLn5hVWS4wvDD86hN7Gv+sdc+tNsSgzScqBkdKYlyI84HNZM2qQKPvlj6Cqk180xCR8A0cxpGlJ7mxcXihiXYKKoHVY2ZlQklR3rKbGSJWJIqMBAQETP9altnRGiluJc3c91KWL7FB4AqKPbvzIzSfXtU2D8xxyf0pu0jnr61NjoVkrJDgcgAAbR6U/aB7/AFojA7inNwMDpRYm4AAYweaeGPXt2pgPt0peuPSixLJGOcYphIFAPy/ShqQhjHuKdAeDUbd+1LC3XimtzSG5aDY6U0vz1qMuPXFNLn0q2zQ5l+/HNQOTT3Pv196iZuOKZBE/Sqz9T6VZcjBqpIwHTpQ7DuRucZ5qBj2706RietVpJOfap0EO8za4INa1nOJV46jrXPu449ven2d0YZQe3Q0xNnVRHJyeQRQh4Kmq0MivGGQ5U9/Sp9wJB6LWYidWO0jOadC2UdTznuaiRirZIwPSlIw4z37UXFYfGwTABz3NTTqv3xkD+dVpQVbcvSpPMZ4dpPA6Cn0F5ontjJMSFwcD7tRGLBJfOO2KjhuGjBCDB6E1caRTCrOPvDFOyaId0yoj7sqCQBxTvPCrsYZIqJGySM0yXKg56U/Qu19BQ6ySbSufrUt1BFs3AgY6gVUjGZAc8d6tXKgAAHrRYHoyGG2jeQZ6Vds4V+0eX2HQ1TVsFcg4rRtsFlKn5+pp8qIm2LdWGZPl7VVutMkWDzMZ56VuK/K55IqaX5lKMPlYUezTMvatHISW0oUHacH2otLdzMAePauq+ykKEIBj/lVG/tvJdXixUumaKtfQryRmIjPB7VIG8pQW5GakuZEktlI+8OtV7j/U5zxio9nYi91qVri5JbCg1JC7Y6ZzUC7WYA/nV6BAAOMikim0lYRLfzO1XUtykW5SQKI9g4zirQcCM56EVXIjOUjMuLpojhulPtn81ODnNZusZcHy89elS6OWjXDnrRdD5dLouNE3mBt+K1rKcMoVjmsO/lZG+TmpYGdYtwOc81GzBq6OliuVQ7c/jTJ41lbP61ztteOZ9rc1qec6YJpp824nBxZbEKKPp6VZHlCLgDNUIJyxzmnNKA39K0TIZIJXVvlHHpUysZF2N3qKORQM44qJ5sPkcVS7j3JLm2kVeMEetUGtO5q8Z5HXAPNNw2Pmwaq2hUW0VY43XG1RjFT7UMJBA3VdgRWjGRzSvDGEz1J9Kdg5zGaBOu3mneQGUkrhqusgXHYe9Wkt4ioIJJNS4l+06mH9l3qdmc1JGJYkxkg57VvRWiZ3bfyqC5S3jJI+/wC9LksUqt9DKHnk8uxFDxKeWbmp2Bz83TtTMDPNTYtMjwqEbR0pctkFeKcV5p6jjGKY7kTIWGT1NPjGzBp+KUgY9qVgv0EI4zSbcDil6U0k8U9hoTPbApx4GaY6/OOtK7jeAc+1DGNZsEE08E9aYfvdehpYm+dgc0gJM8daQnIz3pinhvUGlzxSaJegj49aYrYJpWPFQscMTSKjuSliacOnFQbu1L5voavfc1ZzzngVCx4P6U92Hv8A4VDIcdPzrSxkRS1Uc+pB+lWJGOO1UpeTmpYyGST/APVVaQknuKuLbPKatw6d3IzU3FcxxA79qmjszkE9a3RaBFzjoM0jQ+lS2Lcq2WYjtJ4rQyOmevNVWUgjinxPwQetL1HaxZVmY9M09iSfXHeqwODkHmpoz0yTg8UXuD0JQcgg/rTY225HU9DQMqB3OaanDk0xbhjax9DVyORXAjPbvVfG9DgD60yPIbtx1pp23E9UTXCBJSo+tNmhcw7gOnapJV3MHH3SOfarEbrNGI+69Ku11Yi9jOhU78k8fzqWYjA3daSYGO4246c/WlvVOxJB3qb6FbsgY4JPX3p8cpQ5U4qJmyKBwAcUXW5TVzWsJ3aYFzmtOecsBgdKx9OkTLbzz2q0ku4nnj1rRM5pR1NaNi8QKnkVlzzP57I4IA7mp7ZnTJzke1Wtkc8Zzhqb1M/hepnR252s3XNULqTD7fzrbjRYlYdcVz9+B57EdBzWM7rU0i7sryO0eSOlTWt2VYbqiRlY7SM+1KsQyOeKzUrbltJ7mmZgxDCrySBofc1kxLgA9MdakE5UY9exrTm0Mmrj2t97E9TmnxQlQcU63cselWJm2JyKz5dR8z2ARQFPnPI6UsLKgKkfL2NYl1OxmCqT1xitu1jX7Ll27d6FrsDVkOt44TMCCDnuKt3KjGB27VkQnypiV+6atS3W8cHBqnoNp3J0kVFyuPelhlDNk4xVJGOckVFJKwYYBx3rNPqHKbE8q7cqc+1Vg7ucAVAJvkGeantZFL9hWincLWRPBlGOQfxqySTjNNZQPmBJNIrNniqTIvctBwgAzxVyCMTIDkYrHuH2pk9KW1vwIyM1rFg4tq6Ne7t0MdZ8YdH2gnbTPtxfjPFL5u4DNNtdBK8dzR89li2+1ZMrEuSTUxkYr1zUB5PFS2awVgcs6gHim49OtOzgc0g5PHWpLQdTTvehMChiDRbqO4q88mmMeadnbyaic0xoexAWmsdoFNU5J4zTHOT1qblIlkf5lbA5GOKiyd4yaVug9aUD5QSBk0MtaCEgsf50AYkPHahQN5J6Ypo5ZsZyKTAEbJJzz3oZuhpsfy7yM00H5ee9IQ4t8pFRZ+YZPNKx+f8ACoJZAp5PPpS6lJakrOOartKN2N3Sq8sxY4FRBWPWqckaFSXAHXNV5G47fhT3JbgVPb2byEEjNamDlYz/AC2kb5RV2308nGRWzBYrH/DzVxYdozjmoZLkZcdkq9RTzBjoOK0zGPTpTDGMdDSsK5lSRcHjFVZUI6ZzWvJHzx19+9U5ojnFS0UmZMinNRHI6de9X5Y+uRVSRVHY1NmiwBBX3p0cmARVcYBBz+FSH7wPbFP0DyLIPHBNKx+YdMHiolY7cf1pQeSR1ovZisTxEA89KHbDcHAqIdOKUnKYqgsWC2FxuwMU+2YjcVOWqvCy7fmGRT1/dKWXOM00yGT3cxO0lRkd6WKVZISHwMVDOwkjGeD1qEZVCufpTbEldCPyD29KYCRxnIpd3QGkK4PtS9C0PR9pyKtxXA7/AIVRbAGQaUeuaEJxujUE5A65U1ctX56msOORg3tV22k/eDaTg9quLMpRtobEYWQEg/MKw9Wi8tty8g1stKIo+F+Y1myP9p3LIDk9DSmrmcLp3MZHCtzxnrVuBiX+tV7i3eNyvP4ip4CETd1NY+pq9jWto1x7UlzbIBuAqKynVz94CrNw/wAmMfkatxVjBtpkdqdo5FNuZQ74zSqp8stiqryjJHTFRexS1ZVuI8yZFTRvMq7ckjtSJ+8bINatpApGW5oV2VflWozT4zty4yD3pZ7bEpZScVoK8cabR+OaoXs2xcr1PpVONxRk29CXaFj+bv61VnXcwxUlrIZYSJP1psPEhBwRUONkNIFjIWnrJ5bDFSysAhC1RVXkmwVIWsZNplLXc1ra4LjmrsAJOSMUml2ylPmHNbEFsgG7IraEZMxk0jF1SAtD6Vm20GPlYiuh1eRUToOKwkYuxIrpUbFwk3EJU8sjHSiKUjqafLllxnpUB44FRJdTRK61NDeD0oDiqMbkMBVjqyk073WguWxMckZxxSp8oIwBmkZwBwajL5zk8etFwWo92ApoYcZqMtk460pbnp0pMokJ3HvUb84Ao3Eg+lJuwOPWixS8hTwmD1pq9cnpRI5KjBppPynNBSFPLU7BGB29Kan949aCSWNS+4McTgE+vFRwHCseuTSyHkAUxvkj4NO41sLu2pj1pH4FNzkDvimu3p61DYWEbofT1qleHdIFHUCrbkkgZGBTPJLSbvWl10KTsVooCcH9Kupb5UYwB71PFFgdKsiPjjNOwnJmDbWHIJBrYhgVR0qVEwOlS7cmtUZEapTtuB0qQIadsbFUkSyAqKRl4NTlcCo246igCo8a5qpPGO2K0HwTx2qGZVxyKGhmLMOtUJlyPr6VsyxDnB4rPuIzyB1FZNdzRMzJEwKbG5TIPQ1PMh/CqrdevTipLepaQ8j/ADmn5wR3qlFKVIDHj+VWlOcUCJEYBs05CN7dfaomOH7dKcrdDTQMkA2E/nTix8vbkY9KZuG3jOKD90jPJ6VS0JFDFuCR071LAfnw1QL79e9SHC/MvODmi4mLcJtbI4Aojdc/NzTJZS45+tMU4OaGCWmo6Vst8o4pi8DHSnN1IpgwM0bldCQY/GnxTGKUEdqr9uDQTxTWgnE6S3uYp1AcgGnNEgbcMYHpXNxuyEEGrsN0ejEc1fMmYOnbZl+9VJU3KKzlUliMfgKsEhoW2HrUNuwP+s61m0nsCVkQMPIlyDjv9K0o5VZAWbmiS2jnXsH9u9UprWSPIB4qfh3BtSNZbhCm1TisPUEdZdyg7fWnxblkGc8etXW2yJ81RLVEJcr0MuGR0ZeMc1s295sjHGTVRrYZyO1Iqtux6GnexTsx11dyFsgH+lVZLxiOlXbiPEeACeKzPIYE8VVzSFmi1bXcrsFUda2rOIEDdkmucjl8hiV4qxbak5f73FD1Q5Qb+E6NotgLnnFR2shkmHy/LUllMLmDDde9KWWDjA9qUYpGN+nU0JpPKRSp6+9Pt7sRJlmNY7zl8YOanaIvFnODW2xPL3LdzMLs4FV2tnjYdgeaS1jKnJHAq3c3ClQtVZMe2iKvk5xg00wBMl8fgaeZVUHHWoZJSw5OBSaRauREbWLdqdvpgORjtTZG28A1Bpa5Oz4FNL+nSofM4yOvrS5GOKL3BIlLUBietQhsg/zpFfDUrlJE4fAOTQXOM1BI3XBpC2eKL2KSJQSePXtSuef8KiDYoDZ7n1oGTKcKacrZbJ/Cod+Bt7+tDkKB2qbiJGYMxA6VHI+4gUgYIuBzTEOAzMfpT1sNIeWAOBTWccZ6UwZ5Y9aY3T1qG+gD0yzAd81oJH68VRs13y7jnA5NaQHaiIpDkGB0qQAd6YM96f2FWiWP2Yz6Uq4zinEcZxxTenrWqJ3JAoxR8vSmliR0xSqPUZqmJjCMimkZ4NTEdyKjkH5UWEQEKD0qBwD2FWscfSoHyT8q0gsUJlBJx0qjPCeSvNa8q54NU5l2g4NS1cpGHMm0nrVRwBnIzWrccmqM4BHQCsmupqjPYYzgVJFLkBT1pJMDGelV5ccY60r2HY0Gzj+tG75R6VVgm3YUnmps4PPen5iJEYgdeKlBHr0qsPvdfpT1YA9MelC7MGiUtlhg9ak3lUIHcYqBjjninBwyn8qaYrCj5hzmjoRznNN3EHGKRueTkGgB7t6DmgHjJNNVgR70oPWncNtAyNxz1oI4yKZu7frTgeetABx06e1KoODg03IyfTrzRuxwfzobEWEmKrxSPLyCKqs+DwetKp+XB4FAuU0La52n584+tXhcJJwD9awfM/yaEnZOMjHtS5k0TKnc2TtcngfWlyo+tZtvcHfknirryAAMOQfSpcb6oycbaEwuQqkAGo/tO0hiAR+tZ9xJkk9zUKzsTz096PItUzQudRDDaoODVNrgk9xUiBZRgimT25XoCRTLSitBJHV1GccU62jUgkdareU4I461NG/kkA9/apepa2sjVsZ3hYZBFXZ5fMBPr+lZ0cyvGDnBFT+YWQgdRSuYSV3cmgIByWzVyW62xBVOCaxk3K+T1qZXOTuNXGVhuF3dmpDclEw3OaRpt3INUPNBI5p4f5eTg1fMHJ1LDy471G0uRVZ5Mn3poPJ5pOfQtRLqygDpUcjf/rNRRnJ9qlUgnNJ3Hawi55/kaYWJOOc1IxC5I6VFvAbPek77DRMOlM3cZP4U0uWzzx7VEXJ60N2KSJNxJGe1OkYjjI5qEdKVR70rlEobgDqakUk98H+VQLhQSSakU5PXg0kJkiHuetIzbjk9KaDkbV70yQgLgZzTbF1HOxLcfzpC4OF4piHap9aaGwOR1qb9iiWRsk46D0phbJ55zTWbCgDqadEhkcKO/FS9BIv2CYiLHOTz9KuKDjj/APXSRAKgAGMcVIBkcVoloRcUA9qd9KT6UlVZIC2ASuTimHoOcimB9w6k0hI9TWzFYC2DxUgcjjOahFPQ7eaEFhzHJy2RUZGenNSbtx5pjYLcUCSGHOetNAOc/wAqd7d6aSRQhNEM/XgfjiqjAlshea0M569KifAGe/0otcRlzR55ZeayrlevGK3pge3Ws65Q5ORmoki4sxJlI9MVVdMckEA1pzx5zxVCVcHnpmsmrGxUbrx1qaGfna+PY1E4IHFQuuCOefWmmybGkfmIz1FIXz/KqkM/AWQ5Hapg/wCvX3p2aAseYCmMU4HjAqvnGD60/ODk9KBEh6gjrTlbIIqMsDzmlPbHJHWmIcCN2D1pCTwCaYSGGeKTd0zmkBLu6UmM8U088g0KxpgO6fSpFORyBUBOTzTxnGQ1AA4G/HNBHrSEFhSAsvSlYBGztxSAevFOYkCkzkck0WGABBBBxVoM3lYzn8aqZIHXmpoCdh5NKxMlcjbLHHQUZGe34UMxyR0NIQM9M/hQ0UTQvjlavRzZxuXIrNHtUqswxk81SFKNzReNH5GBTDDGACSMVVEjkDH608P2kORS0Isy4gjZcKP/AK1WreNEQFjz1rMNwAMLgUG5c464pNIOVs0J5U42DFRAjrxVUSFvel3c8k4pX7D5bFksAvFM3k5x0phfjGaFYbjx1p2KWhKQQuc/jSLJnv1qVMHrULjDnj9aVhqzJEOalEg7Gqylcc9aUEHnNNMGiyfm6HiomG04wR6VG0mOO1NJZhxSe40icMNuc03Oc+1MDYA96fuXjA6Uhjic4FBPIqJ3I/HtShiw9KYyTJPQ1KrBVPNV8/N/WnbsdTSsJkwJByf0ppO4knp2qJnJOM4oc7VwtIQpbLYJGKRiM5NRE8jt70bs/e7VLGPZv51oaZHkFz0HArMQGRgo+8xwK34YxFEqDpTiuaQpPoTg+vWnj1NRKRT89q2IJKWmqcdetLk09gsNRgV4py8nGarR/eq3GpI6AVpuU9BxTC5J5pmeMZqXGBjORTWAHIAx609ibkiAFc5pXAx0qAOenQVKWGKL3JYx144qIr71IzA521ERnOelIQvUdAajYcnvUhyB8oGKaqknnApiKjKBkYqrOFGeM1oTqAOKqNGHU0rAjHuFJzxVCWDuelbk0GegFULmIj0rJxNYyMSVME+lVJVPOf0rWuIjznp61QmjC9Km1i73KJGPbNPiuCDhjx/KlkUg8CoJEwKa7CNDdlRnBHtUiknhj0rMimMYwTkelWo5QRkZIpWsItbv4eaerECq5bd/+unK5IxTAl3ZOfXqKdu44zz3qBTg47U4Hkkcine4Mk3ccdqC2MVGTkn2pCx6EGl1AlBBx6UOzKMmmbsDIPFIZNwxT30AlWTI60m7LGoyCoB7Um7kEcHvS2HYmY8c9aUEf/XqLcfXp3oBHrjNPYLEjcHmnwNyecVBk5o3YpIVrkzjDe1JkkcD6UK6lfm6VJmMdRjHv1p21FewwBiBxT1PGSaPOVRhaYZMjmpAmEvXHBpM7jznNQKeTzUqHGMDmhMdrEiqT2FSD5TTVlyacSrDik+4iRGHpUpwV5AJqspwetSZ4PPFAC4wc80pbnjrSB1HPeiSZfSnsMf5mM9qb5u4YzzUbOpA45prP6Y/Ci40TAnPJz9aUsccZxVfcWGM9KkDjaM9fap80UyRTu9qn3LtHQVTD5JpzHGPSjpcTJi2fpSlhtA9agEnqacrZ54obAkGTzT9+Pl4FQeZzz3ppcDp1NAbk4kx3yTTowep/WoVGBuNPLHbgHikDfYcSByf/wBdIWyST0qN2OMevSo2bLBc8Ci3YB5OX9VFKTz7elRlqs2URmYEj5R1z39qgLl/S4dqeYw5PTPYVpIM9DUSAcDpUoO2toqyIbux+MdKcvvTCcnpTxx161QEnApOtNDc05TxTCxDIrKN1LFMSSDkVDKT6nFV2dgDjkiqTsaWuaok3DFRux9cVXtnZsZ6+gq0I2Ye1U7shqxF5h396soSwzyaqMu09Kmgl+XAoSuTJdUTEYBPf2pAu7vQ2BjJpCxBG0HFGxA8RHHakePahOMH1pFYseuKR2+b5jkVROpA4zn3qIRjDY/Kp2YfwjiqkrNyRS2GiOQDBGPyqlKm5SCOKvrjZznOKryLzzzQ0UY88W7OOKzZ48VuXKgZC1mTRHkkZrKSLizKdSO341BIOf1rQkTtVR0IzxmoKKTr+FIpKHKVOy8Yx3qFhyOopolk8UysMEAVPnOCvBrNbjOCc1JFcbMBuhpWFcvbgKfH6etQB1YZUikDEetGvUonY4fj8aUuf/r1Erj/ABo3ZJo8wJ1cY6UhIzkVCHOcUpkOfX6VW4EpbjBpfLLDIqEsCDUiS7VwaQXYISDz+tSAZyRUQYc8cU7cB0FANsUlkzjpTQ3PpSFvmGeRRgdc8UWGSBgelKGznJwPSoVOKcW/yaVxk3y+opRjOB1qEHilzxz0piJg3pj8aVWz0qFSCacWAPpS0CxNkDkcVIGz/wDXqsrLjNOVueOKNgLG8g9+KcGJHWq7AgfzpyPgUrh6EoJ4zxTi428jJqEHJ9aQ4B9KQD1cknjOadnpnrUTNgnaKUSZFA7kxYYoU569KiPIPNAPHtS3ESsx445o3HHJ/Kow4HAP50u8AZ4zRsO4/wB845p27GQOpqEyE4Ap4+71p6B6j91ImScntUZcAYPFPU5OBmpQXJlfP070ryBFHPPpURcKMDqfamjBbJ60EkgJ4PU0meeO9Qlju605FaV1VRz04qXsMntkaZ9qgE989q3baERoFTpUNhbLDHj+I9T6mr6HAxmrirakuQ5cDtin9gaauKkAPWtESOGAKVsmm55IpwODVLQdhoXGeKdnAp3Qc1CRk80DQ8xqQcjHoarvBg5Uirp4XDrUDgg5H5VTQ0ysu+Pk8VaSUsuDndUTOR97kU+KdAaaYS1B4y2OufamhTGw68Vba5VguAARTJB5nOBQ0TfuPj/2jTyVGcDGe1Vh5gHI+tSKpPJ59qrcloaSQaRfmJ4FSOqlTjg1FGcEhsUl2AR1GBjrVcnI5FWxgjkcioyhB571QrlRWVW+vrRKpfPHHqKWZVBJFIspxhVI/GgH3Kk0K8/3qpGMAsK0JAeT3qnNzkdTU2W4JmbcxANgDJNUJY8GtWWJtuc1SnjwuTWTRaZlzrjODx61XcYJ6CrsqcAVXkXjnpU3BlUrhuaY69OancccVE5wKYmMDFTkH8qnWbIw1QHOOetJgD3NGhK0Lef0pwOf/rVRErD3HpU6Sg9Bj3oRfMmWCwB605WAJ7/SoC3B57UqkY44pbDJi2QaUODioQcnBFLjNCY0yTdjJzzQrfgKYSV4xkU5GXvwMUdRj94pVNRtgHJ5pQ23kflQBJk8dKUnPB7UzfkcA0gbn+lCXcEShhxn+dBYUzb7UY59aA6knfPNO2jGD1qINxUgYk0gHooPelztPqBUZJH0p4I60WAe0p6daUN37VCx3HFLkgYPFHW4KxMGweKMk81CCB9TUgb8KQbEq4zzjFNLH+H8qZ1OM0GQIvGaLCuSgHGTQnzHqAO9Qhy+MDilZj0FGgD3fk4pA2D81MVhjHc96XGMHPNAyRc4yelG8ngdPWoyxPA7UIex6UrIZIvXnoKlEhUcHnrUJbAOKYrcHrmkLcnWTByevpS5PUVAOTnNWIInmIxwgPWkARq8jBVyT/nmtqxtlhj9W7mktYVjTCjn9atoM0JX1YmyVMcevvUo49ajQYHT3p4JJ57VoiepKvWpgwAwetRxjnnrTupx61aF1HqMgkGn4x1NNHyjgUoJzzimAhznGOM0pBzxikPXmgnHofrRuMc2W7kmkzgcGmmg4Zehz7VQyKUZXnAqF1GM1O4yOBTDgDIFJlIrZweTg1ctpFUYY5Paq7x5G445psYBZR3NCY2k0X2kAOQfxqSNi3U8VHCkTZ7GmSYViF+lUvMx8iZxg5yCPSoZyM/LmlDHOCPxFRSvhsDnimwQ4S4yKVpGYjGarOVPOakhnVeOKauwaGSq+Mtio42w2CKnmkDL0wRVRtwPTFGzFuT7VKkHFVJwB91cVYiRiOOabLHtPzEH19qe6J6mdKuR92qjRghh1x61ry7QuAeTWZMh3eoqWu4JmXOgBIANUpk646itSZMHPWqMwxnIrJo0uZ8i+9RsM8nirEi555qEqeeTj+VK49yEgZPFNKfMfWpmHHakIzjNHUkr7Tnn8aTgHGOKm2nGaaBz/wDXpCEViDjPHpUiyhuvHaopOCfzqMAsfai4K5a3HH17inK/OCearqCMYPHvTt2Dk/hQUpFgSdiCaaGBOf0qEMR35p2c9TzQVddCXd2zg04knGeagJycA5pd59aVx3JweO/4UueD61CGIPI/ClV/agNyYSFVzSmQ4BFQBuckn6Gnb8e59PSl0AmJOM9+lKCc8moQx9KVWOeMCmFybOCM0u/8PSoQeDk0u/OAO3PNAE4bB4P40o64OfeoVb1pcjGcn8KAJyeRt9KVTgYJ4quJCeBShj3P/wBekwJt4J4FK3Yk/Sog/FISW60gJ9+OEpoJPXGaiRhu9hSljuzimmBLvA/+tQJDnnpUKuME9z2pc88nilvqBOGJ4XpS7sDgVBvznANG7AyKTAlLgHGM0IGJ4GT6UkUTsAQSB61oW8SrzSGJb25bBfv2rThTGABUKAZHGMVZRsDAqktbsbJQeMdqsRnH/wBeoIuasIF71ST6ksenPHSrMagcVFGmOcHNSpnFNIlsk6fdpyjuePU0R44qTgdetUIRunJoAye9Ict+FOzgYPX61TYCjGOe9RFh2z+VOc7unWm4HcmlsNE7KM9c1GwCng0HnoaZu2jn8qq40DZJ45qFjySQaeZCMnB5qJ3LH0pNlIYxyTwcVEwKN6U9mJGDUTv/AHuaV7MpE5O1VYE4PUCrSyxsANpz696yRLwR360+G4aBsj9atST0JcbmmrtGeT9M00MCSTyTVUTNMc5yfensSuP6UXI5QmUYzwKpk7WOPzqR2LZ5qNhv45ouug0ieKUEgE064PHy5JFUGyG6dPenRXBRvm5XpT8iXHqixHcE8ZxilklBT3NU7hwG3KODTlYHBzimm2Q4rcGYEEd/eq0xJztz6VLNhclfXtUZfcuD+dG4kVWwykN0qncR89jV2UEHPrVaUcZ459Kh6lJmbIn1qB1z8pGavyLwSe3aqzoCcDqe9ZtdirlRkxwc00+npU8nHWoW9OcUgGMBjk//AF6jbj7v61IQc9selIADmkiSNV5zRgjnPFPxjntSfgaYAMZPP5005z14pTw3Tn+VL0HHJpXAYozS7T704nFI3Pr+FAajRwTzmkBJGf0NLjnJpSPajoFwBJOCeKdu6Z5+lRlRikAPGMfjQVzdycNx7UFj2qLJHPNLuBGc/WmCZJv7cmgMSc9DTAeex96NxPQ4pMdx4PPNPB596j3cYzS5IPX8qB3JCckYPHc05cdexNQjjPfFO3etJBckLYHHX0pdxIyegqJTnGM0uSTyaSESq2AfU0m5j1pmfSl5PU0mMkJGM0c/gelMX/PFPEZIzQCYdz6etKMZ7k05E4x1NSKoGB0pDSGKjN04q1DEqckZPuaRAOCetSpg0FJIljGR/SrUIPoahhXnP61bT8vehPTUGSKuBuPT0qWNS2MdKYAc+1WIh81VYVx6KV6mp4gSeabGu7r09anCjt2qtiGyZegAOcU4Ln3pqDNSqKpC2FA24p45xTQeOop2c9M1Qh3FRyHinMab1680LsNCJ1yaTp6Ud+TSZ96LDFkfsKiYknkmnA+g5prZbBxipd9yxrFgM/zqNsryeTUhGTjpUb5DY64p3sNEb85J5PrUJHrU8mc8YpMArnPzUmh3sUpeD0pAQ3UHB6U+ZSc96amQccYNG5V9BVcxt3wfSrKS+YMDAwO3Wq7cqFOBUSkxev4VSdtCWrl2VSoz+PSq7k+m0jmpFnBUhqhk3Nk9PSqsQMbII2nPvTWBB96epwct+tMY8c96AIZGdWIPQ/pSwyDkNwO1NbkEmoS2GODTTE1cvO4Yc1VkO0njmljckcmmSn5TQ3cx20I3lzULOASCf/rVHI2BjFQM3BPNTzFJEkq5H+FQMvNTqVYHOd1ROx5GaTQ0V5V4OP8A9dQbT1q04GPXtUDDBJqGtR3I26cCo8AcDrUp/A0xhyOKQmNI5I5pMc49adk/jTeo9BSEIT+dMzngcd81IF4I/Gk28/0p37BsMxz60oHPtTu3oaaTz0xSt3ADj60Z5P060nbPU0Z9cUdRBnGaQnkEYFITyDTGJxwOlAhxbPHeomJ65oLY9P51HI/Oadrg2OLnp0+lRPcMnIJqCSbI/GogdxqkhXfQtreSbui/iKsJdMRgqKpxJ9SKsqg4NDGmyyk5PbmpA+fpUEa/N/SpUGM1OhdyVW/L2pcAGmgdeKkUZFQ+wxQCAMUq84PWhRgY5xUi+pxip1HYcOAeKcuSab165NSL7GnsUCjB/CnqMnjv7Uwcmpl44/Ki9lZlD1Hapo075AqNFP4VbReB60BcfGMAVMMgCmRj16VPGufrTQEsakgdsVYUAYFRooUHPb1qVPpVEliIc/zqbHbimIMAfzqUGqRA9Dt649qcM/hQgGc04ADPaqTdhXFHvStwMjpTN3pSZ544NACg5NLj5cZyabnp0pM478UbDFIHTHNRsADShvXg0EZ65pPUY8dD9KYx4ooqlsWIn3TTcDJooqUBG33vwqJPv0UU30KZFc9TVc9R9RRRSGSD7o+tMm+8tFFOWxIkn3hTmJwOaKKqPUkjPf6VC/3hRRSERt1NVpP60UUS2GhY+lOlJyee1FFN7GUtyk/f61FJ9z8aKKnoMjX75pz/ANaKKobGSdD9agHJNFFR9oFsBA5+pqFvu0UUmKXUTHyinIBgcUUVK3AYfvGj+JqKKESyM9RTOxooolsHQVu1I3f6UUUnugGt2pknU0UU0SiE9KrzfcFFFXHdh0Kz8Px6VMooopklten4VYWiikzTsPH+ranL1NFFZyL6kq9KcnWiijsCHjrjtTu1FFR3LZKv3vwpR9+iimthjx0FSRdKKKOpSLUP3TVhOlFFJ7CZZUcVPB96iitY7C6kg++alj++KKKTDoXE6fjT17/WiiqWxkWYuhpD0NFFWhDR/SmP0ooqZDjuKelHc0UVUSkRj7wqQ0UVMQP/2Q==);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Periungual Bowen disease (squamous cell carcinoma in situ)",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 354px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: The Dermatology Online Atlas, www.dermis.net. Copyright &copy; 2012. All rights reserved.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 488px\">",
"   <div class=\"ttl\">",
"    Periungual Bowen disease (squamous cell carcinoma in situ)",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 468px; height: 504px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: The Dermatology Online Atlas, www.dermis.net. Copyright &copy; 2012. All rights reserved.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f39_19_40250=[""].join("\n");
var outline_f39_19_40250=null;
var title_f39_19_40251="Food poisoning non-GI sxs";
var content_f39_19_40251=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F69368&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F69368&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Major foodborne microbes that usually have non-gastrointestinal manifestations",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Manifestations",
"       </td>",
"       <td class=\"subtitle1\">",
"        Agent of illness",
"       </td>",
"       <td class=\"subtitle1\">",
"        Incubation period",
"       </td>",
"       <td class=\"subtitle1\">",
"        Likely food sources",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"1\" rowspan=\"3\">",
"        Neurologic",
"       </td>",
"       <td>",
"        C. botulinum (botulism)",
"       </td>",
"       <td>",
"        12 to 72 hours",
"       </td>",
"       <td>",
"        Home canned foods, fermented fish, herb-infused oils, bottled garlic, foods held warm for long periods",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Ciguatara toxin",
"       </td>",
"       <td>",
"        2 to 6 hours",
"       </td>",
"       <td>",
"        Large reef fish: grouper, red snapper, amberjack, barracuda",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Scromboid",
"       </td>",
"       <td>",
"        1 min to 3 hours",
"       </td>",
"       <td>",
"        Fish: bluefin, tuna, skipjack, mackerel, marlin, mahi mahi",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"1\" rowspan=\"2\">",
"        Systemic",
"       </td>",
"       <td>",
"        L. monocytogenes (listeriosis)",
"       </td>",
"       <td>",
"        2 to 6 weeks",
"       </td>",
"       <td>",
"        Ready to eat deli meats, hot dogs, unpasteurized soft cheese and milk",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        V. vulnificus",
"       </td>",
"       <td>",
"        1 to 7 days",
"       </td>",
"       <td>",
"        Shellfish",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hepatitis",
"       </td>",
"       <td>",
"        Hepatitis A",
"       </td>",
"       <td>",
"        15 to 50 days",
"       </td>",
"       <td>",
"        Shellfish, prepared foods infected by a food handler",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Modified from Centers for Disease Control and Prevention. Diagnosis and management of food borne illness, a primer for physicians. MMWR Recomm Rep 2001; 50(RR-2):1.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f39_19_40251=[""].join("\n");
var outline_f39_19_40251=null;
var title_f39_19_40252="Methods of genetic testing";
var content_f39_19_40252=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F63290&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F63290&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Methods of genetic testing",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tr>",
"      <td class=\"subtitle1_single\">",
"       DNA-based",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle2_single\">",
"       Direct DNA Testing",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Looks for known mutation that causes a condition; requires that the indicated mutation can be identified by testing.",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle2_single\">",
"       Linkage Testing",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       When the conditions for direct DNA testing are not met, linkage testing can infer the presence of a mutation through the study of several family members to identify DNA markers that are co-inherited with the gene of interest.",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle2_single\">",
"       Methylation Studies",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Analyzes the attachment of methyl groups to the DNA molecule of genes in disorders in which methylation patterns influence disease.",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle2_single\">",
"       Protein Trunction Test (PTT)",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Identifies shortened protein product when the mutation that acts by this method, resulting in reduced or absent protein function.",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle2_single\">",
"       Uniparental Disomy (UPD)",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Detection of two copies of the same chromosome pair from one parent and none from the other parent that can result in genetic disease.",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle2_single\">",
"       X Inactivation Studies",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       In general, one of the pair of X-chromosomes is randomly inactivated in each cell and does not reactivate.",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       When in certain condition, X-inactivation is non-random, it can be measured and carrier status of women with a history of these disorders can be predicted on this basis.",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle1_single\">",
"       Cytogenetic",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle2_single\">",
"       Fluorescence In Situ Hybridization (FISH)",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Viewing of a fluorescence-labeled chromosomal probe introduced into the cell nucleus where it attaches to its match within the cell; used to test for missing or additional chromosome material.",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle1_single\">",
"       Biochemical",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle2_single\">",
"       Analyte",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Quantitative analysis of a substance in the body when increased or decreased amounts may be indicative of a genetic disorder.",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle2_single\">",
"       Enzyme Assay",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       An enzyme assay that quantifies enzyme activity in order to assess genetic disease or carrier status of a specific disease related to this reaction.",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle2_single\">",
"       Protein Analysis",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Analysis of protein structure looking for alteration that may result in a disease state.",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle2_single\">",
"       Array Genomic Hybridization (aGH)",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Quantitative analysis of labeled total genomic DNA to a microarray (DNA chip) to detect submicroscopic deletions and duplications.",
"      </td>",
"     </tr>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from GeneTests (www.genetests.org).",
"    </div>",
"    <div class=\"contractual\">",
"     <br/>",
"     <a href=\"file://www.genetests.org\">",
"      file://www.genetests.org",
"     </a>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f39_19_40252=[""].join("\n");
var outline_f39_19_40252=null;
var title_f39_19_40253="Classification parkinsonism";
var content_f39_19_40253=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEURO%2F80669&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEURO%2F80669&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Etiologic classification of parkinsonism",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tr>",
"      <td class=\"subtitle1_single\">",
"       I. Parkinson disease",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Parkinson disease - sporadic",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Parkinson disease - hereditary",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle1_single\">",
"       II. Multisystem degenerations (\"parkinsonism plus\")",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Progressive supranuclear palsy",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Multiple system atrophy (Shy-Drager syndrome)",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       MSA-P (Striatonigral degeneration)",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       MSA-C (Olivopontocerebellar atrophy)",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Lytico-Bodig or parkinsonism-dementia-ALS complex of Guam",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Corticobasal degeneration",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Progressive pallidal atrophy",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Parkinsonism-dementia complex",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Pallidopyramidal disease",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle1_single\">",
"       III. Heredodegenerative parkinsonism",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Dopa-responsive dystonia",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Huntington disease",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Wilson disease",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Hereditary ceruloplasmin deficiency",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Neurodegeneration with brain iron accumulation (NBIA), including pantothenate kinase-associated neurodegeneration (also known as Hallervorden-Spatz disease), infantile neuroaxonal dystrophy, neuroferritinopathy, and aceruloplasminemia",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Olivopontocerebellar and spinocerebellar atrophies including Machado-Joseph disease",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Frontotemporal dementia with parkinsonism",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Gerstmann-Straussler-Scheinker disease disease",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Familial progressive subcortical gliosis",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Lubag (X-linked dystonia-parkinsonism)",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Familial basal ganglia calcification",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Mitochondrial cytopathies with striatal necrosis",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Ceroid lipofuscinosis",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Familial parkinsonism with peripheral neuropathy",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Parkinsonian-pyramidal syndrome",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Neuroacanthocytosis",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Hereditary hemochromatosis",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Neuroferritinopathy",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Aceruloplasminemia",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle1_single\">",
"       IV. Secondary (acquired, symptomatic) parkinsonism",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle2_single\">",
"       Infectious",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Postencephalitic",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Acquired immunodeficiency syndrome",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Subacute sclerosing panencephalitis",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Creutzfeldt-Jakob disease",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Prion diseases",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle2_single\">",
"       Drugs",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Dopamine receptor blocking drugs (antipsychotic, antiemetic drugs)",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Reserpine",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Tetrabenazine",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       &alpha;-methyldopa",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Lithium",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Flunarizine",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Cinnarizine",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle2_single\">",
"       Toxins",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       MPTP",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Carbon monoxide",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Manganese",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Mercury",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Carbon disulfide",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Cyanide",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Methanol",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Ethanol",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle2_single\">",
"       Vascular",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Multi-infarct",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Binswanger disease",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle2_single\">",
"       Trauma",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Pugilistic encephalopathy disease",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle2_single\">",
"       Other",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Parathyroid abnormalities",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Hypothyroidism",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Hepatocerebral degeneration",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Brain tumor",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Paraneoplastic",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Normal pressure hydrocephalus",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Noncommunicating hydrocephalus",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Syringomesencephalia",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Hemiatrophy-hemiparkinsonism",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Peripherally induced tremor and parkinsonism, and psychogenic",
"      </td>",
"     </tr>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Modified from: Jankovic, J, Lang, AE. Movement disorders: Diagnosis and Assessment. In: Bradley, WG, Daroff, RB, Fenichel, GM, Jankovic, J, eds. Neurology in Clinical Practice, 5th Edition, Butterworth-Heinemann, Philadelphia, PA, 2007. Copyright &copy;2007 Elsevier.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f39_19_40253=[""].join("\n");
var outline_f39_19_40253=null;
var title_f39_19_40254="Causes of coma";
var content_f39_19_40254=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEURO%2F65571&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEURO%2F65571&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Causes of coma",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\" class=\"container\">",
"     <tbody>",
"      <tr>",
"       <td class=\"container\">",
"        <table cellspacing=\"0\">",
"         <tbody>",
"          <tr>",
"           <td class=\"subtitle1_single\">",
"            I. Symmetrical, nonstructural",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"subtitle2_single\">",
"            Toxins",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Lead",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Thallium",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Mushrooms",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Cyanide",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Methanol",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Ethylene glycol",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Carbon monoxide",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"subtitle2_single\">",
"            Drugs",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Sedatives",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Barbiturates*",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Other hypnotics",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Tranquilizers",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Bromides",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Alcohol",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Opiates",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Paraldehyde",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Salicylate",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Psychotropics",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Anticholinergics",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Amphetamines",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Lithium",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Phencylidine",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Monoamine oxidase inhibitors",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"subtitle2_single\">",
"            Metabolic",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Hypoxia",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Hypercapnia",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Hypernatremia*",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Hypoglycemia*",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Hypergylcemic nonketotic coma",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Diabetic ketoacidosis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Lactic acidosis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Hypercalcemia",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Hypocalcemia",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Hypermagnesemia",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Hyperthermia",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Hypothermia",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Reye's encephalopathy",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Aminoacidemia",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Wernicke's encephalopathy",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Porphyria",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Hepatic encephalopathy*",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Uremia",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Dialysis encephalopathy",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Addisonian crisis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Hypothyroidism",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"subtitle2_single\">",
"            Infections",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Bacterial meningitis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Viral encephalitis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Postinfectious encephalomyelitis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Syphilis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Sepsis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Typhoid fever",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Malaria",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Waterhouse-Friderichsen syndrome",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"subtitle2_single\">",
"            Psychiatric",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Catatonia",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"subtitle2_single\">",
"            Other",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Postictal seizure*",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Diffuse ischemia (myocardial infarction, heart failure, arrhythmia)",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Hypotension",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Fat embolism*",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Hypertensive encephalopathy",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Hypothyroidism",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Nonconvulsive status epilepticus",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Heat stroke",
"           </td>",
"          </tr>",
"         </tbody>",
"        </table>",
"       </td>",
"       <td class=\"container\">",
"        <table cellspacing=\"0\">",
"         <tbody>",
"          <tr>",
"           <td class=\"subtitle1_single\">",
"            II. Symmetrical, structural",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"subtitle2_single\">",
"            Supratentorial",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Bilateral internal carotid occlusion",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Bilateral anterior cerebral artery occlusion",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Sagittal sinus thrombosis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Subarachnoid hemorrhage",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Thalamic hemorrhage*",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Trauma-contusion, concussion*",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Hydrocephalus",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"subtitle2_single\">",
"            Infratentorial",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Basilar occlusion*",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Midline brainstem tumor",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Pontine hemorrhage*",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Central pontine myelinolysis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"subtitle1_single\">",
"            III. Asymmetrical, structural",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"subtitle2_single\">",
"            Supratentorial",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Thrombotic thrombocytopenic purpura&bull;",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Disseminated intravascular coagulation",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Nonbacterial thrombotic endocarditis (marantic endocarditis)",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Subacute bacterial endocarditis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Fat emboli",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Unilateral hemispheric mass (tumor, abscess, bleed) with herniation",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Subdural hemorrhage bilateral",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Intracerebral bleed",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Pituitary apoplexy&bull;",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Massive or bilateral supratentorial infarction",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Multifocal leukoencephalopathy",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Creutzfeldt-Jakob disease",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Adrenal leukodystrophy",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Cerebral vasculitis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Cerebral abscess",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Subdural empyema",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Thrombophlebitis&bull;",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Multiple sclerosis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Leukoencephalopathy associated with chemotherapy",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Acute disseminated encephalomyelitis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"subtitle2_single\">",
"            Infratentorial",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Brainstem infarction",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Brainstem hemorrhage",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Brainstem thrombencephalitis",
"           </td>",
"          </tr>",
"         </tbody>",
"        </table>",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * Relatively common asymmetrical presentation.",
"     <br>",
"      &bull; Relatively symmetrical presentation.",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Berger, Joseph R. Clinical Approach to Stupor and Coma. In: Neurology in Clinical Practice: Principles of diagnosis and Management, 4th ed, Bradley, WG, Daroff, RB, Fenichel, GM, Jankovic, J (Eds), Butterworth Heinmann, Philadelphia, PA 2004. p.46. Copyright &copy; 2004 Elsevier.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f39_19_40254=[""].join("\n");
var outline_f39_19_40254=null;
var title_f39_19_40255="MTB in sputum";
var content_f39_19_40255=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F75210&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F75210&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Mycobacterium tuberculosis in sputum",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 356px; height: 240px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Acid- fast stain of the same sputum (x1000). With this stain, the inflammatory cells appear blue and mycobacteria are red, thin, beaded rods.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Harriet Provine.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f39_19_40255=[""].join("\n");
var outline_f39_19_40255=null;
